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ABSTRACT 
Toxoplasma gondii is an intracellular protozoan parasite that infects warm blooded 
animals the world over.  In the host, the parasite exists as either rapidly growing tachyzoites 
or immunologically protected slowly dividing bradyzoites.  While tachyzoites are generally 
cleared by the host’s immune system, bradyzoites persist for life.  If the immune system 
becomes compromised, bradyzoites reconvert to tachyzoites and cause severe illness.  
Bradyzoites develop in response to stressful stimuli, therefore discovering factors that 
modulate bradyzoite conversion as well as determining how Toxoplasma’s stress response 
pathways operate are essential to understanding parasite disease.  In this work, the plant 
alkaloid securinine as well as ten pyrrolidine derivatives were shown to have in vitro anti-
Toxoplasma activity in the micromolar range.  These compounds act in different capacities, 
either restricting parasite’s invasion or by reducing the parasite’s rate of replication.  One 
of the hallmarks of the bradyzoite life stage is slowed replication.  When tested, only 
securinine induced bradyzoite formation at comparable levels to treatment with alkaline 
media, suggesting that it initiates a stressful stimulus. 
When in the bradyzoite stage, Toxoplasma induces a global translational repression 
allowing for the remodeling of the transcriptome.  However it remains unclear how certain 
transcripts are maintained throughout the long term translational repression seen in 
bradyzoites.  Analysis of one such transcript, lactate dehydrogenase 1, showed a 40 
nucleotide cis-acting element with its 5’UTR responsible for this activity.  The formation 
of 16 nucleotide regulatory RNA hairpin is necessary for inducing sustained translational 
repression in bradyzoites, suggesting that it acts as a recognizable feature.  Characterization 
of the transcript reveals that its poly(A) tail does not shorten in bradyzoites, indicating that 
vi 
 
it is likely targeted for long term storage instead of degraded under stress.  Efforts were 
made to capture and analyse the protein complement interacting with the cis-acting element 
using RNA aptamer technologies, however they were unfruitful.  Using extracellular 
parasites, it was determined that a rapid induction of stress is insufficient to selectively 
repress the transcript.  This suggests that the reprogramming of the proteome may be 
necessary for the sustained translational repression of lactate dehydrogenase 1 in 
Toxoplasma bradyzoites.  
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CHAPTER I – General introduction 
 Discovery of Toxoplasma gondii 
Toxoplasma gondii is a single-celled protozoan parasite of the phylum Apicomplexa.  
It is the only species within the genus Toxoplasma.  T. gondii was first discovered 
independently in an African rodent in Tunisia and in a rabbit in Brazil (Nicolle and 
Manceaux, 1908; Splendore, 1908).  It derives its name from the Greek “toξo” meaning 
bow-like and the gundi, the animal from which it was first identified (Nicolle and 
Manceaux, 1909).  Since its discovery, T. gondii has been found to be a wide-spread 
parasite capable of infecting virtually any nucleated cell in warm-blooded animals 
including birds and mammals, earning it the title of the world’s most successful parasite 
(Tenter et al., 2000; Turner et al., 2013). 
 Toxoplasma life cycle 
Toxoplasma gondii is an intracellular parasite that spends most phases of its life cycle 
inside the cells of its host.  This life cycle can be subdivided into the sexual and asexual 
phases (Figure 1.1).  In the sexual life cycle, the parasite differentiates through a 
progression of cell types that allow for genetic crossing in its definitive host.  In the asexual 
life cycle, the parasite alternates between two stages and reproduces through a clonal 
division.  
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Figure 1.1 Sexual and asexual life cycles of Toxoplasma gondii. 
Sexual reproduction occurs in the epithelium of the feline’s small intestine.  Cats shed 
oocysts into the environment which are then taken up by warm blooded animals.  This 
causes an acute infection by tachyzoites which differentiate into bradyzoites upon 
induction of the immune response.  Bradyzoites can be ingested through the consumption 
of infected tissues.  Adapted from Black and Boothroyd, 2000. 
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1.2.1 Sexual life cycle 
Members of the family Felidae act as the definitive host of Toxoplasma gondii.  
Parasites are first taken up by the cat by ingesting either tissue cysts from an infected animal 
through predation or sporulated oocysts from the environment (Dubey et al., 1998).  Once 
either of these two forms encounters the feline’s stomach, the cyst wall is dissolved and 
infectious parasites are released which then infect the epithelial lining of the small intestine 
(Dubey et al., 1998).  Differentiation of the parasite into male and female gametocytes 
proceeds and these combine to form oocysts (Dubey et al., 1998).  Oocysts are then released 
from the cat through its feces where sporulation occurs in the environment (Dubey et al., 
1998). The length of this process is complete in about 1 to 5 days depending on ambient 
temperature (Dubey et al., 1998).  This results in the formation of four sporozoites 
contained within the sporulated oocyst (Dubey et al., 1998).  Sporulated oocysts can 
survive for years in the environment (Torrey and Yolken, 2013).  If they happen to be 
ingested by a feline, another round of sexual reproduction can occur, thus completing the 
cycle (Dubey et al., 1998). 
1.2.2 Asexual life cycle 
Ingestion of tissue cysts or sporulated oocysts from the environment can also lead to 
the commencement of asexual reproduction in warm blooded animals (Dubey et al., 1998).  
Any host other than the cat is termed an intermediate host although asexual reproduction 
also occurs in the feline definitive host (Dubey et al., 1998).  Upon reaching the stomach, 
gastric juices serve to digest the cyst wall and release infectious parasites (Dubey et al., 
1998).  These invade the host’s tissues where they differentiate into rapidly growing 
tachyzoites during an acute infection cycle (Dubey et al., 1998).  During this phase of acute 
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infection, tachyzoites can spread throughout the host as well as be vertically transmitted to 
a pregnant host’s offspring (Montoya and Liesenfeld, 2004).  Infection by Toxoplasma 
causes activation of the host’s immune system.  In response to signals generated from the 
immune response, tachyzoites differentiate into slow growing bradyzoites which are 
immunologically protected (Skariah et al., 2010).  Bradyzoites are encased in a cyst wall 
and persist for the life of the host in a chronic infection (Dubey et al., 1998).  Bradyzoites 
can re-enter the Toxoplasma life cycle if an infected animal containing tissue cysts is eaten 
through carnivorism (Dubey et al., 1998). 
1.2.3 Distribution, prevalence and transmission in animals 
It is estimated that at any given time, approximately 1% of domestic cats are shedding 
oocysts into the environment at a rate of up to 55 million each a day per animal (Torrey 
and Yolken, 2013).  It has been estimated that on average, there may be as many as 9 to 
434 oocysts per square foot of residential area in the United States of America shed by 
domestic and feral cats alone (Torrey and Yolken, 2013).  This value is assumed to be much 
higher in areas where cats selectively defecate such as sand boxes and gardens (Torrey and 
Yolken, 2013).  Importantly, studies have shown that a single oocyst is capable of causing 
infection in animals (Dubey et al., 1998). 
Toxoplasma is transmitted to animals is through the consumption of sporulated 
oocysts or infected meat.  This most often occurs by eating directly off contaminated soil, 
eating small insects that carry oocysts, drinking contaminated water, or carnivorism (Dubey 
and Jones, 2008).  They can also become infected by ingesting contaminated milk (Dubey 
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and Jones, 2008; Tenter et al., 2000).  Infection among small rodents is particularly 
important as they are direct prey for cats. 
Toxoplasma has been found to chronically infect animals on every continent 
including Antarctica (Jensen et al., 2012; Dubey and Jones, 2008).  Toxoplasma infections 
are not limited to wild animals as the parasite has also been seen in companion animals and 
other animals held in captivity such as farm and zoo animals (Dubey and Jones, 2008).  The 
infection of livestock is particularly of concern to human health because the ingestion of 
contaminated undercooked meat or unpasteurized milk can pass the parasite along 
(Montoya and Liesenfeld, 2004; Dubey and Jones, 2008; Tenter et al., 2000).  Pigs, sheep, 
goats, and chickens are more likely to be infected than cattle and raising these animals in a 
free range environment increases the risk of infection because they are not protected from 
oocysts in the environment (Dubey and Jones, 2008). 
1.2.4 Distribution, prevalence and transmission among humans 
Toxoplasma gondii is one of the most wide-spread human parasites with infections 
noted on every continent.  Around the world it is estimated that approximately one third of 
people are infected with Toxoplasma and nearly 200 000 newborns are infected annually 
(Montoya and Liesenfeld, 2004; Torgerson and Mastroiacovo, 2013).  However, infection 
rates can vary greatly from country to country, even between those that are geographically 
close to one another.  For example, seroprevalence in European countries vary from 7% in 
the United Kingdom to 67% in Yugoslavia (Lafferty, 2006).  In Canada and the United 
States of America, studies have estimated that between 12-25% of people are seropositive 
(Lafferty, 2006; Shuhaiber et al., 2003; Kruszon-Moran and McQuillan, 2005).  Risks of 
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infection include cat ownership and raw meat consumption (Jones et al., 2009).  Sanitary 
conditions have also been shown to be important for controlling Toxoplasma infection.  For 
example in 1995, the world’s most serious Toxoplasma outbreak was recorded in Victoria, 
British Columbia and was attributed to oocyst contamination of the water supply (Mullens, 
1996).  While Toxoplasma infection is usually acquired orally, other methods of 
transmission are also possible.  These include receiving an infected organ during 
transplantation or congenital transmission from pregnant mother to fetus (Montoya and 
Liesenfeld, 2004). 
Multiple Toxoplasma genotypes have been found to infect people across the globe.  
Phylogenetic studies have revealed that most Toxoplasma infections in North Americans 
and Europeans are caused by three main clonal lineages commonly known as types I, II 
and III (Howe and Sibley, 1995).  Many other Toxoplasma genotypes exist as well.  For 
instance, isolates from South America appear to be much more genetically diverse (Khan 
et al., 2006).  The high prevalence of types I, II, and III is likely due to their highly 
successful asexual clonal expansion amongst the population (Khan et al., 2006).  There is 
also a correlation between Toxoplasma type and severity of infection.  Infections with type 
II and III strains are less virulent and more common than infection with type I strains (Khan 
et al., 2006). 
 Toxoplasmosis 
Infection with T. gondii can cause the disease toxoplasmosis.  Infection can be 
divided into acute, latent, and recurrent phases.  The acute phase of infection is caused by 
rapidly growing tachyzoites and is generally considered to have mild to moderate 
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symptoms depending on a variety of parasite and host-related factors.  The latent phase of 
infection is associated with the presence of bradyzoites that persist for the life of host.  
Symptoms are not easily discernible and historically, chronic infection has been considered 
to be asymptomatic in humans.  Immunosuppression followed by the subsequent 
conversion of bradyzoites into tachyzoites is responsible for recurrent toxoplasmosis.  This 
phase has the most severe effects in adults because the infection is already established 
throughout the host and the immune system cannot combat the infection (Montoya and 
Liesenfeld, 2004). 
1.3.1 Acute toxoplasmosis 
Acute toxoplasmosis occurs during the initial infection of the host with the parasite.  
In immunocompetent hosts initial infection with T. gondii is generally benign, however 
mild flu-like symptoms and / or swollen lymph nodes can occur (Montoya and Liesenfeld, 
2004).  Typically, tachyzoites, the causative agents of acute toxoplasmosis, are cleared by 
the immunocompetent host’s immune system (Montoya and Liesenfeld, 2004).  Therefore, 
except in rare cases, these symptoms are usually quickly resolved and leave no lasting 
effects (Montoya and Liesenfeld, 2004).  Factors affecting the severity of symptoms 
include parasite strain and virulence, the number of parasites taken in during initial 
acquisition, as well as the sex, age, and immunological status of the host (Montoya and 
Liesenfeld, 2004). 
Although a rare occurrence in immunocompetent people, severe cases of acute T. 
gondii infection can cause serious disease to the eye.  Ocular toxoplasmosis can cause 
temporary cloudy eyesight when reproducing tachyzoites obstruct the path of light in the 
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eye as well as permanent partial blindness when they destroy localized areas of the retina 
(Mullens, 1996).  While the cloudy vision can clear up once drugs are used to control the 
initial infection, any destruction of retinal tissue results in permanent eyesight impairment 
(Montoya and Liesenfeld, 2004). 
If a woman becomes acutely infected for the first time during pregnancy, the parasite 
can be vertically transmitted to the fetus through the placenta, causing congenital 
toxoplasmosis.  Generally, the earlier in gestation that transmission occurs, the more severe 
effects congenital toxoplasmosis can have on fetal development (Montoya and Liesenfeld, 
2004).  The most severe symptoms include problems associated with eyesight such as 
blindness and many debilitating effects on the brain including enlargement of the skull, 
atrophy of the brain, the presence of brain lesions, and mental retardation (Montoya and 
Liesenfeld, 2004).  In the most severe circumstances, congenital toxoplasmosis can cause 
spontaneous abortion or stillbirth, with this being a leading cause of stillbirth and abortive 
births in sheep (Montoya and Liesenfeld, 2004; Innes et al., 2009). 
In contrast to healthy individuals, previously unexposed patients who receive an 
organ or hematopoietic stem cell transplant from a seropositive donor can suffer severe 
consequences (Tenter et al., 2000).  These include neurological problems and, most 
severely, a multi organ response which can lead to sepsis, a mostly fatal outcome (Vaughan 
and Wenzel, 2013). 
1.3.2 Latent toxoplasmosis 
Latent toxoplasmosis is the term associated the persistent infection of a host with 
Toxoplasma bradyzoites (Montoya and Liesenfeld, 2004).  Once this occurs, infection is 
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incurable and lasts for life.  Virtually any nucleated cell can be infected by the parasite and 
bradyzoites have been found in many different tissues, including skeletal and cardiac 
muscle, as well as eye and brain tissues (Montoya and Liesenfeld, 2004).  Latent 
toxoplasmosis has been traditionally considered asymptomatic and because of this, 
infection rates are under-diagnosed in the population (Montoya and Liesenfeld, 2004; 
Tenter et al., 2000). 
Interestingly, reports have emerged suggesting that latent toxoplasmosis can give rise 
to long-term behavioural and phenotypic changes, thereby challenging the assumption of 
asymptomatic infection (reviewed by Flegr, 2013).  For example, people who test 
seropositive for Toxoplasma have decreased reaction times in standardized testing and 
display a higher rate of work-related or traffic accidents than the average population (Flegr, 
2013).  Furthermore, personality and psychological testing has revealed that infected 
individuals are more likely to characterize themselves as risk takers and are more prone to 
psychological disorders including depression, schizophrenia, and suicidal behaviour (Flegr, 
2013).  Whilst latent toxoplasmosis appears to have nuanced effects on human behaviour, 
the results can be striking in other animals.  For example, chronically infected rats see an 
abolishment of their innate avoidance of preditorial scents (Berdoy et al., 2000).  Instead, 
they display an attraction to the scent of feline urine, effectively increasing their predation 
by the parasite’s definitive host in the wild and thus completing the parasite’s lifecycle 
(House et al., 2011). 
These characteristics and diseases may be associated with alterations in hormone and 
neurotransmitter levels that occur upon long term Toxoplasma infection.  For example, 
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increased testosterone levels are seen in chronically infected men, and increases in γ-
aminobutyric acid (GABA) and dopamine are seen in rodents (Hodková et al., 2007; Fuks 
et al., 2012; Stibbs, 1985).  Notably, these chemicals are linked to the psychiatric issues 
described above and T. gondii possesses the ability to directly increase the levels of these 
neurotransmitters as it encodes the complete pathway for converting glutamate to GABA 
as well as two tyrosine hydroxylases that produce the dopamine precursor L-dopa (MacRae 
et al., 2012; Gaskell et al., 2009).  By altering these chemical levels, the parasite could be 
thought to subtly increase the mortality rate of those infected, potentially increasing 
Toxoplasma’s ability to come in contact with a new host. 
1.3.3 Recurrent toxoplasmosis 
Although recent research is illuminating the ways in which chronic toxoplasmosis 
affects human health, by far the most common and serious pathologies of toxoplasmosis 
are seen when encysted bradyzoites reconvert to tachyzoites in the host.  Referred to as 
recurrent toxoplasmosis, this process can affect any previously infected individual if they 
become immunocompromised.  The immune status of the host can become compromised 
due to illnesses or pharmacological interventions, the most common of which include the 
taking of immunosuppressant drugs following organ transplantation, undergoing 
chemotherapy as a treatment for various cancers, or the development of acquired immune 
deficiency syndrome (AIDS) due to HIV infection (Montoya and Liesenfeld, 2004; Tenter 
et al., 2000). 
Because recurrent toxoplasmosis relies on the reactivation of dormant bradyzoites 
previously disseminated throughout the body, drastic pathologies can emerge following 
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their conversion into tachyzoites.  Common symptoms include ocular complications such 
as retinitis and toxoplasmic encephalitis (Tenter et al., 2000).  Encephalitis occurs when 
reactivated tachyzoites reproduce and lyse infected neurons causing brain lesions and 
necrotic foci in the host (Montoya and Liesenfeld, 2004).  This damage to the central 
nervous system can cause speech abnormalities, motor deficits, seizures, changes in mood, 
psychosis, and is potentially fatal if left untreated (Montoya and Liesenfeld, 2004).  
Toxoplasmic encephalitis occurs in up to 40% of AIDS patients worldwide and, at the turn 
of the millennium, complications arising from Toxoplasma infection accounted for 
approximately 10-30% of the fatal outcomes in seropositive HIV positive individuals 
(Tenter et al., 2000).  Other issues that can arise from the reactivation this opportunistic 
pathogen are the development of skin lesions; toxoplasmic pneumonia; the swelling of 
organs including, but not limited to, the heart, liver, and the gastrointestinal tract; and, a 
disseminated toxoplasmosis leading to sepsis (Lowichik and Ruff, 1995; Tenter et al., 
2000). 
 Prevention and treatment 
Currently, there exists only one Toxoplasma vaccine, a live attenuated parasite strain 
that is defective in cyst formation (Kur et al., 2009).  However, it is only approved for 
veterinary use in sheep, has a limited shelf life, is prohibitively expensive, and has the 
potential to revert to a more virulent phenotype (Kur et al., 2009; Liu et al., 2012).  
Although many attempts have been made, there are no approved vaccines for use in humans 
and therefore efforts to prevent human infection rely on education, public health initiatives, 
and careful hygienic practices (Kur et al., 2009; Montoya and Liesenfeld, 2004; Verma and 
Khanna, 2013). 
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1.4.1 Approved drug regimens 
Toxoplasmosis is usually considered asymptomatic in immune-competent 
individuals and therefore treatment of Toxoplasma infection is limited only to those 
showing signs of acute infection, newly infected pregnant mothers, or preventative 
treatment for seropositive individuals at high risk of recurrent toxoplasmosis (Montoya and 
Liesenfeld, 2004).  Anti-toxoplasmosis drug regimens consist exclusively of the 
administration of multi-drug cocktails (Montoya and Liesenfeld, 2004).  The most 
commonly used is the combination of sulfadiazine and pyrimethamine; alternatively, 
sulfamethoxazole and trimethoprim may also be used (Montoya and Liesenfeld, 2004).  
These drugs inhibit the dihydropteroate synthase (DHPS) activity of the bifunctional 
hydroxymethyldihydropterin pyrophosphokinase-DHPS enzyme and the dihydrofolate 
reductase (DHFR) activity of the bifunctional enzyme DHFR-thymidylate synthase, 
respectively (Aspinall et al., 2002).  Together, these drug combinations act synergistically 
to inhibit de novo synthesis of folinic acid in Toxoplasma (Aspinall et al., 2002; Meneceur 
et al., 2008).  While the DHPS molecular target of sulfonamides is absent in humans, a 
DHFR orthologue does exist and therefore, to minimize toxicity to the host, folinic acid is 
always given in conjunction with pyrimethamine or trimethoprim (Warhurst, 1986; 
Montoya and Liesenfeld, 2004).  Notably, while all animals rely on dietary folates for 
nucleotide synthesis, Toxoplasma is unable to use preformed folates for its metabolic needs, 
making folinic acid supplementation an effective way to minimize host toxicity (Warhurst, 
1986; Aspinall et al., 2002; Montoya and Liesenfeld, 2004). 
Although supplementation with folinic acid is standard practise, the use of 
pyrimethamine in animals has the potential to cause neural tube defects and other issues in 
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the early phases of fetal development (Montoya and Liesenfeld, 2004; Peters et al., 2007).  
Within the first two trimesters, the macrolide spiramycin is alternatively used because it 
achieves high concentrations in the placenta, thereby reducing the potential for fetal 
transmission (Montoya and Liesenfeld, 2004; Halonen and Weiss, 2013).  Another 
common treatment issue arises in individuals who are intolerant or allergic to sulfonamides.  
When this occurs, either the protein synthesis inhibitor clindamycin or the cytochrome b 
inhibitor atovaquone is given in conjunction with pyrimethamine and folinic acid 
(Meneceur et al., 2008; Montoya and Liesenfeld, 2004; Halonen and Weiss, 2013). 
Although the currently used drug regimens are generally effective, concerns have 
arisen regarding the spread of drug insensitivity and resistance.  For example, reports have 
documented the resistance of clinical isolates to sulfonamides from animal and human 
samples collected in the United Kingdom and France (Aspinall et al., 2002; Meneceur et 
al., 2008).  Furthermore, a large variation in susceptibility to pyrimethamine as well as 
atovaquone has also been demonstrated between clinical isolates (Meneceur et al., 2008).  
While outright resistance towards pyrimethamine has not yet been observed in Toxoplasma 
gondii isolates, this phenomenon is widely spread in Plasmodium falciparum, the causative 
agent of malaria and an apicomplexan parasite (Fohl and Roos, 2003).  Two mutations 
within the DHFR-TS gene are required to induce resistance in P. falciparum, and 
sequencing from multiple T. gondii clinical isolates shows that DHFR-TS is already 
polymorphic, suggesting potential for the development of pyrimethamine resistance also 
exists in Toxoplasma (Fohl and Roos, 2003; Aspinall et al., 2002; Meneceur et al., 2008; 
toxodb.org v.12.0). 
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1.4.2 Novel drug discovery 
Since currently used drug regimens have severe side effects and have variable 
efficacies, the discovery of alternative compounds displaying anti-Toxoplasma activity 
acting against different molecular targets is desirable.  Some of the efforts take advantage 
of the differences between the biology of Toxoplasma and the human host.  While these 
have yet to be translated to a clinical setting, many compounds show high efficacies in vitro 
or in a mouse model of infection.  For example, the herbicide fluridone specifically inhibits 
the synthesis of the plant hormone abscisic acid by the apicoplast, a parasite-specific 
organelle of red algal origins (Nagamune et al., 2008; van Dooren and Striepen, 2013).  
Furthermore, it has been shown to decrease parasite burden in a mouse model and is well 
tolerated by mammalian cells since, while the production of this hormone is essential for 
the completion of the parasite’s lifecycle, the pathway is absent in mammalian and avian 
hosts (Nagamune et al., 2008). 
Some drug discovery efforts have taken advantage of the similarities between the 
apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii.  For example the 
currently used anti-malarial drug artemisinin has shown effectiveness in vitro and in mouse 
models at inhibiting Toxoplasma growth (Hencken et al., 2010; Schultz et al., 2014).  
Artemisinin, the active compound in the traditional Chinese herb qinghao, is particularly 
interesting because its synthetic derivatives are currently the only compounds that are 
effective at clearing Toxoplasma bradyzoites (Hencken et al., 2010; Schultz et al., 2014).  
Many more large scale drug screening efforts have been directed towards P. falciparum in 
part because malaria causes many more fatalities, thus increasing the interest in the 
development of novel chemotherapeutics.  Importantly, these efforts have yielded a library 
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of approximately twenty thousand compounds that show anti-malarial activity in vitro, 400 
of which are freely available (Spangenberg et al., 2013).  Screening of these compounds 
discovered several novel agents with different chemical backbones that display high 
selectivity against Toxoplasma, suggesting that building upon the work of malaria drug 
research may eventually yield novel anti-Toxoplasma agents (Boyom et al., 2014). 
Another common vein of drug discovery rests upon the repurposing of drugs 
currently used on humans for non-related diseases since these are generally already known 
to be well tolerated and therefore may have fewer regulatory hurdles to overcome.  Of 
particular interest is the activity of drugs acting on the central nervous system, since they 
are known to cross the blood-brain barrier and because the majority of complications from 
recurrent toxoplasmosis occur in the brain.  For example, one study has shown that the 
antipsychotic haloperidol, which acts in opposition to dopamine, and the mood stabilizer 
valproic acid, which increases GABA activity and reuptake, inhibit Toxoplasma growth in 
vitro at concentrations below their bio-availabilities in vivo (Jones-Brando et al., 2003; 
Kornhuber et al., 1999).  While noting the ability of the parasite to synthesize these 
neurotransmitters (MacRae et al., 2012; Gaskell et al., 2009), these examples may suggest 
that altering the availability of these neurotransmitters may modulate Toxoplasma growth. 
 Lytic cycle 
The most serious outcomes of toxoplasmosis are etiologically caused by the 
destruction of host cells which is itself caused by tachyzoites undergoing multiple 
replicative cycles.  In an immunocompromised host, tachyzoites are free to rapidly divide 
and invade new cells and do so through a repeating process called the lytic cycle (Black 
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and Boothroyd, 2000).  The lytic cycle can be subdivided into three major parts: the 
attachment and invasion of an uninfected cell by an extracellular parasite, followed by 
multiple rounds of intracellular growth and replication of tachyzoites, and completed by 
the lysis of the host cell with subsequent parasite egress.  The newly freed tachyzoites then 
migrate towards new host cells and the cycle begins anew (illustrated in Figure 1.2).  
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Figure 1.2 Lytic cycle of Toxoplasma gondii. 
Extracellular parasites first attach and invade an uninfected host cell.  The intracellular 
parasite undergoes multiple replicative rounds.  Once the host cell’s size limit is reached, 
the tachyzoites escape from the lysed host and the extracellular parasites migrate towards 
and invade a new host cell. Adapted from Gubbels, 2014. 
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1.5.1 Attachment and invasion 
T. gondii is an obligate intracellular parasite and as such, when it finds itself in the 
extracellular environment, it must attach to the host cell’s membrane and subsequently 
invade it in order to survive.  The initial attachment of the host by the parasite is mediated 
through the recognition of specific host cell factors, namely host cell surface glycoproteins 
(Black and Boothroyd, 2000; Robinson et al., 2004; Friedrich et al., 2010).  One of the 
main mediators of attachment is the family of surface antigens, SAGs.  The most prominent 
member, SAG1, is a marker of the tachyzoite stage and has been shown to interact 
specifically with glucosamine, found on the cell surface (Robinson et al., 2004).  The SAG 
family members are not the only host cell-binding mediators as SAG1 knockout mutants as 
well as bradyzoites, which do not express SAG1, still attach and invade host cells 
(Robinson et al., 2004). 
More recently, it has been shown that sialic acid plays a major role in the maintenance 
of the parasite-host interaction.  After initial contact is formed with the host cell, the parasite 
reorients its apical end towards the host cell and secretes the contents of its microneme, an 
apical secretory organelle which contains the MIC family of adhesins (Soldati-Favre, 
2008).  The MIC1-4-6 complex and, in an independent complex, MIC13 are anchored to 
the parasite’s membrane and are responsible for binding sialic acid, one of the most 
abundant oligosaccharides that are incorporated onto cell surface glycoproteins and 
glycolipids (Blumenschein et al., 2007; Friedrich et al., 2010).  Interestingly, the 
widespread usage of sialylated conjugates on the cell surface throughout the animal 
kingdom and in various tissues may be a reason why Toxoplasma has such a large tropism 
(Schauer, 2004). For example, in addition to invading any nucleated cell in any warm 
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blooded animal, T. gondii also successfully invades host cells in which the parasite cannot 
survive like those of mosquitoes and fish (Buckley, 1973; Omata et al., 2005). 
Immediately after the microneme ejects MIC proteins into the parasite’s membrane, 
another apical secretory organelle, the rhoptry, injects its content of rhoptry neck proteins 
(RON)s into the membrane of the host cell (Soldati-Favre, 2008).  The microneme-derived 
and parasite-anchored AMA1 interacts with the host cell-anchored RON2, forming a stable 
link between parasite and host (Lamarque et al., 2011; Tyler and Boothroyd, 2011).  The 
RON2-4-5-8 complex serves to anchor the parasite to the host cell and, together with the 
AMA1 protein, serve to act as the moving junction.  Interestingly, this demonstrates that 
Toxoplasma provides its own cell surface receptor in RON2 and is another indication as to 
why the parasite can invade a multitude of cell types (Besteiro et al., 2011).  Contrary to 
other intracellular pathogens where the host cell internalizes them, T. gondii actively 
invades its host.  The cytoplasmic portion of AMA1, as well that of another adhesin MIC2, 
interact with the parasite’s aldolase (Jewett and Sibley, 2003; Sheiner et al., 2010).  In 
apicomplexan parasites, in addition to serving a metabolic role, aldolase also serves as the 
bridge between adhesins and the parasite’s actin cytoskeleton (Jewett and Sibley, 2003).   
Through an active process dependent on Toxoplasma’s actin-myosin motor system 
(Jewett and Sibley, 2003), the parasite causes an invagination of the host’s membrane and 
progressively passes further into the host until it is completely internalized within the 
parasitophorous vacuolar membrane.  This membrane delimits the nonfusogenic 
parasitophorous vacuole and is composed of host cell lipids and a mix of parasite and 
selected host cell membrane proteins (Sinai, 2008).  Toxoplasma secretes proteins from its 
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rhoptries (ROP)s and its dense granules (GRA)s that integrate within the parasitophorous 
vacuole to control its fate within the host cell.  By reorganising the host’s intermediate 
filament and microtublar networks, the parasitophorous vacuole migrates towards the 
nucleus where it stably associates with the endoplasmic reticulum through the action of 
GRA3 and with mitochondria through a mechanism that may or may not involve the ROP2 
family (Laliberté and Carruthers, 2008; Kim et al., 2008; Sinai and Joiner, 2001; Pernas 
and Boothroyd, 2010). 
1.5.2 Growth and replication 
As an intracellular parasite, Toxoplasma must coopt the normal functioning of its 
host cell for its own benefit, converting it from potentially hostile environment to one that 
promotes the parasite’s growth and replication.  The parasite accomplishes this through a 
variety of mechanisms.  For example, a decrease in host cyclin B1 causes it to arrest at the 
G2/M interface while both the extrinsic and intrinsic apoptosis pathways are inhibited due 
to increased expression of a variety of anti-apoptotic proteins (Brunet et al., 2008; Carmen 
and Sinai, 2007).  These are important because, as an intracellular parasite, T. gondii would 
not be able to survive in a cell undergoing apoptosis and would undoubtedly encounter 
difficulties within an actively dividing host cell.  To accomplish these feats, Toxoplasma 
drastically reprograms the host cell at the transcriptional level by modulating a number of 
transcription factors upon infection. For example, the polymorphic kinases ROP16 and 
ROP18, as well as the dense granule proteins GRA2 and GRA15 have been shown to 
modulate the activities of NF-κB and the STAT family of transcription factors in a strain 
specific manner (Du et al., 2014; Butcher et al., 2011; Jensen et al., 2013).  Alleles of these 
genes from virulent type I parasites tend to activate STATs and inhibit NF-κB while type 
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II parasites do the reverse (Du et al., 2014; Butcher et al., 2011; Jensen et al., 2013).  
Notably, the downstream targets of these transcription factors are varied and include cell 
cycle and anti-apoptotic genes (Du et al., 2014; Butcher et al., 2011).  Importantly, not just 
protein coding transcripts are modified.  Reports have shown that T. gondii specifically 
induces the expression of certain host miRNAs, some of which are upregulated through the 
activation of STAT3 and have anti-apoptotic properties (Zeiner et al., 2010; Cai et al., 
2013).  Taken together, this suggests that Toxoplasma has ideally evolved to remodel the 
host environment to be conducive for parasite survival and growth. 
In addition to modulating the host cell environment, the parasite has developed 
methods to siphon its nutritional requirements from the host cell.  By promoting the 
degradation of its regulatory partner through an unknown effector, Toxoplasma causes an 
increase in host hypoxia-inducible-factor-1 (Wiley et al., 2010).  Downstream targets of 
this transcription factor include growth factors and genes that promote increased glucose 
metabolism and iron uptake (Laliberté and Carruthers, 2008).  Toxoplasma is auxotrophic 
for the amino acids tryptophan, arginine, and serine, purines, cholesterol, certain lipids, and 
small molecules such as choline and polyamines (Laliberté and Carruthers, 2008).  The 
host’s endo-lysosomal pathway, in conjunction with the modified microtubular network 
and the activity of GRA7, is used to deliver a constant supply of lipids and cholesterol 
needed for growth (Coppens et al., 2006).  In addition, the parasite is able to gather small 
molecules such as sugars, amino acids, nucleotides, and ions by diffusion through the 
porous parasitophorous vacuole membrane (Laliberté and Carruthers, 2008).  Together, 
these processes satisfy not only the parasite’s nutritional needs, but also allow growth and 
the rapid, efficient replication that is characteristic of tachyzoites. 
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Parasite virulence is directly tied to the rapidity with which tachyzoites can complete 
their cell cycle and successfully replicate (Radke et al., 2001).  While all Toxoplasma 
strains spend approximately 60% of the cell cycle in G1 and 30% in S phase at a genomic 
content of 1.8N, virulent type I strains have an increased replication rate, completing the 
entire cycle in 5-6 hours while slower growing type II tachyzoites take approximately 9 
hours (Radke et al., 2001).  Since the highest proportion of time is spent in G1, it suggests 
that the main driving force behind the increase in virulence is the ability for the tachyzoite 
to grow.  Interestingly, as alluded to above, the type I allele of ROP18 correlates with 
increased virulence (Taylor et al., 2006).  When this allele is transformed into a type II 
strain, the tachyzoites proceed through the cell cycle at an increased rate and become more 
virulent in mice, thus reinforcing the necessity of remodelling the host environment for 
optimal growth (Taylor et al., 2006). 
Toxoplasma gondii displays a streamlined cell cycle compared to most eukaryotic 
model organisms.  For example, the G2 phase is absent and mitotic spindle assembly occurs 
in late S phase while the parasite only has a genomic content of 1.8N, suggesting a lack of 
clear delineation between S and M phases (Radke et al., 2001; Gubbels et al., 2008).  
Furthermore, mitosis occurs in its entirety without the dissolution of the nuclear membrane 
and with only limited chromosomal condensation (Gubbels et al., 2008).  Parasite 
duplication occurs through a process of internal budding, known as endodyogeny.  This 
produces two immature daughter cells, each delineated by the inner membrane complex, 
within the mother.  The inner membrane complex is a membrane and cytoskeletal network 
that serves as a scaffold for the recruitment of the nucleus and a complete organellar 
complement (Ouologuem and Roos, 2014).  Shortly after receiving these, the inner 
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membrane complex pinches closed and the daughters emerge from the mother, leaving 
behind a residual body whose materials are recycled within the parasitophorous vacuole 
(Gubbels et al., 2008).  The entire process from the commencement of mitosis until the 
completion of cytokinesis occurs within a matter of 35-40 minutes (Radke et al., 2001). 
1.5.3 Parasite egress 
In all cases, the most serious consequences of Toxoplasma gondii infection are 
caused by the destruction of infected cells due to the escape of tachyzoites.  Several signals 
can cause egress and produce viable extracellular parasites.  These can be extrinsic factors, 
such as mechanical disruption of the host cell due to physical strain or from an immune 
response (Blackman and Carruthers, 2013), or through parasite-driven factors.  After 
repeated rounds of multiplication, the parasitophorous vacuole fills with parasites.  The 
plant hormone abscisic acid is produced by the parasite apicoplast, serving as a quorum 
sensing molecule to signal the release of intracellular calcium stores (Nagamune et al., 
2008; McCoy et al., 2012).  The release of calcium activates the calcium dependent protein 
kinase 3 which induces microneme secretion (McCoy et al., 2012).   The micronemes 
secrete a perforin-like protein that breaks the parasitophorous vacuole membrane (Kafsack 
et al., 2009).  The lysis of the parasitophorous vacuole increases the concentration of 
intracellular calcium in the host, activating the host protease calpain 1 which in turn 
degrades the host’s cytoskeleton, facilitating parasite egress (Chandramohanadas et al., 
2009; Blackman and Carruthers, 2013).  The parasites then liberate themselves from the 
weakened host cell and in total, this process takes between one and ten minutes (Caldas et 
al., 2007).  Once extracellular, they are free to attach, invade and colonize a new host cell 
to complete the lytic cycle. 
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 Bradyzoites 
Bradyzoites are the most important developmental phase of the parasite asexual 
lifecycle.  Without this stage, depending on parasite virulence and dosage, a tachyzoite 
infection would either be rapidly cleared by the immune system or would illicit an 
overwhelming inflammatory response in the host, ultimately leading to a rapid death.  
Instead, bradyzoites provide an alternate path, serving to act as a non-immunogenic state 
where the establishment of an incurable chronic infection for the life of host occurs.  
Furthermore, they reportedly alter host behaviour in ways that increase host mortality, 
thereby increasing the odds that they will be ingested by a predator or scavenger and 
transmit the infection to a new host (House et al., 2011; Flegr, 2013).  Bradyzoites have 
developed a variety of adaptations that aid them in persisting long term within the host cell.  
One of these includes modifying the parasitophorous vacuole into an elastic, glycoprotein-
rich, protective cyst wall whose integrity is crucial for tissue cyst maintenance in vivo 
(Zhang et al., 2001; Tomita et al., 2013).  Other classic features include a stalling of parasite 
growth and replication as well as a reduction in their metabolic needs. 
1.6.1 Changes to growth and metabolism 
The modulation of parasite growth is an important step in the establishment of 
chronic disease.  If uncontrolled growth occurs, the host is unable to stem the infection and 
ultimately succumbs.  This is particularly demonstrated by type I parasites, who grow 
rapidly, are deficient in bradyzoite development, and are considered much more virulent in 
vivo than type II parasites (Radke et al., 2001; Soête et al., 1994; Sibley and Boothroyd, 
1992).  In contrast, parasites that successfully convert to bradyzoites exit the cell cycle in 
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the G1 phase and remain non proliferative, existing solely with a 1N genomic content 
(Radke et al., 2003). 
Accompanying this decrease in growth and replication is a fundamental shift in 
metabolism.  Bradyzoites likely lack the ability to complete the tricarboxylic acid cycle and 
their unique mitochondrion loses membrane potential indicating an absence of oxidative 
phosphorylation (Denton et al., 1996; Toursel et al., 2000).  Furthermore, along with an 
upregulation of the enzymes needed for gluconeogenesis, bradyzoites are marked by the 
appearance of cytoplasmic amylopectin storage granules whose presence has been 
hypothesized to serve as an energy reservoir that allows them to survive the transition from 
one host to another (Fleige et al., 2008; Coppin et al., 2003).  Together, these metabolic 
characteristics underline the importance of glycolysis in bradyzoites, where glycolytic 
throughput is much greater in the functionally anaerobic bradyzoites than in tachyzoites 
(Denton et al., 1996). 
Interestingly, most of the enzymes involved in the glycolytic pathway are duplicated 
in the Toxoplasma genome and at least some of these show differential stage expression, 
enzymatic properties, and / or cellular functions between one another, suggesting 
specialized adaptations between tachyzoite and bradyzoite life stages has occurred (Fleige 
et al., 2007; Manger et al., 1998, Dzierszinski et al., 1999; Dzierszinski et al., 2001; Yang 
and Parmley, 1997; Dando et al., 2001).  For example, the bradyzoite-specific lactate 
dehydrogenase (LDH) 2, which converts pyruvate to lactate and regenerates the essential 
coenzyme NAD+, is much more suited to the bradyzoite environment than the tachyzoite-
specific LDH1 even though they share 71% identity (Yang and Parmley, 1997).  LDH2 is 
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able to offer a much larger throughput of NAD+ regeneration because it is insensitive to 
pyruvate concentration, whereas LDH1 displays substrate inhibition (Dando et al., 2001).  
The inverse is true in the case of Toxoplasma enolases (ENO)s, where the tachyzoite-
specific ENO2 displays a higher specific activity than the bradyzoite ENO1 (Dzierszinski 
et al., 2001).  Intriguingly, the Toxoplasma ENOs both display nuclear localization and 
more recently they have been shown to act as stage-specific transcription factors or 
transcriptional regulators, underlining that stage-specific adaptations are not just limited to 
enzymatic functionality (Ferguson et al., 2002; Mouveaux et al., 2014). 
1.6.2 Stage-specific transcriptional gene regulation 
Differential gene regulation between life stages is an essential feature of any 
organism that needs to adapt to a changing environment.  In its infancy, studies directed 
toward bradyzoite-specific gene transcriptional upregulation in Toxoplasma had only 
revealed a handful of model genes, such as the heat shock protein bradyzoite antigen 1 
(BAG1), and the metabolic enzymes LDH2 and ENO1 (Bohne et al., 1997; Yang and 
Parmley, 1997; Dzierszinski et al., 2001).  In fact, along with verifying the absence of the 
tachyzoite-specific LDH1, ENO2, and SAG1 proteins, seeing the protein products of these 
genes had emerged as canonical markers of successful induction of the bradyzoite stage 
(Ferguson, 2004).  The development and application of microarray and SAGE technologies 
to the Toxoplasma transcriptome revealed many more stage-specifically regulated 
transcripts (Cleary et al., 2002; Radke et al., 2005).  These studies showed that upon 
bradyzoite induction, a remodeling of the transcriptome occurs within the broadly defined 
families of surface antigens, metabolic enzymes, cell cycle regulators, and proteins targeted 
to secretory organelles (Cleary et al., 2002; Radke et al., 2005).  However, it was unknown 
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if bradyzoite-induced genes were upregulated transcriptionally or through post 
transcriptional mechanisms, such as through a systematic increase in their mRNA half-lives 
(Cleary et al., 2002; Radke et al., 2005).  This question was categorically answered when 
it was shown that the promoters of canonical bradyzoite-induced genes contained cis-acting 
elements that were capable of inducing bradyzoite-specific developmental regulation when 
inserted in the promoters of otherwise constitutively expressed genes (Behnke et al., 2008).  
Furthermore, these cis-acting elements were able to selectively bind unknown nuclear 
proteins, suggesting they interacted with unknown transcription factors (Behnke et al., 
2008). 
Perhaps surprisingly, despite the completion of the Toxoplasma genome project and 
the known importance of so called “just-in-time” transcriptional regulation to 
apicomplexan cell biology, initial efforts to identify transcription factors had proved largely 
unfruitful (Bozdech, 2003; Meissner and Soldati, 2005).  It wasn’t until relatively recently, 
when sequence-based homology searches directed against predicted DNA-binding motifs 
in the Plasmodium genome were performed that a large number of plant-like AP2 
transcription factors were suggested to be present and active in apicomplexan parasites 
(Balaji et al., 2005).  Interestingly, when studied in Toxoplasma, not only were many of the 
newly identified AP2 transcription factors found to be regulated in a cell cycle dependent 
manner, yet more were specifically upregulated in bradyzoites (Behnke et al., 2010).  
Furthermore, these transcription factors were suggested to bind different promoter 
regulatory cis-acting elements, suggesting that these factors mediate the transcription of 
genes throughout progression and withdrawal from the cell cycle (Behnke et al., 2010).  
More recently, it has been shown that different bradyzoite-induced AP2 family members 
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can selectively induce or repress the transcription of the same subset of canonical 
bradyzoite transcripts, underlining their importance in stress response and developmental 
transcriptional regulation (Walker et al., 2013; Radke et al., 2013). 
1.6.3 Bradyzoite differentiation in vivo 
Conversion to the bradyzoite stage offers a means to the parasite to persist in the host 
indefinitely, and this ability appears to be strain-specific.  While the type I lineage of 
parasites is more virulent and usually fatal in mouse models, type II parasites cause a much 
less severe disease and readily persist as bradyzoite-containing cysts (Robben et al., 2004).  
The difference between these outcomes is primarily mediated through modulation of the 
host’s inflammatory response, which itself is mediated through the interaction between the 
parasite and macrophages, sentinel cells that are a key component of the innate immune 
system.  Upon host cell egress, type II tachyzoites infect macrophages where they 
specifically induce the classical inflammatory activation pathway through the activity of 
the secreted dense granule protein GRA15 (Jensen et al., 2011; Rosowski et al., 2011).  
Through an unknown mechanism, GRA15 induces the phosphorylation of the IκB kinase 
which in turn phosphorylates the NF-κB inhibitory protein IκB, causing its ubiquitination 
and subsequent degradation (Rosowski et al., 2011).  The newly freed NF-κB transcription 
factor then translocates to the nucleus where it initiates the transcription of pro-
inflammatory genes such as the cytokines tumour necrosis factor α and interleukin-12 
(Rosowski et al., 2011; Robben et al., 2004).  These cytokines promote Th1 cell activation 
and the production of interferon γ (IFNγ) in a variety of cell types, which in turn promotes 
NF-κB activation, creating a positive feedback loop that induces a robust inflammatory 
response (Schroder et al., 2004). 
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IFNγ has long been known to be a key mediator of bradyzoite differentiation and its 
presence is essential to survival in a mouse model of type II infection (Jones et al., 1986; 
Suzuki et al., 1988; Suzuki et al., 1991).  Among the many downstream targets with anti-
parasitic activities that are upregulated by IFNγ are inducible nitric oxide synthase (iNOS) 
and indoeamine 2,3 dioxygenase (Schroder et al., 2004).  While the latter depletes the 
intracellular environment of tryptophan, iNOS produces the reactive nitrogen intermediate 
nitric oxide (NO) from arginine (Schroder et al., 2004).  Toxoplasma is auxotrophic for 
both of these amino acids and while their depletion could be cause for cellular stress, it is 
the production of NO that is essential for long term host survival and mediates bradyzoite 
differentiation (Laliberté and Carruthers, 2008; Scharton-Kersten et al., 1997; Bohne et al., 
1994).  Molecular targets of NO include enzymes of the Krebs cycle, such as succinate 
dehydrogenase, and the essential heme groups of the cytochromes involved in complexes 
I-IV of the mitochondrial respiratory chain (Dai et al., 2013).  Notably, succinate 
dehydrogenase activity is not detectable in bradyzoites and the drug atovaquone, which 
specifically inhibits cytochrome b in complex III of the respiratory chain, causes bradyzoite 
differentiation (Denton et al., 1996; Tomavo and Boothroyd, 1995).  Together with the 
observations that NO acts upon the parasite’s unique mitochondrion and that loss of 
mitochondrial potential is associated with the bradyzoite differentiated state, a model 
becomes apparent where type II parasites initiate the macrophage-induced production of 
NO to promote their own differentiation and persistence (Bohne et al., 1994; Toursel et al., 
2000). 
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1.6.4 Bradyzoite differentiation in vitro 
Studying the interconversion between tachyzoite and bradyzoite is a challenging area 
of research, particularly in vivo.  The combination of low parasite abundance and the 
complexities added by a live host background make the need for an in vitro model of 
Toxoplasma infection and differentiation apparent.  Over the last few decades, a 
standardization of Toxoplasma in vitro culture and differentiation methods has emerged.  
For example, parasites are routinely cultured in confluent human foreskin fibroblasts 
(HFF)s because Toxoplasma more easily infects monolayers than suspension cells and they 
can replicate many times in this long and narrow cell type, yielding a high number of 
parasites with little host cell contamination after host cell lysis (Roos et al., 1994).  Also, 
benefiting from the parasite-specific selectable marker hypoxanthine-xanthine-guanine 
phosphoribosyltransferase (HXGPRT), it is possible to study stage-specific gene 
expression in an in vitro system (Bohne and Roos, 1997). 
Induction of bradyzoite differentiation in tissue culture systems was unreliable and 
poorly understood in its infancy.  While addition of IFNγ or sodium nitroprusside, a 
chemical NO donor, to tissue culture systems induced bradyzoite formation, they only did 
so at moderate rates (Bohne et al., 1993; Bohne et al., 1994).  However, it had also been 
shown that certain Toxoplasma lineages could spontaneously convert from tachyzoite to 
bradyzoite in vitro even in the absence of immunologic factors, suggesting that the 
conversion process may be activated by other signals in addition to NO (Dardé et al., 1989).  
Shortly thereafter, it was revealed that a variety of chemical and physical stimuli could 
induce bradyzoite development nearly completely, making it possible to reliably study the 
bradyzoite stage in vitro for the first time (Soête et al., 1994).  These conditions included 
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prolonged heat shock at 43°C, increased pH of culture media with concurrent CO2 
reduction to atmospheric levels, or addition of the oxidative stress agent sodium arsenite 
(Soête et al., 1994).  Other studies have identified pyrrole- and pyrrolidine-containing 
chemicals that induce differentiation through poorly characterized mechanisms (Radke et 
al., 2006; Conde de Felipe et al., 2008).  A systematic analysis has examined the relative 
proficiency of these alternate methods of inducing bradyzoite conversion (Behnke et al., 
2008).  Although the trisubstituted pyrrole, termed compound 1, appeared to be the most 
efficient, increasing the pH of the media with concurrent induction of pyrimidine starvation 
through the reduction of CO2 levels has emerged as the most common method for initiating 
bradyzoite differentiation in vitro (Behnke et al., 2008; Bohne and Roos, 1997).  
More recently, studies have focused on determining how Toxoplasma copes with a 
variety of cellular stresses and how these drive the differentiation of tachyzoites towards 
bradyzoites.  By submitting parasites to a barrage of cellular stresses, it has been suggested 
that in response to nearly any stress, Toxoplasma initiates a process of translational control 
(Sullivan et al., 2004; Narasimhan et al., 2008; Joyce et al., 2010; Konrad et al., 2011; 
Konrad et al., 2013a; Joyce et al., 2013; Konrad et al., 2013b).  While under the effects of 
this generalized translational control mechanism, stress-responsive transcripts are 
prioritized for translation and this has been suggested to be the driving force behind the 
tachyzoite to bradyzoite conversion (Joyce et al., 2013). 
 Post-transcriptional gene regulation in gene expression 
Gene expression is the summation of transcriptional and post-transcriptional events 
that occur to a particular transcript, as well as the collection of post-translational regulatory 
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events.  Transcriptional gene regulation relies on inducing, suppressing, or otherwise 
modifying the amount of DNA transcription at a particular genomic locus.  While this 
process is widely used to control gene expression throughout different tissues, 
developmental stages, and / or under different environmental conditions, transcriptional 
regulation is a relatively slow process and is insufficient to rapidly and precisely modulate 
gene expression when compared with the potential finesse that post-transcriptional gene 
regulation (PTGR) offers (Moore, 2005; Hall et al., 2005; Mair et al., 2006).  While PTGR 
may more commonly be considered to consist of methods for regulating mRNA translation, 
it is a more general umbrella term encompassing a variety of mechanisms that control the 
expression of gene products by operating at the transcript level.  Importantly, all PTGR 
mechanisms rely on the interaction between cis-acting elements encoded within the 
transcript and the trans-acting factors that bind and recognize them (Moore, 2005).  
Together, the mRNA and the collection of RNA-binding proteins (RBP)s form the 
messenger ribonucleic particle (mRNP), a dynamic complex that changes as the transcript 
is shuttled from one location to the next in the cell (Moore, 2005).  The components of the 
mRNP at any given time dictate which biological processes the transcript will undergo at 
any given time (Moore, 2005).  Therefore, it is important to note that decisions made early 
in the mRNA’s biogenesis directly affect its participation in downstream regulatory events 
by influencing the content of its cis-acting elements and its subsequent ability to recruit 
certain RBPs (Moore, 2005; Darnell, 2013).  Below follows a description of mRNA 
maturation and cap-dependent translation to serve as a reference point from which to build 
on downstream regulatory events. 
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1.7.1 mRNA maturation and nuclear PTGR mechanisms 
Transcript maturation and the mechanisms of nuclear PTGR are intimately linked, 
since each step in the maturation process leaves a trace on the transcript either in the form 
of altered nucleotide composition and / or through deposition of RBPs at specific locations.  
The first step in maturation is the co-transcriptional introduction of one of the most 
universally recognizable cis-acting elements, the 5’ 7-methylguanosine cap (Topisirovic et 
al., 2011).  The 5’ cap is added by a 5’ to 5’ linkage to the 20-30 nucleotide long nascent 
transcript through the sequential actions of the enzymes nucleotide triphosphatase, 
guanylyltransferase, and N7-methyltransferase (Topisirovic et al., 2011).  The 5’ cap serves 
as protection from the many 5’ to 3’ exonucleases in the cell and as a key recognition point 
for a variety of cap-binding proteins including the nuclear cap-binding complex (nCBC; 
Topisirovic et al., 2011; Moore, 2005; Carmody and Wente, 2009). 
The next major maturation event, occurring within thirty seconds of transcription, is 
the addition of the 3’ poly(A) tail to the pre-mRNA (Darnell, 2013).  To gain a poly(A) tail, 
the cleavage and polyadenylation specificity factor first binds the encoded polyadenylation 
signal and, after inducing an endonucleolytic cut, recruits nuclear poly(A) polymerase 
(Gruber et al., 2014).  In metazoans, this template-independent polymerase generates a tail 
of between 200 to 250 adenosines which is then coated by nuclear poly(A)-binding protein 
(PABP; Gruber et al., 2014).  In transcripts containing multiple polyadenylation sites, the 
usage of alternative polyadenylation sites plays an important role in modulating transcript 
translatability and stability by mediating the inclusion or exclusion of cis-acting elements, 
including potential microRNA-binding sites, within its 3’ untranslated region (UTR; 
Gruber et al., 2014; Darnell, 2013).  This PTGR mechanism likely occurs in many T. gondii 
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transcripts.  For example, the DHFR-TS 3’UTR varies in length from approximately 250 to 
900 nucleotides depending on which of fourteen polyadenlyation sites is used (Matrajt et 
al., 2004). 
The final step to generate a mature transcript is the splicing out of introns.  While 
some splicing can occur while the nascent pre-mRNA is still being transcribed, the majority 
occurs after RNA polymerase II has finished transcribing and polyadenylation is complete 
(Darnell, 2013).  Splicing of an intron involves the participation of the 5’ donor and 3’ 
acceptor sites, and an adenosnine branch point residue located upstream of a 
polypyrimidine tract within the intron (Suvorova and White, 2014).  The components of 
the spliceosome are recruited through interaction with nCBC and sequentially mediate 
cleavage at the 5’ donor site, lariat formation through the transesterification of the 5’ donor 
site guanosine to the branch point adenosine, and the cleavage of the 3’ acceptor site with 
concurrent linkage of 5’ and 3’ exons (Topisirovic et al., 2011; Darnell, 2013; Suvorova 
and White, 2014).  A successful splicing event yields a correct linkage between the 5’ and 
3’ splice sites and the deposition of the exon junction complex (EJC) approximately 20 to 
30 nucleotides upstream of each exon-exon junction (Moore, 2005; Carmody and Wente, 
2009).  The alternative use of splice sites is a mechanism that can be used to generate 
multiple protein isoforms through the use of a single genomic locus by including or 
excluding selected exons and / or introns into a mature transcript (Hassan et al., 2012).  
However, alternative splicing can also be used to selectively post-transcriptionally 
downregulate gene expression.  For example, if an EJC is deposited onto the 3’UTR of a 
transcript, it serves as a marker of an improperly spliced transcript and will signal its demise 
through nonsense mediated decay in the cytoplasm (Moore, 2005).  Interestingly, while 
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Toxoplasma contains functional splicing machinery and over 75% of predicted genes 
contain introns, few studies have examined alternative splicing as a means of PTGR 
(Suvorova et al., 2013; Suvorova and White, 2014).  Despite this, sporadic reports have 
shown that some transcripts, including the widely used selectable marker HXGPRT are 
alternatively spliced (Hasan et al., 2012; White et al., 2000). 
The final step of nuclear PTGR is the export of the mature transcript to the cytoplasm 
through the nuclear pore complex.  In most cases, this requires the recruitment of the 
transcription-export complex which, in metazoans, is indirectly recruited through the 5’ cap 
and EJC deposited on spliced transcripts (Carmody and Wente, 2009).  Alternatively, if a 
transcript is improperly processed, it is degraded by the nuclear exosome (Carmody and 
Wente, 2009).  Shuttling of the mature mRNP occurs through the nuclear pore complex 
likely through a 5’ to 3’ threading process and the emergent transcript can be directly 
recruited to the translational machinery, even before it has entirely entered the cytoplasm 
(Moore, 2005; Carmody and Wente, 2009). 
1.7.2 Cap-dependent translation 
The export of the mRNP from the nucleus into the cytoplasm signals a dramatic 
remodeling of protein complement associated with the transcript.  For example, after an 
initial round of translation, the nCBC and the nuclear PABP are exchanged for their 
cytoplasmic equivalents, priming the transcript for translation (Moore, 2005).  Cap-
dependent translation is the most common mode by which eukaryotic organisms initiate 
protein production (Figure 1.3; reviewed in Sonenberg and Hinnebusch, 2009).  Under 
optimal conditions, cap-dependent translation begins with the recognition of the 5’ cap by 
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a collection of eukaryotic initiation factors (eIF)s termed the eIF4F complex, which is 
composed of the cap binding protein eIF4E, the DEAD-box helicase eIF4A, the eIF3-
interacting eIF4B, and the eIF4G scaffold (Sonenberg and Hinnebusch, 2009).  Notably, 
eIF4E is one of the most highly regulated proteins involved in translation and many 
organisms produce multiple isoforms that can have specialized roles in certain tissues, in 
developmental phases, or in stress response (Topisirovic et al., 2011; Martínez-Silva et al., 
2012).  Furthermore, in certain cases, different eIF4E and eIF4G isoforms can combine to 
form specialized eIF4F complexes that show transcript specificity by either favouring short 
and unstructured 5’UTRs or promoting the translation of transcripts containing longer, 
structured 5’UTRs (Mayberry et al., 2011; Martínez-Silva et al., 2012).  Intriguingly, 
Toxoplasma encodes at least two eIF4E isoforms and multiple proteins that contain 
canonical eIF4G domains, however these remain uninvestigated (Xia et al., 2008). 
Upon binding of the 5’ cap by eIF4F, the mRNA circularizes through the interaction 
between eIF4G and PABP in the closed loop model of eukaryotic translation (Figure 1.3; 
Sonenberg and Hinnebusch, 2009).  This facilitates the recruitment of the pre-initiation 
complex which is composed of the small 40S ribosomal subunit, eIFs 1, 1A, 3, 5, and the 
ternary complex (Sonenberg and Hinnebusch, 2009).  The ternary complex contains the 
initiator transfer RNA, Met-tRNAi, and eIF2-GTP, which is responsible for recruiting Met-
tRNAi to the pre-initiation complex (Sonenberg and Hinnebusch, 2009).  After the pre-
initiation complex is recruited to the mRNA, it commences processively scanning the 
5’UTR until perfect complementarity is achieved between the AUG start codon and the 
anti-codon contained within the Met-tRNAi (Hinnebusch, 2011).  In particularly long or 
highly structured 5’UTRs, scanning is facilitated through the ATP-dependent helicase 
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activity eIF4A and other helicases (Hinnebusch, 2011).  Most start codons are flanked by 
an adenosine three nucleotides upstream and a guanosine four nucleotides downstream of 
the translational start site and if these conditions are not met a downstream AUG can be 
selected as the preferred start codon in a process known as leaky scanning (Kozak, 1987; 
Hinnebusch, 2011).  This sequence preference is conserved in T. gondii and thought to be 
important for mediating contacts between these residues and other eIFs (Seeber, 1997; 
Hinnebusch, 2011).  Recognition of the start codon triggers the irreversible eIF2-mediated 
hydrolysis of GTP, the release of eIFs, and recruitment of the large 60S ribosomal subunit 
(Sonenberg and Hinnebusch, 2009).  Translation of the mRNA then proceeds through 
successive rounds of translational elongation until reaching the stop codon, a termination 
signal that signals for the dissociation of the ribosome.  
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Figure 1.3 Eukaryotic cap-dependent translational initiation and its regulation. 
An assembled eIF4F complex binds the mRNA 5’cap causing its circularization.  The 
pre-initiation complex is then recruited and scanning of the 5’UTR is conducted until 
start codon recognition.  eIF2 mediated GTP hydrolysis occurs, inducing the recruitment 
of the 60S large ribosomal subunit and departure of most eIFs.  Regulation of 
translational initiation occurs by phosphorylation events mediated by the TOR and eIF2α 
kinases.  Adapted from Sonenberg and Hinnebusch, 2007. 
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 Translational control and translational repression 
The selective control of translation is an important regulatory mechanism for 
controlling gene expression.  General modes of translational control operate under stressful 
conditions and permit the widespread translational repression of most transcripts while 
promoting the translation of a limited number of stress-responsive transcripts.  In contrast, 
transcript-specific translational control selectively withdraws transcripts from the 
translational pool and can be commonly seen on a case by case basis operating under 
optimal growth conditions, stressful conditions, or throughout developmental phases.  
However it is important to note that none of the general or transcript-specific translational 
repression mechanisms are mutually exclusive. 
1.8.1 Translational control mediated by target of rapamycin 
In principle, the many steps of eukaryotic translation are subject to regulation, 
however, the most common regulatory events control the rate-limiting steps of translational 
initiation (Gastens and Fischer, 2002; Sonenberg and Hinnebusch, 2009).  A key regulatory 
mechanism in higher eukaryotes rests upon modulating the ability of eIF4F complex to 
bind the 5’ cap, which is accomplished by the kinase target of rapamycin (TOR; Figure 1.3; 
Sonenberg and Hinnebusch, 2009).  In metazoans, under optimal conditions that include 
the presence of mitogens and growth factors, TOR is activated by the kinase AKT which 
itself is activated through PI3K (Hay and Sonenberg, 2004).  TOR is responsible for either 
directly or indirectly phosphorylating many components of the eIF4F complex (Hay and 
Sonenberg, 2004).  Through the downstream effector ribosomal protein S6 kinase, TOR 
contributes to the phosphorylation of eIF4B which serves to increase the recruitment the 
small ribosomal unit to the pre-initiation complex and to promote the helicase activity of 
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eIF4A, allowing for increased 5’UTR scanning (Hay and Sonenberg, 2009; Baird and Wek, 
2012).  Furthermore, while the phosphorylation of eIF4G has unknown consequences, that 
of eIF4E-binding proteins (4E-BP)s decrease their affinity for the cap-binding eIF4E, 
thereby allowing the latter to participate in the eIF4F complex (Hay and Sonenberg, 2004; 
Sonenberg and Hinnebusch, 2009).  In contrast, upon amino acid starvation TOR is 
inactivated, reducing cap-dependent translation and causing a generalized translational 
repression (Hay and Sonenberg, 2004; Sonenberg and Hinnebusch, 2009; Baird and Wek, 
2012). 
Interestingly, certain mRNA subsets appear to be preferentially repressed while 
others are more favourably translated under TOR inactivation (Hay and Sonenberg, 2004; 
Baird and Wek, 2012).  The loss of functional eIF4B decreases eIF4A helicase processivity, 
reducing the ability of the pre-initiation complex to scan through and melt strong secondary 
structures in transcripts containing long and structured 5’UTRs (Baird and Wek, 2012).  
TOR inactivation also results in the sequestration of eIF4E by hypophosphorylated 4E-BPs 
and causes a global inhibition of 5’ cap recognition and translational repression (Figure 1.3; 
Sonenberg and Hinnebusch, 2009; Baird and Wek, 2012).  However, transcripts whose 5’ 
most nucleotides consist of an oligopyrimidine tract are particularly prone to TOR-
mediated translational repression.  Notably, interactions between eIF4E and the transcript 
are formed through both the 7-methylguanosine cap and the first nucleotide of the transcript 
and it has been suggested that eIF4E has a comparatively reduced affinity for mRNAs with 
5’ terminal oligopyrimidine tracts (Topisirovic et al., 2010; Thoreen et al., 2012).  
Consequently, even a mild reduction in 4E-BP phosphorylation levels can trigger a 
dramatic translational reduction for these transcripts (Thoreen et al., 2012). 
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In contrast, stress-induced translational activation is seen in a subset of mRNAs that 
contain an internal ribosomal entry site (IRES) within their 5’UTR (Sonenberg and 
Hinnebusch, 2009; Martínez-Salas et al., 2013).  IRESes are cis-acting elements that are 
diverse in both structure and sequence composition and are found in a variety of metazoan 
transcripts whose gene products are important for mediating the stress response, such as 
transcription factors (Martínez-Salas et al., 2013; Sonenberg and Hinnebusch, 2009).  
When under cellular stress, context-specific IRES trans-acting factors are recruited to their 
cognate IRESes and serve to stabilize and / or remodel them to promote the direct 
recruitment of the translational machinery (Martínez-Salas et al., 2013).  This mechanism 
allows these transcripts to bypass the generalized cap-dependent translational repression 
that occurs under stresses such as amino acid starvation.  Interestingly, TOR has also been 
shown to be responsive to amino acid starvation in Toxoplasma (Ghosh et al., 2011).  
However, while it has been shown to be a key regulator in the stress-induced autophagic 
loss of T. gondii’s unique mitochondrion, its influence on the two eIF4Es and role in 
translational control remain unexplored (Ghosh et al., 2011; Xia et al., 2008). 
1.8.2 Translational control mediated by eIF2α phosphorylation 
Another stress-induced generalized translational control mechanism rests upon 
limiting the amount of ternary complex available for pre-initiation complex assembly 
(Sonenberg and Hinnebusch, 2009).  After eIF2 hydrolyses GTP and dissociates from the 
pre-initiation complex, it must have its GDP exchanged for a GTP through the action of the 
nucleotide exchange factor eIF2B before being able to participate in another round of 
translational initiation (Figure 1.3; Sonenberg and Hinnebusch, 2009).  Various stressful 
stimuli induce the phosphorylation of the eIF2α subunit and this increases its affinity for 
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eIF2B, thereby turning it into a competitive inhibitor of the nucleotide exchange factor 
(Sonenberg and Hinnebusch, 2009).  In turn, this reduces the turnover of eIF2-GDP, 
limiting the pool of ternary complex available for cap-dependent translational initiation and 
causes a generalized translational repression (Sonenberg and Hinnebusch, 2009).  
Phosphorylation of eIF2α occurs at position Ser51 in yeast and humans and can be 
performed by one of four mammalian eIF2α kinases, depending on the particular cellular 
stress (Sonenberg and Hinnebusch, 2009).  The eIF2α kinases HRI, PKR, PERK, and 
GCN2 are activated by low haem concentration or oxidative stress, the presence of long 
double-stranded viral RNA, accumulation of unfolded proteins in the ER lumen, and amino 
acid starvation, respectively (Sonenberg and Hinnebusch, 2009; Yamasaki and Anderson, 
2008; Anderson and Kedersha, 2008).  This mechanism is also conserved in T. gondii, with 
stressful stimuli inducing phosphorylation of the cognate Ser71 through the activity of 
stress-responsive eIF2α kinases (Sullivan et al., 2004).  T. gondii encodes four eIF2α 
kinases termed TgIF2K-A through -D (Narasimhan et al., 2008).  TgIF2K-A is a homolog 
of PERK and is activated during conditions causing ER stress (Narasimhan et al., 2008).  
Like HRI, TgIF2K-B is activated upon oxidative stress and likely other forms of 
cytoplasmic stress (Narasimhan et al., 2008).  Two GCN2-like paralogues are expressed; 
TgIF2K-C mediates the intracellular stress response under amino acid starvation while 
TgIF2K-D acts solely during the extracellular phase of the lytic cycle (Konrad et al., 2013b; 
Konrad et al., 2011; Joyce et al., 2010). 
While eIF2α phosphorylation is a powerful general repressor of translation, a subset 
of transcripts that contain one or a series of small open reading frames upstream of the main 
start codon (uORF)s actually see their translation increased under these conditions 
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(Sonenberg and Hinnebusch, 2009; Baird and Wek, 2012).  Most commonly, uORF-
containing transcripts encode stress-responsive proteins such as transcription factors and 
have their translation suppressed under optimal growth conditions (Sonenberg and 
Hinnebusch, 2009; Baird and Wek, 2012).  Under normal growth conditions, uORFs 
mediate the suppression of the main protein by one of two mechanisms depending on their 
number and positioning within the 5’UTR (Baird and Wek, 2012).  In the first mechanism, 
an out of frame uORF overlaps the main start codon (Baird and Wek, 2012). The ribosome 
translates the small peptide and dissociates, having bypassed the main start codon (Baird 
and Wek, 2012).  In the second mechanism, a series of uORFs positioned within the 5’UTR 
is used to suppress translation of the main ORF by successively promoting dissociation of 
the ribosome as it passes each stop codon (Baird and Wek, 2012).  In contrast, under 
conditions of stress, uORF-containing transcripts benefit from the reduced amount of 
ternary complex available to promote their translation (Baird and Wek, 2012).  After 
translating the first uORF, the small ribosomal subunit can either dissociate or resume 
scanning the 5’UTR in the absence of ternary complex (Baird and Wek, 2012).  Since 
ternary complex is in low abundance, the scanning small ribosomal is more likely to scan 
through proximal inhibitory start codons and re-initiate translation at downstream start 
codons, thereby promoting translation of the main protein in these systems (Baird and Wek, 
2012). 
As in higher eukaryotes, generalized translational repression mediated through eIF2α 
phosphorylation induces the preferential translation of a subset of stress responsive 
transcripts in Toxoplasma and, if kept in a phosphorylated state either through inhibiting 
its dephosphorylation or by maintaining various stressful conditions, bradyzoite 
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development ensues (Yamasaki and Anderson, 2008; Joyce et al., 2013; Konrad et al., 
2013a; Sullivan et al., 2004; Narasimhan et al., 2008).  Included among the subset of 
preferentially translated mRNAs are bradyzoite surface antigens, heat shock proteins, and 
a subset of uORF-containing AP2 transcription factors (Joyce et al., 2013).  This underlines 
that the stress-dependent modulation of cap-dependent translation is key to the bradyzoite 
transition process by offering an interesting link between stress-induced translational 
control and the extensive stage-specific transcriptional regulation known to be important 
for bradyzoite development.  Further research in this field will likely yield intriguing 
results. 
1.8.3 Transcript-specific translational repression 
General translational control mechanisms can account for large changes to gene 
expression in response to cellular stresses.  However, many transcripts are post-
transcriptionally regulated under optimal or stressful conditions or throughout 
developmental phases through the use of specific regulatory RBPs.  Although the partners 
involved vary on a case by case basis, all transcript-specific regulatory mechanisms rely on 
the interaction between cis-acting elements generally encoded within the 5’- or 3’UTR of 
the transcript and trans-acting factors which either bind the RNA directly or through an 
intermediate.  At any given time, the collection and placement of trans-acting factors along 
the mRNP dictate the localization, stability, and translational competency of the transcript 
(Moore, 2005). 
Targeting an estimated 60% of the transcriptome in humans, the microRNA 
(miRNA) system is one the most widely used mechanisms to target transcripts for 
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withdrawal from the translational pool within the cell (Friedman et al., 2009; Carthew and 
Sontheimer, 2009).  miRNAs are derived from RNA polymerase II-derived transcripts or 
from spliced out intronic sequences (Carthew and Sontheimer, 2009).  miRNA precursors, 
which form RNA hairpins, are processed first in the nucleus by the double-stranded 
ribonuclease Drosha and, after nuclear export, by the related cytoplasmic nuclease Dicer, 
generating a 22 nucleotide RNA duplex with 3’ dinucleotide overhangs (Carthew and 
Sontheimer, 2009).  This RNA duplex is then loaded onto the ribonuclease Argonaute 
(AGO), which preferentially incorporates whichever one of the two strands has weaker 5’ 
end base pairing (Carthew and Sontheimer, 2009).  The loaded miRNA is used by AGO as 
a guide to target transcripts destined for PTGR (Carthew and Sontheimer, 2009).  Targeting 
is mediated through the use of the miRNA’s seed sequence, consisting of nucleotides 2-8, 
which binds through Watson-Crick base pairing to a generally 3’UTR located cis-acting 
element on target transcript (Carthew and Sontheimer, 2009).  Interestingly, approximately 
40% of human transcripts have differential polyadenylation site selection which can 
mediate the inclusion or exclusion of miRNA binding sites within the 3’UTR, offering a 
direct link between nuclear PTGR and downstream gene regulatory events (Darnell, 2013). 
Generally, the binding of AGO to a transcript has an inhibitory effect on its 
translation through one of two mechanisms.  If the miRNA-target interaction consists of 
perfect base pairing and if the AGO isoform is catalytically active, the target transcript is 
cleaved, inducing its degradation through the actions of cellular exonucleases (Carthew and 
Sontheimer, 2009).  However, if the miRNA-target interaction contains base pair 
mismatches outside of the seed sequence or if the AGO isoform is catalytically inactive, 
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cleavage does not occur and the transcript is generally withdrawn from the translational 
pool (Carthew and Sontheimer, 2009). 
While the importance of miRNA-directed PTGR is well documented in plants and 
metazoans, its importance in protozoan parasites as an endogenous regulatory mechanism 
is only just beginning to emerge.  It has recently been shown that Toxoplasma produces 
many small regulatory RNAs with the characteristics of miRNAs, some of which are strain-
specifically regulated, suggesting that a large number of genes are likely targeted to be 
post-transcriptionally regulated (Braun et al., 2010).  Also, a functional RNA silencing 
machinery is expressed, however it is somewhat modified compared to most widely 
characterized systems (Braun et al., 2010; Musiyenko et al., 2012).  While perfect miRNA-
target matches can be cleaved by AGO, imperfect matches are also cleaved through the 
actions of a Tudor nuclease, which is recruited to AGO through a methylation-dependent 
mechanism (Musiyenko et al., 2012). 
Many more cases of transcript-specific translational repression occur through the 
direct interactions between cis-acting elements and RBPs.  These act to withdraw the 
transcript from the translational pool while serving as key factors in the remodeling of the 
mRNP complex.  One of the most commonly studied families of cis-acting elements that 
mediate translational control in mammalian cells are AU-rich elements (ARE)s which 
consist of overlapping AUUUA motifs (Brooks and Blackshear, 2013).  Typically located 
within 3’UTRs, AREs have been shown to bound by a variety of translational repressors 
such as tristeraprolin (TTP) which generally induces the degradation of the transcript 
(Brooks and Blackshear, 2013; Arribas-Layton et al., 2013).  AREs are also capable of 
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binding other factors such as the T cell internal antigen-1 (TIA1), which is an RBP involved 
in the translational repression and storage of transcripts under stress (Cruz-Gallardo et al., 
2013).  Furthermore, TIA1 also binds 5’oligo pyrimidine tracts, which represents a major 
category of repressed transcripts upon stress-induced TOR-inactivation (Cruz-Gallardo et 
al., 2013; Thoreen et al., 2012). 
A large amount of research on transcript-specific translational repression has been 
conducted on oocytes and the early embryogenesis stages of development.  During these 
stages, transcription is non-functional and all protein translation derives from stored 
maternal transcripts, therefore offering an opportunity to study translational control in a 
biological system without the background signal potentially generated from ongoing 
transcription (Vardy and Orr-Weaver, 2007; Barckmann and Simonelig, 2013).  In 
Drosophila, a key upstream regulator in the developmental gene expression cascade is the 
RBP SMAUG, which binds a structural cis-acting element in the 3’UTR of its target 
transcript NANOS (Vardy and Orr-Weaver, 2007; Crucs et al., 2000).  This element consists 
of bipartite RNA hairpins with terminal CNGGN loop motifs extending from a central stem 
and underlines that RNA structure plays an important role in its function (Crucs et al., 2000; 
Barckmann and Simonelig, 2013).  In order to confer translational repression, SMAUG 
recruits the 4E-BP CUP which competes with eIF4G in order to inhibit translational 
initiation and deadenylation (Nelson et al., 2004; Vardy and Orr-Weaver, 2007).  
Interestingly, the NANOS protein itself is also involved in the translational repression of 
transcripts containing the nanos response element (NRE), a UC-rich element consisting of 
two central UUGU motifs (Vardy and Orr-Weaver, 2007; Zamore et al., 1997).  
HUNCHBACK contains a NRE within its 3’UTR and is bound by PUMILIO, a PUF family 
48 
 
protein which is responsible for recruiting the other members of the NRE complex, 
NANOS and BRAIN TUMOR (Vardy and Orr-Weaver, 2007).  In turn, the NRE complex 
recruits the deadenylation complex and d4EHP, an inhibitory cap-binding protein with high 
homology to eIF4E that lacks the capacity to interact with eIF4G (Vardy and Orr-Weaver, 
2007). 
PUF family members have been shown to play roles as translational repressors 
involved in the controlling of developmental stage progression in a variety of organisms 
throughout the evolutionary tree including apicomplexan parasites (Gomes-Santos et al., 
2011).  In Plasmodium female gametocytes, the PUF2 protein binds a large number of 
translationally repressed transcripts, including those encoding the major ookinete surface 
antigens P25 and P28, through a PUF-binding element which consists of a UGUX3-5UA 
motif located in either the 5’ or 3’UTR of the target transcript (Miao et al., 2013; Braks et 
al., 2008).  Translational repression of these transcripts is relieved upon conversion to 
zygotes, where transcription is restricted after gamete fertilization (Mair et al., 2006).  
Interestingly, PUF2-mediated translational repression also acts in other stages of the 
parasite’s life cycle.  Disruption of PUF2 in the salivary gland sporozoite stage of 
development causes the premature translation of repressed transcripts, including 
transcription factors (Miao et al., 2013).  In turn, large scale alterations in the parasite’s 
transcriptome occur resulting in the premature conversion to the mammalian liver stage of 
the parasite while still in the mosquito (Miao et al., 2013).  These changes point to 
Plasmodium PUF2 serving as a master regulator of developmental progression by working 
as a stage-specific translational repressor (Miao et al., 2013).  Intriguingly, the Toxoplasma 
PUF2 homolog, PUF1, is capable of binding Plasmodium PUF-binding elements in vitro, 
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is upregulated in bradyzoites, and preferentially translated under stressful conditions, 
raising the interesting possibility of it serving a similar function in mediating Toxoplasma 
development (Liu et al., 2014; Joyce et al., 2013). 
 Fate of translationally repressed mRNAs 
 The translational machinery and repressor proteins remain in competition throughout 
the life of the transcript since, under the right conditions, repressed transcripts can re-enter 
the translational pool (Anderson and Kedersha, 2008).  However, by limiting access to the 
translational machinery, a translational repressor can remodel the mRNP components by 
revealing novel sites on the transcript for RBP interactions and by directly promoting the 
association of other RBPs involved in mediating a transcript’s turnover, long-term 
maintenance, and / or sub-cellular localization (Vardy and Orr-Weaver, 2007; Arribas-
Layton et al., 2013; Hooper and Hilliker, 2013).  Although the processes of translational 
repression can be separated from its downstream fate, withdrawal from translation typically 
induces the physical movement of the transcript into sub-cellular foci where they are 
processed either for degradation, short-term storage, or long-term storage and maintenance 
(Anderson and Kedersha, 2008). 
1.9.1 Processing bodies and mRNA degradation 
In many cases, RBPs that induce translational repression also promote the association 
of machinery involved in the transcript’s degradation.  For example, the translational 
repressors TTP and PUF proteins have been shown to interact with the machinery involved 
in the removal of the poly(A) tail and 5’cap (Godwin et al., 2013; Arribas-Layton et al., 
2013).  Typically mRNA decay occurs in a series of steps, the first of which is the 
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degradation of its poly(A) tail through the actions of the 3’ to 5’ poly(A) specific 
ribonuclease or a functional equivalent (Godwin et al., 2013).  Notably, this step is 
reversible and while the shortening of the poly(A) inhibits the association of PABP with 
eIF4G, its lengthening by a cytoplasmic poly(A) polymerase is key to re-initiation of 
translation (Sonenberg and Hinnebusch, 2009; Godwin et al., 2013).  Maintaining a short 
poly(A) tail is a key method by which transcripts are kept in a state of translational 
quiescence and the balance of tail shortening versus tail lengthening helps dictate the 
translational competence throughout development (Godwin et al., 2013).  Deadenylation 
greatly enhances the second step in mRNA decay, the removal of the 5’ cap from the 
transcript (Arribas-Layton et al., 2013).  The decapping complex, consisting of DCP1 and 
DCP2, catalyses the removal of a 7-methyl-GDP from the transcript, leaving a 
monophosphate 5’ terminal nucleotide (Arribas-Layton et al., 2013).  The decapping 
machinery can be specifically recruited to transcripts through the use of RBP adaptors such 
as TTP, PUF proteins, and the yeast DEAD box helicase DHH1 (Arribas-Layton et al., 
2013). 
Aside from serving as recognizable components to promote translation, the 5’cap and 
poly(A) tail also play an important role in protecting the transcript from the ribonucleases 
present in the cell (Topisirovic et al., 2011; Nagarajan et al., 2013; Chlebowski et al., 2013).  
Removal of these elements subjects the transcript to 3’ to 5’ degradation as it is threaded 
into the exosome as well as to the 5’ to 3’ exonuclease activity of XRN1.  These 
exonucleases also act in other pathways with the exosome being responsible for degrading 
transcripts through nonsense mediated decay and removing the 5’ fragment of AGO-
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cleaved transcripts while the XRN1 exonuclease degrades the 3’ fragment (Chlebowski et 
al., 2013; Nagarajan et al., 2013). 
In most eukaryotes, the mRNA degradation machinery is preferentially localized in 
cytoplasmic foci called processing bodies (P-bodies; Anderson and Kedersha, 2008).  In 
metazoans, P-bodies contain a key scaffolding protein, GW182, while the decapping and 
deadenylase machinery are characteristic components of P-bodies in all organisms (Moser 
and Fritzler, 2010; Eulalio et al., 2007; Anderson and Kedersha, 2008).  They also contain 
translational repressor proteins such as PUF proteins, TTP, DHH1, and AGO while 
excluding PABP and translational initiation factors (Anderson and Kedersha, 2008; 
Godwin et al., 2013; Hooper and Hilliker, 2013).  While P-bodies can be present under 
normal growth conditions, they have been shown to increase in aggregation under stressful 
conditions (Anderson and Kedersha, 2008).  Interestingly, it has been suggested that the 
stress-induced increase in P-body formation is a result rather than a mechanism of increased 
transcript decay, as degradation proceeds unimpeded if P-body assembly is inhibited 
(Anderson and Kedersha, 2008; Eulalio et al., 2007). 
1.9.2 Stress granules and short term storage of transcripts 
Stress granules (SGs) are cytoplasmic foci that form rapidly in response to eIF2α 
phosphorylation and consist of transcripts stalled in the process of translational initiation 
(Anderson and Kedersha, 2008).  While SGs and P-bodies share many components 
including translational repressors like TIA1, TTP, AGO, DHH1, and SMAUG as well as 
mRNA, SGs are uniquely characterized by the inclusion of PABP, various eIFs and the 
small 40S ribosomal subunit consistent with its role in aggregating stalled translational 
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machinery (Anderson and Kedersha, 2008).  Furthermore, in contrast to P-bodies and 
consistent with SGs containing primarily stalled initiation transcripts, mRNAs within SGs 
are polyadenylated (Stoecklin and Kedersha, 2013). 
In contrast to most other large cytoplasmic mRNP granules, the aggregation of SGs 
is fairly well defined (Moser and Fritzler, 2010; Anderson and Kedersha, 2008).  The 
decrease in available ternary complex in response to eIF2α phosphorylation drastically 
reduces the rate of translational initiation, while translational elongation and termination 
proceeds unimpeded (Anderson and Kedersha, 2008).  This causes the run off of translating 
ribosomes and the accumulation of stalled initiation complexes (Anderson and Kedersha, 
2008).  The removal of the translational machinery from the transcript at this step may 
allow for increased RBP interactions causing transcript-specific translational repression 
(Arribas-Layton et al., 2013).  Subsequently, mRNP aggregation and nucleation occurs, 
likely through the actions of prion-like domains in certain RBPs, such as those seen in TIA1 
and some RNA helicases (Anderson and Kedersha, 2008; Voronina et al., 2011).  This 
aggregation then intensifies as more RBP-mRNA and protein-protein interactions occur 
(Anderson and Kedersha, 2008).  Notably, the interactions mediating SG assembly are 
thought to be fairly weak and SGs have been said to have a liquid-like structural fluidity, 
with RBP components such as TIA1, TTP, and PABP rapidly shuttling in and out of SGs 
(Voronina et al., 2011, Stoecklin and Kedersha, 2013; Moser and Fritzler, 2010; Anderson 
and Kedersha, 2008).  Furthermore, inhibition of translational elongation depletes SGs 
formation, suggesting that the dynamic SG components are in equilibrium with the 
translational machinery (Anderson and Kedersha, 2008). 
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While the identity of many SG-associated RBPs is known, the identity of transcripts 
that accumulate in SGs upon stress is less well established.  However, studies have shown 
that inclusion of transcripts within SGs is selective and mediated by cis-acting elements 
(Anderson and Kedersha, 2008; Hooper and Hilliker, 2013).  For example, housekeeping 
transcripts are preferentially recruited to SGs while transcripts corresponding to stress-
responsive genes get excluded (Anderson and Kedersha, 2008).  Notably, while the latter 
category consists of transcripts that are translationally permissive under stress, the former 
members are translationally repressed.  This has led to the theory that SGs are essential to 
the relief of cellular stress by allowing stress-responsive transcripts to receive preferential 
access to the limited amount of functional translational machinery (Kedersha and 
Anderson, 2002; Yamasaki and Anderson, 2008). 
The existence of stress-induced mRNA cyctoplasmic foci with the appearance and 
characteristics of SGs has recently been found in T. gondii (Lirussi and Matrajt, 2011).  
These granules appear exclusively during the extracellular phase of the parasite, are 
phospho-eIF2α dependent, and contain both PABP and the Toxoplasma homolog of yeast 
DHH1, but do not include AGO (Lirussi and Matrajt, 2011; Cherry and Ananvoranich, 
2014).  Notably, immunocytochemistry experiments have shown that both PABP and 
DHH1 completely overlap the signal generated by a fluorescent oligo-dT probe (Lirussi 
and Matrajt, 2011; Cherry and Ananvoranich, 2014).  Another study has found granules in 
extracellular parasites which are marked by the presence of the RBPs ALBA1 and ALBA2, 
with both proteins also showing perfect overlap with polyadenylated mRNA (Gissot et al., 
2013).  However, these granules have a distinct perinuclear localization and co-
immunoprecipitation studies using a mix of intracellular and extracellular tachyzoites have 
54 
 
shown that ALBA1 is associated with AGO as well as a host of translational machinery 
(Gissot et al., 2013).  Furthermore, ALBA1 has been implicated in the translational 
activation of transcripts (Gissot et al., 2013).  While different experimental conditions and 
/ or the dynamics of the partners involved may account for these discrepancies, further 
research into the composition and dynamics of stress-induced polyadenylated mRNA-
containing granules is needed. 
Interestingly, the formation of mRNA-containing granules has been shown to be 
important for Toxoplasma to successfully transition from the extracellular to the 
intracellular environment (Lirussi and Matrajt, 2011).  Extracellular tachyzoites that were 
inhibited from forming mRNA-containing granules displayed reduced invasion and growth 
(Lirussi and Matrajt, 2011).  It was suggested that these granules served to promote the 
sequestration of “intracellular” transcripts during the extracellular period, therefore giving 
preference to “extracellular”-responsive transcripts and preparing for intracellular growth, 
in turn increasing the fitness of the parasites (Lirussi and Matrajt, 2011).  This suggests a 
short-term salvage strategy is used by the parasite to selectively withdraw transcripts from 
the translation pool under stressful conditions and maintain them for use in a later 
developmental phase and is consistent with the hypothesized role of canonical stress 
granules (Lirussi and Matrajt, 2011; Kedersha and Anderson, 2002; Yamasaki and 
Anderson, 2008; Moore, 2005). 
1.9.3 Germ granules and long term storage of transcripts 
It has been suggested that in Toxoplasma, stress-induced generalized translational 
repression provokes the degradation of translationally repressed transcripts through mRNA 
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decay mechanisms (Joyce et al., 2013).  While this is likely the case in the vast majority of 
repressed transcripts, it raises the question as to what happens to those transcripts that lack 
translational competency and yet are maintained at appreciable levels in bradyzoites, which 
can lie dormant for decades before initiating stage conversion to tachyzoites.  This 
observation is suggestive of a developmentally-controlled mechanism that selectively 
reduces the mRNA turnover of certain transcripts while inhibiting their translation. 
A common system for studying the long-term maintenance of transcripts and how 
this relates to developmental cycles in eukaryotes is the oocyte and its transition to the early 
zygote after fertilization (Vardy and Orr-Weaver, 2007; Barckmann and Simonlelig, 2013).  
Oocytes contain a variety of specialized mRNA-containing granules, some of which are 
able to stably store transcripts over the period of days to years depending on the organism 
(Voronina et al., 2011; Hooper and Hilliker, 2013; Schisa, 2012).  Importantly, these 
transcripts appear to be recruited in a transcript-specific manner mediated by the interaction 
between specific cis-acting elements and trans-acting factors (Vornonina et al., 2011; 
Schisa, 2012).  For example, in Drosophila, the RBP BRUNO binds the Bruno response 
element in the 3’UTR of the OSKAR transcript and recruits CUP, causing its translational 
repression and recruitment to germ granules, which have been implicated in long-term 
mRNA storage (Vornonina et al., 2011; Barckmann and Simonelig, 2013). 
Importantly, while germ granules, P-bodies, and SGs have been shown to share many 
components, they are distinct entities.  In contrast to SGs, germ granules do not contain 
translational initiation components (Voronina et al., 2011).  While germ granules may seem 
more similar to P-bodies, the former contain a greater amount of transcript-specific 
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translational repression machinery and does not lead to the decay of transcripts (Voronina 
et al., 2011; Barkmann and Simonelig, 2013).  It has therefore been suggested that germ 
granules may be a functional hybrid or specialized form of SGs and / or P-bodies (Voronina 
et al., 2011).  Supporting this hypothesis is the fact that shared components can have 
different functions in these granules.  For example, while the homolog of DHH1 in 
Drosophila aids in the recruitment of decay machinery in P-bodies, it is an essential 
component for the stability of transcripts in germ granules and its loss leads to sterility 
(Voronina et al., 2011).  Also, in mouse oocytes it has been shown that GCN2 kinase is 
upregulated which causes an increase in eIF2α phosphorylation that is only alleviated after 
zygote formation (Alves et al., 2009).  Notably, this occurs concurrently to the disruption 
of germ granules and an increase in general translation (Alves et al., 2009).  Taken together, 
these results offer a link between generalized translational repression, germ granule 
formation, and the long-term storage and maintenance of transcripts as well as between 
germ granule dissolution, translational activation, and developmental progression in higher 
eukaryotes. 
In Plasmodium, similar mRNA-containing granules have been shown to form in 
female gametocytes (Mair et al., 2006; Mair et al., 2010).  It is important to note that in the 
Plasmodium lifecycle, gametocytes reside in mammalian red blood cells and must wait 
until they are taken up by the mosquito in order to initiate fertilization and progression into 
zygotes.  eIF2α is maintained in a phosphorylated state by the kinase IK4 in gametocytes 
and transcripts, including the zygote-specific surface antigens P25 and P28, are maintained 
in a state of translational quiescence (Zhang et al., 2012; Hall et al., 2005).  Importantly, 
these transcripts localize to mRNA granules contingent on a 47 nucleotide U-rich cis-acting 
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element that can be located in either the 5’- or 3’UTR (Mair et al., 2006; Hall et al., 2005; 
Braks et al., 2008).  More recently, these elements have been shown to be bound by the 
translational repressor PUF2 in vitro and notably, a PUF2 deletion mutant displayed 
increased P25 and P28 steady state transcript and protein levels, suggesting that this 
interaction is essential for their translational repression in vivo (Miao et al., 2013).  The 
maintenance of these mRNA granules depends on the Plasmodium DHH1 orthologue, 
DOZI (Mair et al., 2010).  Similar to metazoan germ granules, disruption of DOZI causes 
the loss of stored transcripts, including P25 and P28, and the inability to develop into 
zygotes after fertilization (hence the name Development Of Zygote Inhibited; Voronina et 
al., 2011; Mair et al., 2010).  Although a co-immunoprecipitation study failed to find an 
association between PUF2 and DOZI in female gametocytes, these data would correlate 
with a model very similar to that of sexual development in higher eukaryotes and led the 
authors to suggest that the mRNA granules in Plasmodium female gametocytes act 
specifically to store translationally repressed transcripts in anticipation of stage conversion, 
similar to what is seen for maternal transcripts in the germ line of metazoans (Mair et al., 
2010). 
Interestingly, it appears that this mechanism is not limited to sexual reproduction in 
apicomplexan parasites.  The transmission of Plasmodium from mosquitoes is also marked 
by a long delay where sporozoites must wait in the mosquito salivary glands until they are 
delivered to the mammalian host, where they can then enter the next developmental phase 
in the mammalian liver.  Salivary gland sporozoites are under a state of global translational 
repression mediated by IK2-induced eIF2α phosphorylation and this stage is characterized 
by polyadenylated mRNA and PABP-containing granules that are needed in order to 
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maintain their developmental state (Zhang et al., 2010).  Furthermore, deletion of PUF2 in 
salivary gland sporozoites, which normally displays granular localization, causes the 
release of translationally repressed transcripts, including those encoding transcription 
factors, and premature differentiation into liver-stage parasites (Gomes-Santos et al., 2011; 
Müller et al., 2011).  The potential involvement of DOZI in sporozoite storage granules 
remains unexplored, however its involvement may be limited since it is transcriptionally 
down regulated during this stage (Müller et al., 2011). 
These data are consistent with the notion that in apicomplexan parasites, select 
translationally repressed transcripts are shuttled to storage granules by RBPs based on their 
recognizable cis-acting elements and maintained until the commencement of the next 
developmental phase.  In contrast to the “just-in-time” model of transcriptional regulation, 
this “store-and-go” mode of PTGR may be more favourable in certain circumstances since 
it allows for more rapid translation with less energy input upon developmental transition 
(Mair et al., 2006). 
To date, the existence of bradyzoite-specific mRNA-containing storage granules 
have not been discovered in Toxoplasma and a comprehensive list of translationally 
quiescent transcripts has been impossible to generate because, although the identification 
of most transcriptionally regulated transcripts are known through EST, SAGE, and 
microarray experiments, a study identifying the bradyzoite proteome, which could be used 
to generate such a list, has not been performed (Manger et al., 1998; Radke et al., 2005; 
Cleary et al., 2002).  Instead, sporadic reports throughout the literature have demonstrated 
that while certain genes have their transcripts expressed at appreciable levels in both stages, 
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their cognate protein is undetectable in bradyzoites.  Examples include the RNA-binding 
DNA repair enzyme TgDRE and the canonical tachyzoite marker LDH1 (Dendouga et al., 
2002; Yang and Parmley, 1997).  Furthermore, a transcriptional pulse-chase assay 
identified a number of transcripts whose overall mRNA abundance is maintained in 
bradyzoites despite reduced transcriptional activity suggesting that they are preferentially 
stored (Cleary et al., 2005).  These include transcripts that encode transcriptional and 
translational machinery as well as the canonical tachyzoite marker SAG1 (Cleary et al., 
2005).  Like LDH1, the SAG1 protein is widely used as an immunological marker to 
identify the tachyzoite stage and is not present in mature bradyzoites (Ferguson, 2004).  
These findings, taken together with the role of stage-dependent translational repression 
suggest that, as seen in Plasmodium, a stage-specific mechanism exists in bradyzoites to 
selectively store and maintain transcripts in anticipation of tachyzoite stage conversion. 
 Objectives 
Successful tachyzoite and bradyzoite interconversion is crucial for the parasite’s 
survival and for its ability to be transmitted to a new host.  As such, understanding how 
Toxoplasma copes during a stressful insult is an essential part of understanding its 
fundamental biology.  This works aims to further the investigation into the stress response 
mechanism.  In Chapter 2, a demonstrated anti-parasitic agent, securinine, was investigated 
in an in vitro model of Toxoplasma infection.  Its influence on parasite replication and 
bradyzoite differentiation is outlined.  Using the translationally repressed LDH1 as a model, 
Chapter 3 describes the identification and characterization of a small RNA cis-acting 
regulatory element that is responsible for mediating transcript-specific translational 
repression in bradyzoites.  Finally, Chapter 4 outlines efforts made towards identifying the 
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trans-acting factors associated with the LDH1 transcript while it is undergoing translational 
repression as well as generally characterizing the mechanism.  
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CHAPTER II – Toxoplasma gondii: Inhibitory activity and encystation effect of 
securinine and pyrrolidine derivatives on Toxoplasma growth 
 Introduction 
Toxoplasma gondii is a widespread opportunistic pathogen of both veterinary and 
human importance.  In the otherwise healthy individual, the immune system keeps the 
parasite in the asymptomatic dormant bradyzoite state.  However, upon immune system 
suppression the conversion of bradyzoites to the rapidly growing tachyzoites cause a 
recurrence of acute infection which may lead to toxoplasmic encephalitis (Montoya and 
Liesenfeld, 2004).  The current treatment for acute toxoplasmosis calls for a combined 
approach using pyrimethamine and sulfadiazine, both folate inhibitors.  In certain 
circumstances, clindamycin, a protein synthesis inhibitor, may also be indicated.  However, 
the currently available drugs have a variety of side effects including intolerance (Montoya 
and Liesenfeld, 2004).  Also, resistance to some of the classical drugs of treatment has been 
reported in T. gondii (Aspinall et al., 2002), as well as other apicomplexans, most notably 
pyrimethamine resistant Plasmodium falciparum (Mita et al., 2009).  It is therefore 
important to discover novel drugs that act upon a multitude of parasite-specific targets. 
Many studies have been launched to investigate currently used drugs for their 
possible uses as anti-parasitic agents.  Jones-Brando et al. (2003) showed that a number of 
drugs acting on the central nervous system (CNS), such as the anti-psychotics haloperidol 
and olanzapine, exhibit anti-Toxoplasma activity.  Cortez et al. (2008) showed that 
simvastatin, an anti-hypercholesterolemic statin, inhibits the growth of T. gondii in 
macrophages in vitro.  Other efforts have turned towards the active ingredients found in 
traditional Chinese medicines for drug discovery (Jiang et al., 2008; Ke et al., 1990). 
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One compound that has shown promise is securinine, an alkaloid produced by 
Securinega suffruticosa.  As reviewed by Raj and Luczkiewicz (2008), the plant is one of 
the 50 basic medical plants in traditional Chinese phytotherapy and was used in the 
treatment of various ailments ranging from rheumatic disease, quadriplegia, paralysis 
following infectious disease, and impotence.  Also, in Russia, where it was initially isolated 
and used for its GABA antagonistic activity as a CNS stimulant, securinine was referred to 
as a drug in the 10th Russian Pharmacopoeia-1968, although its drug registry later expired.  
A previous report has shown that this compound also shows an inhibitory effect against P. 
falciparum (Weenen et al., 1990). More recently, Rana et al. (2010) reported that securinine 
can preferentially kill cancer cells while protecting normal cells and acts via the p73-
dependent apoptotic pathway. 
In this study we have analysed the effects of securinine on the proliferation of T. 
gondii in vitro. Moreover, 10 pyrrolidine compounds, which were synthesized from trans-
4-hydroxy-L-proline to complete the asymmetric total synthesis of (–)-securinine 
(Dhudshia et al., 2009), have been selected for the study.  Assessing their inhibitory effect, 
we show that securinine and the pyrrolidine derivatives have unique properties in inhibiting 
T. gondii proliferation in comparison to pyrimethamine, the classical anti-toxoplasmosis 
drug. 
 Materials and methods 
2.2.1 Host cell and parasite cultures 
All experiments were carried out using human foreskin fibroblasts (HFF) that were 
cultured using DMEM medium with L-glutamine and high glucose (Invitrogen, Canada), 
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supplemented with 10% Cosmic calf serum (Hyclone, Logan, Utah), 0.5x antibiotic–
antimycotic (Invitrogen, Canada) in 5% CO2.  Tachyzoites of T. gondii strains RHΔHX 
(NIH AIDS Research and Reference Reagent Program-2857), a commonly used laboratory 
strain lacking the gene hypoxanthine-xanthine-guanine phosphoribosyl transferase (Donald 
et al., 1996), and 2F (ATCC-50839) were propagated in HFF grown in MEM medium with 
L-glutamine (Invitrogen, Canada), supplemented with 1% dialyzed fetal bovine serum 
(Hyclone) and 0.5x antibiotic–antimycotic. 
2.2.2 Inhibition and cytotoxicity assays 
Securinine and 10 pyrrolidine derivatives (Figure 2.1) were dissolved in DMSO to 
obtain a final concentration of 1 mM. Various concentrations of these compounds (0.1–100 
µM followed by 1–1000 µM if the compound showed anti-Toxoplasma activity but no host 
cell cytotoxicity in the first range tested) were tested for inhibitory effects on T. gondii 
proliferation using 96-well plates.  Fifty freshly released 2F tachyzoites, which express β-
galactosidase (McFadden et al., 1997), were inoculated onto 6/8 wells in each column.  On 
day 3, the β-gal substrate, chlorophenol red–β-D-galactopyranoside, was added and the 
plate was incubated overnight.  On the fourth day, cytotoxicity effects of tested compound 
were measured in the remaining 2/8 wells per column using the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) colorimetric assay as previously 
described (Tominaga et al., 1999).  Colour reactions in all wells were read in a Victor3 
microplate reader (PerkinElmer).  Experiments were performed in triplicate.  DMSO 
(solvent for the stock solution) was also tested for its inhibitory effect and cytotoxicity (data 
not shown).  After normalizing for experimental variations and expressing data in 
percentage positivity to control for individual experimental variations (Gubbels et al., 
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2003), all inhibitory concentrations (IC50) and toxic doses (TD50) were determined using 
the Reed–Muench formula (Reed and Muench, 1938) and the therapeutic index (TI) was 
calculated with the formula TI = TD50/IC50 (Table 2.1).  Calculated partition coefficient 
(clogP) and partition coefficient (logP) values were obtained using ChemDraw version 
11.0 software (Cambridgesoft, Cambridge, MA).  
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Figure 2.1 Securinine and 10 pyrrolidine precursors generated via the retrosynthesis of 
(–)-securinine. 
The pyrroldinine precursors (Dhudshia et al., 2009) are divided into groups by their anti-
Toxoplasma activity.  The structurally unrelated pyrimethamine, the classical anti-
toxoplasmosis agent, is included for reference. 
  
Group A
Group B
Group C
Group D
Reference
Compounds
1 3 8
3154
11 21
41 51
PyrimethamineSecurinine
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2.2.3 Tachyzoite growth rate assessment 
Both confluent HFF monolayers grown on cover-slips and freshly lysed RHΔHX 
tachyzoites were harvested and incubated for one hour in the tested compound at their 
respective IC50 (DMSO used as control).  After the initial one hour incubation, the parasites 
were allowed to infect the cover-slips and grow for either 24 or 36 h for the determination 
of growth inhibition.  The cover-slips were subjected to 3% paraformaldehyde fixation and 
then Hoechst stained (final concentration 10 µM).  For each compound, 100 vacuoles were 
counted from three independent trials.  Average vacuole size was determined using the 
weighted average and doubling time was determined using algorithm provided by 
http://www.doubling-time.com/compute.php. 
2.2.4 Invasion assay 
Confluent HFF monolayers were grown on cover-slips and an equal number of 
extracellular tachyzoites (approximately 7.5 x 104) were incubated with parasite culture 
media in the presence of selected compounds at their respective IC50 for 1 h.  The parasites 
were then used to infect the HFFs and allowed to grow for 24 h, after which they were fixed 
and stained with Hoechst.  Fifty randomly chosen microscopic fields of view were then 
examined and the density of parasitophorus vacuoles per field of view was determined.  
Each experiment was performed in triplicate. 
2.2.5 Extracellular viability assay 
Freshly lysed RHΔHX tachyzoites were pelleted and resuspended in parasite 
culturing media containing the compound of interest at their respective IC50 (DMSO for 
control) for 1, 2, 3, or 24 h.  At each time point, tachyzoites were stained with propidium 
90 
 
iodide (final concentration 1 µg/ml; Sigma Aldrich) and placed on a slide.  Ten random 
fields of view were chosen for each tested compound and tachyzoite viability was assessed 
by propidium iodide staining. 
2.2.6 Determination of parasite differentiation 
To evaluate the ability of the test compounds to induce parasite differentiation, 
freshly lysed RHΔHX tachyzoites were used to infect confluent HFF monolayers grown on 
cover-slips in the presence or absence of tested compounds for 3 days.  At least three 
independent experiments were performed for each compound.  Cover-slips were fixed in 
3% paraformaldehyde then permeabilized with 0.25% Triton-X in PBS for 10 min and then 
incubated with 5% BSA in PBS for 1 h. Cover-slips were subsequently incubated with 
Dolichos biflorus lectin conjugated with FITC (Sigma Aldrich) in order to probe for the 
presence of the cyst wall glycoprotein, a marker of parasite differentiation (Zhang et al., 
2001).  Hoechst stain was used for localizing the nuclei of parasite and HFF.  As control 
conditions for the detection of differentiation and cyst wall formation, the parasite was 
grown under alkali conditions (RMPI medium containing 25 mM HEPES, pH 8.3, 5% 
dialyzed fetal bovine serum) and atmospheric CO2.  Slides were mounted and examined 
with a Leica DMIRB microscope.  All images were taken with a cooled Q-Imaging CCD 
camera using the Northern Eclipse software.  One hundred vacuoles from each independent 
experiment were examined for the presence of cyst wall glycoprotein among vacuoles 
formed. 
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 Results and discussion 
2.3.1 Cytotoxic and inhibitory effect of securinine and pyrrolidine derivatives 
Ideally an anti-microbial compound should have minimal toxicity towards the host 
while showing high selectivity and toxicity toward microorganisms.  Therefore, we first 
evaluated the cytotoxic effects of securinine and pyrrolidine derivatives on HFFs in 
comparison to pyrimethamine.  Using MTT assays, tested compounds showed varied 
cytotoxic doses (TD50) ranging from 32 to 291 µM (Table 2.1).  Securinine was less 
cytotoxic (TD50 = 81 µM) compared to pyrimethamine, the reference compound (TD50 = 
44 µM).  Compounds 1 and 8 were the most cytotoxic with TD50 of 32 and 34 µM, 
respectively, while the other compounds exhibited equal or less cytotoxicity than 
pyrimethamine.  Compound 21 showed the least cytotoxicity with TD50 of 291 µM with a 
high standard deviation. 
Using β-gal expressing 2F tachyzoites, we evaluated the anti-Toxoplasma property 
of securinine and pyrrolidine derivatives.  Securinine exhibited an inhibitory effect against 
T. gondii proliferation with an IC50 of 9.8 µM (Table 2.1).  Most of the synthetic pyrrolidine 
precursors of securinine had good activity against T. gondii with IC50s in the micromolar 
range.  Based on their inhibitory effect, these pyrrolidine derivatives can be categorized 
into four groups.  Group A contains compounds 1, 3 and 8 with similar IC50 values ranging 
between 3 and 6 µM.  Group B includes compounds 4, 5, and 31 showing IC50 values ~30 
µM.  Group C, comprised of compounds 11 and 21, show IC50 values of ~60 μM.  The 
fourth group, Group D, made up of compounds 41 and 51, which have negative logP values, 
did not show any inhibitory effect on parasite proliferation at the tested concentrations (IC50 
> 100 µM).  Since logP values are an indicator of physicochemical properties and reflect 
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how well a compound will distribute across cell membranes (the higher logP value, the 
more hydrophobic the compound; Patrick, 2009), their lack of inhibitory effect on T. gondii 
proliferation could be explained by their inability to cross the host cell membrane.  Notably, 
the most effective compounds in inhibiting T. gondii proliferation, Group A, have the 
highest calculated logP values (clogP ~5) and the lowest IC50 (~5 µM).  Group C has logP 
values less than 1 with IC50 > 100 µM and is the least biologically effective.  The data thus 
suggest that the pyrrolidine derivatives showing the most biological activity are those that 
are most able to diffuse across the cell membrane. 
Among the pyrrolidine compounds tested here, we found that the higher the logP 
value, the lower IC50 value.  However, this biological and physicochemical relationship 
cannot be extended to explain the biological effect of securinine (logP = 0.54).  This is 
possibly due to its different structural features.  Securinine, with a tricyclic structure, does 
not retain the pyrrolidine structure, although it is derived from the same trans-4-hydroxy-
L-proline precursor (Dhudshia et al., 2009).  We thus postulated that securinine inhibits the 
parasite proliferation using a different mode and / or target than pyrrolidine derivatives. 
To evaluate whether tested compounds show promising therapeutic properties, we 
used the therapeutic index as an indicator to compare securinine and pyrrolidine derivatives 
to pyrimethamine (TI of 100).  All compounds tested here showed much lower therapeutic 
indices than pyrimethamine (Table 2.1), suggesting that further chemical modifications 
onto the structure of securinine and pyrrolidine analogs tested here are required to achieve 
equivalent or better anti-toxoplasmosis activity.  Securinine and Group A (compounds 1, 3 
and 8) showed the best therapeutic indices (TI = ~9).  Compounds 4 and 5 are stereoisomers 
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and show the same TI of 3.  Group C (compounds 11 and 21) showed some inhibitory effect 
with variable cytotoxicity.  Although these compounds are not yet suitable for a commercial 
development, it is crucial to gain a better understanding of their mode of action.  The 
information will aid future rational drug design of anti-toxoplasmosis agents.  We therefore 
chose to further examine securinine as well as Group A compounds as they displayed the 
highest anti-Toxoplasma activity. 
Table 2.1 T. gondii inhibitory concentrations (IC50) and HFF toxic doses (TD50) of 
securinine and pyrrolidine derivatives in comparison to those of pyrimethamine. 
 
a Values ± standard deviation. 
b Calculated logP. 
c compounds not biologically active at tested concentrations (0.1 – 100 μM). 
 
2.3.2 Inhibitory effect of securinine and pyrrolidine derivatives on the parasite lytic cycle 
During infection leading to toxoplasmosis, T. gondii tachyzoites progress through the 
lytic cycle, comprised of three distinct phases: invasion of host cells, intracellular 
replication, and destruction of host cells (Black and Boothroyd, 2000).  The destruction of 
host cells coincides with the egress of tachyzoites which remain extracellular until they 
Compound logP IC50
a TD50
a TI 
Securinine 0.54 9.8 ± 1.6 81 ± 20 8 
1 5.4695b 3.9 ± 1.2 32 ± 14 8 
3 4.8175b 5.6 ± 1.6 54 ± 17 10 
4 2.92155b 27.4 ± 17 80 ± 2 3 
5 2.92155b 26.6 ± 12.2 83 ± 3 3 
8 4.66115b 3.9 ± 0.6 34 ± 11 9 
11 0.48 63.3 ± 8.4 84 ± 4 1 
21 0.45 60.4 ± 22.7 291 ± 268 - 
31 2.64 27.0 ± 18.5 49 ± 4 2 
41c -0.03  -   -  - 
51c -0.21  -   -  - 
Pyrimethamine 2.69 0.4 ± 0.1 44 ± 2 100 
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successfully invade new host cells and begin another cycle.  We therefore examined various 
steps of the lytic cycle to further understand the mechanisms by which securinine and 
Group A compounds affect intracellular growth. 
We first examined the effects these compounds had on intracellular replication by 
treating them with the compounds at their respective IC50 or DMSO as control.  The 
parasites were allowed to proceed for either 24 or 36 h post-infection after which they were 
fixed and stained with Hoechst to allow for examination of the intracellular growth rates.  
DMSO treated tachyzoites were able to replicate and give parasitophorus vacuoles 
containing 2, 4, 8, or 16 parasites at 24 h post-infection (Table 2.2).  Most vacuoles (63%) 
contained eight parasites at 24 h post-infection, whereas at 36 h the majority (50%) 
vacuoles contained 32.  This indicated a doubling time of approximately 6 h.  This is similar 
to that observed in RHΔHX parasites grown without DMSO (Radke et al., 2001).  We 
therefore concluded that the solvent of choice had little effect on intracellular growth rates 
and proceeded to see the effects of Group A compounds. 
Pyrimethamine, securinine and Group A compounds had an inhibitory effect on 
intracellular growth as can be seen by the decrease in the average vacuole size of these 
compounds when compared to DMSO treatment (Table 2.2).  Compounds 1 and 8 
suppressed intracellular growth the most, with the majority of vacuoles containing only two 
parasites at 24 h.  At 36 h, the majority of vacuoles contained eight parasites for all 
compounds tested with the exception of pyrimethamine, a difference of two replicative 
cycles from the DMSO control.  Although all compounds showed a decrease in average 
vacuole size, some were unable to decrease growth rate (as shown by doubling time) of the 
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parasites.  Securinine and compound 8 proved to be the most effective, increasing the 
doubling time by twofold, whereas compound 3 and pyrimethamine only moderately 
affected the growth rate.  Interestingly, compound 1 showed little effect on doubling time 
perhaps indicating that its anti-Toxoplasma effects rely primarily on an earlier step in the 
lytic cycle, possibly influencing host cell invasion. 
Table 2.2 Inhibition of T. gondii growth by securinine and pyrrolidine derivatives. 
 
a Averages of three trials. 
 
We therefore examined whether extracellular tachyzoites pretreated with either 
DMSO, securinine, compound 1 or pyrimethamine would impair invasion of host cells.  An 
equal number of extracellular tachyzoites were incubated in parasite culture media in the 
presence of selected compounds at their respective IC50 for 1 h, and then used to infect HFF 
monolayers.  The number of parasitophorus vacuoles per microscopic field of view was 
determined in order to give an indication of the parasite’s ability to infect host cells.  When 
treated with compound 1, the average vacuole density (0.35 ± 0.23 vacuoles per field of 
Compound 
Time 
(h) 
Number of parasites per vacuole (%)a 
Average 
vacuole 
Doubling 
    2 4 8 16 32 64 size time (h) 
DMSO 24 5 24 63 8   7  
 36 2 4 12 22 50 10 27 6 
Securinine 24 31 53 16    4  
 36 13 27 37 23   8 12 
Compound 1 24 55 43 2    3  
 36 11 20 39 26 3 1 10 7 
Compound 3 24 37 56 7    4  
 36 13 24 38 21 4  9 9 
Compound 8 24 51 48 2    3  
 36 17 31 46 6   6 12 
Pyrimethamine 24 23 56 21    4  
  36 2 11 34 45 8   13 8 
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view; VPF) decreased drastically by 70% when compared to the DMSO control (1.2 ± 0.28 
VPF), indicating that treatment with compound 1 impaired invasion.  A moderate decrease 
of about 40% was also observed in securinine (0.73 ± 0.13 VPF) and pyrimethamine (0.73 
± 0.29 VPF) treatments. 
A decrease in the number of vacuoles detected may either be due to a decrease in the 
ability of the parasite to invade a host cell, or due to a loss of viability of extracellular 
parasites during the 1 h incubation with the tested compound.  We therefore examined the 
effects of the above compounds on the viability of extracellular tachyzoites.  Freshly 
released extracellular tachyzoites were incubated in culture media in the presence of tested 
compounds for various durations.  Their viability was determined microscopically using 
propidium iodide staining.  Viable parasites are able to exclude the dye, while impaired or 
dead parasites accumulate the fluorescent dye.  As shown in Table 2.3, tachyzoites 
incubated with the tested compounds show similar viability as those treated with DMSO.  
We concluded that securinine, compound 1 and pyrimethamine were incapable of 
eliminating extracellular parasites under the tested conditions.  A previous report by Camps 
and Boothroyd (2001) found that pyrrolidine dithiocarbamate (PDTC), a pyrrolidine- 
containing compound, was able to selectively kill extracellular T. gondii tachyzoites.  
However, their results suggested that the cidal activity relied on a pro-oxidant pathway, not 
related to the pyrrolidine ring.  Our results support this and suggest that the primary role of 
the pyrrolidine ring in the extracellular cidal activity of PDTC may simply be to increase 
its hydrophobic nature, thereby facilitating crossing of the T. gondii membrane.  
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Table 2.3 Extracellular tachyzoite viability after compound treatment. 
 
 
2.3.3 Effect of securinine and pyrrolidine derivatives on parasite differentiation 
The rate of replication of intracellular parasites may be indicative of the 
developmental stage of the parasite.  While residing within warm-blooded animals, actively 
replicating tachyzoites switch into slow growing encysted bradyzoites in response to the 
immune system attack during disease progression.  Since the treatment of infected 
monolayers with securinine and some Group A compounds slowed the rate of parasite 
replication, we further investigated whether these compounds can induce T. gondii 
differentiation.  Tachyzoites were allowed to invade HFF without any pre-treatment.  The 
infected monolayers were then cultured in the presence of securinine or pyrrolidine 
derivatives at their respective IC50 for 3 days under normal culturing conditions (1% serum, 
pH 7, 5% CO2).  To detect presence of a cyst wall structure, we stained infected monolayers 
with FITC-labelled Dolichos biflorus lectin, which has high affinity to cyst wall 
glycoproteins.  As shown in Figure 3.2A, treatment with DMSO did not cause the formation 
of encysted parasites (upper panel).  Securinine treatment induced the formation of cyst 
structures (Figure 3.2A, middle panel) similar to those observed by induction under alkali 
conditions (pH 8.3, atmospheric CO2; Figure 3.2A, lower panel).  We thus compared the 
ability to induce differentiation by securinine to that of alkaline conditions.  We detected 
Time (h) Viability (%) 
  DMSO Sec C1 Py 
0 91 82 81 77 
1 92 86 89 82 
2 83 77 88 78 
3 80 78 84 82 
24 35 37 34 30 
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that approximately the same amount of RHΔHX strain parasites can be induced to form 
encysted bradyzoites under both conditions (Figure 3.2B).  Interestingly, none of the Group 
A compounds tested, including compound 8, which greatly decreased parasite doubling 
time, induced the formation of encysted parasites under tested conditions. 
  
99 
 
 
Figure 2.2 Securinine causes bradyzoite differentiation in vitro. 
RHΔHX tachyzoites were incubated for 3 days with selected compounds or in alkaline 
media. They were then stained with Hoechst (Hz) and with a cyst-specific FITC-
conjugated lectin (Dol-FITC) and microscopically examined for bradyzoite formation. 
(A) Visual comparison of tachyzoites treated with DMSO, securinine or alkaline media 
for 3 days. Scale bar equals 10 μm. (B) Differentiation rates of RHΔHX parasites 
incubated for 3 days in selected compounds. Sec, securinine; C1, compound 1; C3, 
compound 3; C8, compound 8; Py, pyrimethamine. 
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 Conclusion 
We have shown that securinine, a widely used alkaloid in traditional Chinese 
medicines, is useful as an anti-Toxoplasma agent that induces bradyzoite formation in vitro.  
Interestingly, Rana et al. (2010) have recently shown that securinine is also able to 
selectively kill p53 deficient colon cancer cells.  As an agent able to act upon the CNS (Raj 
and Luczkiewicz, 2008), securinine may have potential in cancer patients who have been 
previously infected with T. gondii.  Upon immune suppression from chemotherapy 
treatment, bradyzoites residing in the CNS may convert to tachyzoites, leading to 
toxoplasmic encephalitis (Montoya and Liesenfeld, 2004).  The addition of securinine to 
the chemotherapy mix may assist in both fighting the cancer and maintaining T. gondii in 
the dormant bradyzoite state. 
In addition to securinine, we also examined 10 synthetic precursors from the 
synthesis of (–)-securinine.  Although these pyrrolidine derivatives show varying potential 
as anti-Toxoplasma agents, they do offer important information in the development of 
future anti-toxoplasmosis compounds.  Their activity seems to correlate best to their 
hydrophobicity.  However, Group A compounds inhibit T. gondii proliferation at different 
steps of lytic cycle.  Compound 1 reduces T. gondii proliferation by limiting its invasion of 
host cells.  Compounds 3 and 8 slow down the intracellular growth rate of T. gondii without 
inducing bradyzoite differentiation.  These compounds show promise as a starting point 
from which to work forward in the development of novel invasion and growth inhibitors of 
T. gondii.  
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CHAPTER III – Sustained translational repression of lactate dehydrogenase 1 in 
Toxoplasma gondii bradyzoites is conferred by a small regulatory RNA hairpin 
 Introduction 
Toxoplasma gondii is an obligate intracellular parasite of the phylum Apicomplexa.  
It infects warm blooded animals with world-wide distribution and is estimated to infect up 
to a third of people (Pappas et al., 2009; Lafferty, 2006).  In intermediate hosts, T. gondii 
exists as one of two haploid stages, the rapidly growing tachyzoite or the dormant 
bradyzoite.  Tachyzoites are generally eliminated by the host’s immune system or drug 
therapy.  Under stressful conditions caused by the induction of the immune response, 
tachyzoites convert into encysted bradyzoites (Skariah et al., 2010).  The presence of 
encysted bradyzoites is responsible for a chronic infection and is generally non-responsive 
to the immune system and drug treatments (Moreno and Li, 2008).  If a chronically infected 
host becomes immunocompromised, bradyzoites can reconvert to tachyzoites and cause 
serious illness (Montoya and Liesenfeld, 2004). 
Gene expression is highly regulated throughout the different stages of the 
Toxoplasma life cycle.  Determining the mechanisms by which genes are differentially 
regulated between tachyzoites and bradyzoites will aid in gaining a better understanding of 
the conversion process.  Previous work on transcriptional regulation in Toxoplasma has 
shown that a variety of genes are controlled through stage-specific promoters (Saksouk et 
al., 2005; Behnke et al., 2008).  Research aimed at understanding post-transcriptional 
regulation has suggested that controlling the translational competency of transcripts is 
equally important for regulating gene expression, particularly in bradyzoites.  The 
mechanisms controlling translational competency under stressful conditions are crucial for 
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modulating the survival of parasites within the host and the prognosis of toxoplasmosis 
(Konrad et al., 2013). 
Previous studies have demonstrated that a global translational repression (TR) is 
induced in Toxoplasma in response to stressful conditions.  These conditions include being 
in the extracellular environment and being subjected to environmental changes that induce 
differentiation into bradyzoites, examples of which include amino acid starvation and 
accumulation of unfolded proteins (Joyce et al., 2010; Narasimhan et al., 2008; Konrad et 
al., 2013; Joyce et al., 2013).  The global TR also persists throughout the bradyzoite stage 
and has been thought to aid in the preferential translation of stress-response proteins 
(Narasimhan et al., 2008; Joyce et al., 2013; Sullivan et al., 2004).  Regulation of the global 
TR response in Toxoplasma relies on the phosphorylation of eukaryotic initiation factor 2 
(eIF2) by eIF2 kinases A-D (Narasimhan et al., 2008; Konrad et al., 2013; Konrad et al., 
2011).  Phosphorylation by eIF2 kinases also occurs in other organisms under stressful 
conditions (Sonenberg and Hinnebusch, 2009).  Phosphorylated eIF2 has a greater affinity 
for its nucleotide exchange factor eIF2B, limiting the ability of eIF2B to maintain a pool 
of functional eIF2 (Sonenberg and Hinnebusch, 2009). This in turn causes a general 
decrease in protein translation by reducing translational initiation (Sonenberg and 
Hinnebusch, 2009). 
Successful implementation of the global TR response is necessary for the parasite to 
cope with changes to its environment by allowing the remodeling of its transcriptome.  This 
occurs through two complementary mechanisms.  First, a subset of mRNAs is preferentially 
translated (Joyce et al., 2013).  These transcripts correspond primarily to stress-response 
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proteins and transcription factors which probably induce the transcription of a variety of 
stress-responsive downstream targets (Joyce et al., 2013).  This subset of translationally 
permissive transcripts has been suggested to be preferentially translated due to the presence 
of upstream open reading frames within their 5’ untranslated regions (UTRs; Joyce et al., 
2013).  The second mode by which the transcriptome is remodeled is by removing 
unneeded transcripts from the translation pool.  Many repressed transcripts are probably 
degraded through standard mRNA decay and turnover (Joyce et al., 2013).  Interestingly, 
in bradyzoites some translationally silent transcripts such as lactate dehydrogenase 1 
(LDH1) are maintained (Yang and Parmley, 1997), indicating that another mechanism is 
acting to selectively withdraw transcripts from the active translation pool and maintain 
them in a sustained TR throughout stress.  This mechanism would allow translationally 
permissive transcripts access to the limited supply of functional translation machinery 
(Yamasaki and Anderson, 2008). 
It is currently unknown how repressed transcripts are directed for sustained TR in 
Toxoplasma bradyzoites.  The process of storing quiescent transcripts that are needed for 
the transition between developmental phases is highly conserved across species (Kronja 
and Orr-Weaver, 2011).  In animals for example, transcription is inhibited during late 
meiosis throughout the initial stages of embryogenesis (Kronja and Orr-Weaver, 2011).  
Production of new proteins necessary for driving the cell cycle is tightly controlled and 
relies on the translational activation of previously stored maternal transcripts (Kronja and 
Orr-Weaver, 2011).  In Plasmodium female gametocytes, sustained TR plays a critical role 
in the maintenance of genes necessary for the transition to zygote.  This activity is achieved 
by the presence of recognizable RNA sequences within these transcripts that are bound by 
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TR-promoting proteins (Mair et al., 2006; Miao et al., 2013).  The widespread conservation 
of this regulatory system suggests that any transcripts that undergo sustained TR in 
Toxoplasma bradyzoites, such as LDH1, are necessary for the reconversion to tachyzoites 
upon relief of stress. 
Other well characterized examples of transcript-specific TR-inducing mechanisms 
include the targeting of transcripts through the miRNA pathway and through the binding 
of a variety of regulatory cis-acting elements by corresponding RNA binding proteins that 
act to inhibit translation (Sonenberg and Hinnebusch, 2009). Since there is a large 
heterogeneity in cis-acting elements and RNA binding proteins, they likely function 
through different mechanisms to achieve a similar result.  However, all of these 
mechanisms share in common the ability to distinguish transcripts through the 
identification of recognizable cis-acting elements, indicating that an RNA-centric view 
must be taken to study sustained TR.  In this study, we sought to determine if cis-acting 
elements could be responsible for the specific targeting of a transcript for sustained TR in 
Toxoplasma bradyzoites. 
The gene encoding LDH1 is unique and suitable for this study because it is one of the 
only experimentally verified post-transcriptionally regulated genes in bradyzoites (Yang 
and Parmley, 1997). While the LDH1 protein is present only in tachyzoites, its mRNA is 
present in both tachyzoites and bradyzoites at similar levels (Yang and Parmley, 1997), 
strongly suggesting a sustained TR mechanism is at play.  Furthermore, it has been shown 
that this regulation is mediated through the sequences flanking the LDH1 coding sequence 
(Yang and Parmley, 1997).  We hypothesized that the regulation of LDH1 is mediated 
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through a regulatory cis-acting element located in one or both its UTRs that is capable of 
specifically conferring sustained TR.  In this study, we examined the flanking sequences of 
LDH1 and found a 40 nucleotide element located within its 151 nucleotide 5’UTR.  This 
cis-acting element, termed the K45–85 element, is capable of conferring sustained TR in a 
heterologous context to transcripts that normally do not exhibit stage-specific regulation.  
Furthermore, this element requires the formation of a small regulatory RNA hairpin for its 
activity.  These results offer insight into the wider capability of Toxoplasma to selectively 
distinguish transcripts and target them for sustained TR under stressful conditions. 
 Materials and methods 
3.2.1 Host cell and parasite culturing conditions 
Human foreskin fibroblasts (ATCC: SCRC-1041) were grown to confluency in 
DMEM medium (Invitrogen, Ontario, Canada) supplemented with 10% cosmic calf serum 
(Hyclone, Utah, USA) and 0.5x antibiotic-antimycotic (Invitrogen) at 5% CO2.  Confluent 
monolayers were infected with the type II T. gondii strain PLKΔHX (NIH AIDS program, 
Division of AIDS, NIAID, cat#2860; Roos et al., 1994; Pfefferkorn and Borotz, 1994) 
which were grown for 24 h or 5 days under tachyzoite or bradyzoite culturing conditions 
respectively.  Tachyzoites were grown in MEM medium (Invitrogen) supplemented with 
1% dialysed fetal bovine serum (Hyclone) and 0.5x antibiotic-antimycotic at 5% CO2.  
Bradyzoites were grown at ambient CO2 levels in alkaline RPMI medium (Invitrogen) 
supplemented with 5% dialysed fetal bovine serum and buffered with 50 mM HEPES (pH 
8.2).  Freshly lysed parasites were transformed by electroporation with purified plasmids 
using a previously established protocol (Roos et al., 1994).  Transformed parasites were 
selected with tachyzoite culture medium containing 20 µg∙ml-1 mycophenolic acid and 50 
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µg∙ml-1 xanthine.  Stable transgenic clonal lines were obtained by isolating single plaques 
following serial dilution of transformed cultures in 96-well plates. 
3.2.2 Plasmid construction 
3.2.2.1 Whole UTR constructs 
All plasmids created in this study are modified from pTUBmycGFP_HX (Hettmann 
et al., 2000).  This construct, termed pCTRL for this study, contains the α-tubulin TUB8 
promoter and 5’UTR upstream of the GFP coding sequence followed by the SAG1 3’UTR 
(Table 3.1).  LDH1 (TGME49_032350) upstream (600 bp containing the promoter and 
5’UTR) and downstream (780 bp containing the 3’UTR) flanking regions were obtained 
by PCR.  See Appendix A for a list of oligonucleotides.  Constructs containing the flanking 
regions were created by digesting the relevant PCR fragments and pCTRL with either KpnI 
and HindIII or PacI and BamHI to form compatible ends and to remove TUB8- or SAG1-
related sequences from the vector followed by gel purification and ligation.  The construct 
consisting of GFP flanked by both upstream and downstream LDH1 regions was termed 
p53L1 because it contains of the 5’ and 3’UTRs of LDH1 (Table 3.1).  Similarly in p5L1, 
GFP is flanked 5’ by LDH1 while in pT3L1 GFP is flanked with LDH1 sequences 3’ while 
maintaining the TUB8 promoter and 5’UTR (Table 3.1). 
The pT5L1 construct was created by digesting p53L1 with EcoRI and PstI to excise 
the fragment consisting of the LDH1 5’UTR to the distal end of the GFP coding sequence.  
This was ligated into EcoRI / PstI digested pCTRL.  This construct therefore is a fusion of 
the TUB8 and LDH1 5’UTRs where the TUB8 promoter was used to drive the 
transcriptional unit (Table 3.1).  
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Table 3.1 Outline of sequences flanking selected GFP reporter constructs. 
 
a XX represents nucleotides deleted from LDH1 5’UTR. 
3.2.2.2 5’ UTR fragment constructs 
Deletion mapping of the LDH1 5’UTR was done using pT5L1 as a template.  
Oligonucleotides (Appendix A) were designed to anneal within the LDH1 5’UTR back to 
back (omitting the segment to be deleted) and to introduce an AfeI restriction site at the 
deletion site for screening purposes.  PCR amplification was performed as per the 
manufacturer’s instructions (Phusion High Fidelity, Thermo Scientific, Ontario, Canada) 
followed by phosphorylation and ligation of PCR products. 
Constructs designed to test for the effectiveness of selected 5’UTR cis-acting 
elements were termed pT5L1:K106–151 and pT5L1:K45–85 because they keep the 
fragment consisting of nucleotides 106-151 or 45-85 and 133-151 respectively and were 
made from the pT5L1 background (Table 3.1).  Briefly, pT5L1:K106–151 was made by 
deleting nucleotides 2-105 of the LDH1 5’UTR in pT5L1 while pT5L1:K45–85 was made 
by deleting nucleotides 86-132 from pT5L1:Δ2-44 using the process described above.  See 
Appendix A for oligonucleotide combinations. 
  Promoter 5'UTR 3'UTR 
CTRL TUB8 TUB8 SAG1 
P53L1 LDH1 LDH1 LDH1 
P5L1 LDH1 LDH1 SAG1 
PT3L1 TUB8 TUB8 LDH1 
PT5L1 TUB8 TUB8-LDH1 SAG1 
PT5L1:ΔXX-XXa TUB8 TUB8-LDH1(truncated) SAG1 
PT5L1:K45-85 TUB8 TUB8-LDH1(segment) SAG1 
PGRA:CTRL GRA1 GRA1 SAG1 
PGRA:K45-85 GRA1 GRA1-LDH1(segment) SAG1 
 1 
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Constructs where the TUB8 promoter and 5’UTR were replaced with corresponding 
GRA1 (TGME49_070250) fragments were termed GRA:K45–85 and GRA:CTRL where 
K45–85 and CTRL correspond to above acronyms (Table 3.1).  Briefly, 610 bp of the 
upstream region of GRA1 was selectively amplified from PLKΔHX genomic DNA by PCR 
using oligonucleotides “gra1_upstrm_fw” and “gra1_upstrm_rv” (Appendix A).  This 
region has been shown to be effective for driving expression (Messina et al., 1995).  
pT5L1:K45–85 and pCTRL vectors and the GRA1 PCR fragment were digested with KpnI 
and EcoRI to excise TUB8-related sequences and generate compatible ends followed by 
ligation. 
3.2.3 pT5L1:K45–85 mutational analysis 
The LDH1-derived sequences from the pT5L1 5’UTR were assessed for predicted 
secondary structures using the Mfold webserver located at http://mfold.rna.albany.edu/ 
(Zuker, 2003).  Oligonucleotides were designed back to back against predicted stems in 
order to introduce mutations that either disrupt or restore predicted hairpins as well as to 
introduce restriction endonuclease sites to allow for plasmid screening (See Appendix A 
for oligonucleotide list).  Plasmids were created in a similar fashion as described above 
using pT5L1-K45:85 as a template. 
3.2.4 Western blot analysis 
One million parasites of freshly released tachyzoites or bradyzoite-infected 
monolayers were harvested and lysed in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS).  Protein samples were resolved on a 
10% SDS/PAGE gel.  After transfer to a nitrocellulose membrane, blots were blocked in 
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5% milk for 1 h and probed with α-LDH1 (1:2000; a gift from Dr.  Parmley, Palo Alto, CA, 
USA), α-BAG1 (1:250; a gift from Dr.  Weiss, Albert Einstein College, NY, USA), α-GFP 
(1:2500; Rockland, PA, USA) or α-TUB (12G10, 1:1000; DSHB, IA, USA).  Blots were 
then probed with horseradish-peroxidase-conjugated α-rabbit (1:20 000), α-mouse (1:10 
000) or α-goat (1:10 000) secondary antibodies as appropriate.  Chemiluminescent signals 
were visualized on an Alpha-Imager system.  Densitometry measurements were obtained 
from at least three independent blots using the ImageJ software (version 1.42q).  A blot was 
performed using a serially diluted tachyzoite sample and probed with α-TUB to assess the 
linear range for densitometric analysis (data not shown).  A one tailed Student t test 
assuming unequal variances was performed using the data analysis package available 
through Microsoft Excel 2007. 
3.2.5 Quantitative RT-PCR 
RNA was isolated from freshly released tachyzoites or bradyzoite-infected 
monolayers using the guanidium isothiocyate-based method according to the 
manufacturer’s instructions (BioBasic, Ontario, Canada).  Isolated RNA (approximately 15 
µg) was resuspended in DEPC-treated H2O and 20 mM ribonucleoside vanadyl complexes 
(NEB, Ontario, Canada) and treated with 1 unit of DNase for 30 minutes at 37°C.  Treated 
RNA samples were then run on a 1 % agarose gel to ensure integrity and complete genomic 
DNA digestion.  The reverse transcriptase reaction was completed as per manufacturer’s 
instructions (M-MLV; BioBasic, Ontario, Canada) with the exception of dNTPs being 
present in the reaction mixture at 2 mM.  A negative control reaction excluding reverse 
transcriptase was also performed (NoRT).  Real-time RT-PCR was conducted on the 
StepOne Plus system (ABI, Ontario, Canada) using SyBR green reagents 
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(KapaBiosystems, Ontario, Canada) as per manufacturer’s instructions.  All tachyzoite and 
bradyzoite samples were run in technical triplicates and LDH1, GFP, and BAG1 signals 
were normalized using the Δ(ΔCt) method against GAPDH.  NoRT reactions were run in 
conjunction to ensure lack of carry-over DNA contamination.  The complete 
oligonucleotide list is given in Appendix A.  Relative mRNA amounts were determined 
from three independent biological replicates and a two tailed Student t test assuming 
unequal variances was performed using the data analysis package available through 
Microsoft Excel 2007. 
3.2.6 Fluorescence microscopy 
Human foreskin fibroblasts grown to confluency on coverslips were infected with 
clonal transgenic parasites and allowed to grow under either tachyzoite or bradyzoite 
culturing conditions for the allotted time.  The infected monolayer was then fixed in 3% 
paraformaldehyde.  After DNA staining with 10 µM Hoechst (Invitrogen), coverslips were 
mounted on slides and infected monolayers were visualized with a Leica DMIRB inverted 
microscope.  All images were taken with a cooled Q-Imaging CCD camera using the 
Northern Eclipse software (Image Scanning Technology, Ontario, Canada).  Images were 
processed for publication using Adobe Photoshop software (version 7.0). 
3.2.7 Relative GFP fluorescence measurement and analysis 
GFP-expressing parasites were measured for their relative fluorescent intensity 
(RFI), determined by the formula RFI = (Iv/Ib) – 1 where Iv and Ib are the average intensity 
readings for vacuoles and the background respectively as determined by the Northern 
Eclipse measurement function.  This formula allows for the GFP fluorescent signal to be 
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expressed as a function of the endogenous background signal, thereby minimizing any 
interference due to local background fluorescence variations.  At least 100 vacuoles in each 
life stage were measured for each clone.  Between three and seven clones were analyzed 
for each construct with no fewer than 300 counts per life stage per construct.  For each 
clone, the distribution of tachyzoite measurements was normalized to have a mean count 
of 100% expression while the corresponding bradyzoite counts were expressed as a 
function of cognate tachyzoite readings.  For each construct, the descriptive statistics 
function available in the Microsoft Excel 2007 Data Analysis pack was used to calculate 
the population means of tachyzoite and bradyzoite samples (xTz and xBz, respectively) as 
well as their variances (σTz2 and σBz2, respectively).  In order to assess the percent change 
between tachyzoite and bradyzoite samples, the margin of error of the difference between 
the two means (xTz - xBz) was assessed at a confidence interval of 99.9% using a two tailed 
z test.  The standard deviation of this distribution was calculated using the formula σTz-Bz = 
√[(σTz2/nTz) + (σBz2/nBz)] where nTz and nBz represent the tachyzoite and bradyzoite sample 
size, respectively.  To assess the statistical significance of a decrease of xBz in relation to 
xTz, a one tailed z test was performed with α = 0.001. 
 Results 
3.3.1 LDH1 is translationally repressed in bradyzoites 
The post-transcriptional regulation of LDH1 is likely performed though a sustained 
TR mechanism, defined here as the sustained inhibition of translation and the maintenance 
of the transcript throughout the bradyzoite stage.  To address whether the sequences 
flanking the LDH1 coding sequence were able to confer bona fide TR, we adopted a system 
in which a green fluorescent protein (GFP) reporter was flanked upstream and downstream 
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by LDH1-derived sequences which encompass its promoter, 5’UTR, and 3’UTR.  This 
transgenic parasite strain was named P53L1 (Table 3.1, Figure 3.1A).  We compared the 
expression profile of this parasite to a control GFP reporter flanked by non-related 
sequences (CTRL; Table 3.1, Figure 3.1A; Hettmann et al., 2000).  A previous study has 
shown that a CAT reporter flanked upstream by tubulin-related sequences and downstream 
by SAG1 did not display stage-specific regulation (Bohne et al., 1997). 
The transgenic parasite strains were analysed for their reporter expression in 
tachyzoites and bradyzoites.  While the CTRL showed a small non-statistically significant 
decrease, GFP protein expression was markedly reduced in bradyzoites to 28% ± 22% that 
of tachyzoites in P53L1 (Figure 3.1B).  The reduction of GFP mirrors the large decrease 
seen in endogenous LDH1 (94% ± 5%; Figure 3.1B) and is in accordance with observations 
from Yang and Parmley that a CAT reporter flanked on either side by LDH1-derived 
genomic segments yielded a decrease of 70% signal in bradyzoites (Yang and Parmley, 
1997). This may reflect the maximal achievable reduction in reporter expression when 
flanked by LDH1-derived genomic sequences.  Notably, although efforts were made to load 
each lane in the western blot with the same number of parasites, a consistent decrease in 
tubulin (TUB) signal was observed in bradyzoites (Figure 3.1B).  While it could be argued 
that this may represent an effect of general TR due to eIF2α phosphorylation, the specific 
LDH1 and GFP decreases seen when normalized to TUB suggest rather that variation in 
TUB signal is probably due to variation in accurate parasite loading. 
The steady state levels of LDH1 and GFP mRNA were also analysed in the parental 
PLKΔHX and transgenic lines.  While PLKΔHX bradyzoites showed a 35% decrease in 
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LDH1 mRNA, it was not significant (P ≥ 0.01; Figure 3.1C).  In the tested reporter 
constructs, GFP transcripts were maintained in tachyzoites and bradyzoites at similar levels 
(± 10%; Figure 3.1C).  Notably, all bradyzoite samples were shown to express BAG1 
mRNA and protein, a marker of the bradyzoite stage (Figure 3.1B,C) thus confirming in 
vitro stage conversion.  Taken together, these results confirm that LDH1 is post-
transcriptionally regulated through a sustained TR mechanism.  
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Figure 3.1 Post-transcriptional regulation of LDH1 and GFP reporter constructs. 
(A) Graphical representation of P53L1 and CTRL reporter constructs.  (B) Western blot 
and densitometry analysis of LDH1 and GFP protein expression in tachyzoites and 
bradyzoites.  Relative LDH1 and GFP expression levels as measured by densitometry 
were normalized against α-TUB levels and converted relative to tachyzoite values.  
Values were obtained from at least three independent experiments.  BAG1 was probed 
as verification of successful bradyzoite differentiation.  (C) Relative quantification of 
mRNA expression of LDH1, GFP and BAG1 in tachyzoites and bradyzoites of selected 
clones.  Expression levels were obtained via the Δ(ΔCt) method and normalized against 
the internal control, GAPDH.  Values were obtained from at least three independent 
experiments.  Bars reflect normalized mean ± standard deviation.  Dark bars, tachyzoites; 
light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 0.01. 
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3.3.2 LDH1 sustained translational repression is mediated through its 5’UTR 
To assess whether the upstream or downstream flanking region of LDH1 is 
responsible for conferring TR, we constructed two additional transgenic strains named 
P5L1 and PT3L1 (Table 3.1) with the goal of determining which flanking region was 
responsible for conferring post-transcriptional regulatory effects.  These strains, along with 
P53L1 and CTRL, were evaluated by fluorescent microscopy and their relative GFP 
expression was quantified as a function of normalized GFP fluorescent signal (Figure 3.2A, 
B).  In both CTRL and PT3L1 parasites, a similar bradyzoite-specific increase in GFP 
fluorescent intensity was observed (19% ± 10% and 19% ± 9%, respectively; P = 0.999).  
Furthermore, GFP transcript levels remained unchanged between tachyzoites and 
bradyzoites (Figure 3.2C).  This indicated that neither the 3’UTRs of LDH1 nor SAG1 
contribute any regulatory effects to their transcript and are unlikely to contain any cis-acting 
elements either promoting or inhibiting translation. 
The apparent bradyzoite-specific increase in GFP fluorescent intensity was 
unexpected as western blot densitometry showed that GFP protein levels did not increase 
in bradyzoites (Figure 3.1B).  This apparent increase was likely due to the difference in 
vacuole morphology seen in Toxoplasma tachyzoites and bradyzoites.  A tighter clustering 
of individual parasites within bradyzoite vacuoles resulted in a moderately higher 
fluorescent signal due to the stacking of parasites over one another; this does not occur in 
tachyzoites (compare tachyzoite and bradyzoite vacuole morphology in Figure 3.2A).  This 
moderate bradyzoite-specific increase of GFP fluorescence was taken into account and used 
as a baseline of zero repression for all comparison because the morphology of tachyzoite 
and bradyzoite vacuoles among all the tested clonal strains remained constant.  GFP signals 
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were quantified to allow for a robust statistical analysis among the different strains.  The 
analysis was performed for individual vacuoles within the population, reflecting the 
heterogeneity of possible gene regulation and growth.  Furthermore, this method permits 
the rapid collection of a large dataset for each clonal line tested (at least three clonal lines 
per construct were quantified for each parasite strain mentioned throughout this study). 
In contrast to CTRL and PT3L1, both P53L1 and P5L1 which are GFP constructs 
flanked upstream by LDH1 sequences (Table 3.1) displayed a decrease of 31% ± 6% and 
45% ± 4%, respectively, in fluorescent signal (P = 0.999) while mRNA levels did not 
significantly change between the two stages (Figure 3.2A-C).  These data demonstrated 
that the sustained TR seen in LDH1 is due to its 5’ flanking sequence.  Since TR is a post-
transcriptional regulatory process, the activity is likely restricted to the LDH1 5’UTR.  To 
ensure the same level of transcriptional control between TUB8 and LDH1 5’ flanking 
sequences, we generated the PT5L1 construct where the LDH1 5’UTR was fused between 
the TUB8 5’UTR and GFP coding sequence used in CTRL (Table 3.1, Figure 3.3A).  By 
doing so, it allowed for the control of any regulatory activities that might have been caused 
by upstream sequences other than the LDH1 5’UTR.  Our results showed that the TUB8 
promoter is stronger than that of LDH1 (Figure 3.2A) and therefore, using the TUB8 
promoter to drive GFP expression in PT5L1, had the added benefit of generating parasites 
with a brighter fluorescent signal, making the parasites more amenable for visualization.  
Most importantly, by fusing the two 5’UTRs, it allowed for the direct and non-ambiguous 
determination whether the LDH1 5’UTR was able to induce sustained TR.  Analysis of 
GFP fluorescence in PT5L1 revealed a bradyzoite-specific decrease of 53% ± 3% (P = 
0.999) while mRNA levels remained stable (Figures 3.2A-C and 3.3A), indicating TR was 
120 
 
occurring in PT5L1.  This conclusively demonstrated that the LDH1 5’UTR confers a TR-
promoting activity to its transcript.  Interestingly, these results also showed that this activity 
was capable of overriding the constitutive expression profile possibly attributable to the 
TUB8 5’UTR.  Since this regulation was likely due to the presence of a cis-acting element 
located within the LDH1 5’UTR, we therefore attempted to locate and identify a minimal 
element.  
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Figure 3.2 LDH1 5’UTR is responsible for conferring TR. 
(A) Fluorescent images of representative GFP-containing transgenic parasite strains 
under tachyzoite and bradyzoite conditions.  Scale bar represents 5 μm.  (B) Relative 
GFP fluorescence (RFU) of transformed parasites under tachyzoite and bradyzoite 
conditions.  Bars show normalized average readings ± standard error (N ≥ 700) obtained 
from at least three independent clones per construct.  (C) Relative quantification of 
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones.  Expression 
levels were obtained via the Δ(ΔCt) method and normalized against the internal control, 
GAPDH. Values were obtained from at least three independent experiments.  Bars reflect 
normalized mean ± standard deviation. Dark bars, tachyzoites; light bars, bradyzoites; 
asterisk, bradyzoite-specific decrease where P ≤ 0.001. 
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3.3.3 The LDH1 5’UTR contains a cis-acting element capable of inducing sustained TR 
In order to identify and localize minimal and essential cis-acting element(s), 
segments of approximately either 20 nucleotides or 40 nucleotides were deleted in a 
stepwise fashion along the LDH1 5’UTR of the plasmid used to make PT5L1 (Figure 3.3A).  
This construct was chosen as a template for deletion studies for three reasons.  First, as 
previously mentioned, the transcriptional unit is driven by the TUB8 promoter which is 
stronger than the LDH1 promoter, generating brighter GFP-containing parasites and 
making them more amenable to fluorescent visualization (compare GFP intensities in 
Figure 3.2A).  Second, in a fusion 5’UTR, the structural and sequence context near the 
transcriptional start site is unlikely to change while examining the effects of deletions 
within the LDH1 portion.  Importantly, 5’UTRs are prone to being regulated by RNA 
structures (Kozak, 1991). For example, highly structured 5’UTRs can inhibit ribosome 
scanning while even moderate structural elements near the transcriptional start site can 
hinder the recruitment of the 40S ribosomal subunit (Kozak, 1991).  Because altering the 
nucleotide sequence can cause local changes in secondary structure (Zuker, 2003), using 
PT5L1 as a template for deletional analysis of the LDH1 5’UTR ensures that the TUB8 
portion of the 5’UTR can insulate against these and other potential unintended regulatory 
consequences.  The final advantage of using the TUB8-LDH1 fusion 5’UTR is that it would 
allow for the rapid determination of a deletion’s effect on regulation.  Maximal repression 
would generate a fluorescent signal similar to the reduction of 53% seen in full length 
PT5L1 (Figure 3.2C).  In contrast, since the difference between PT5L1 and CTRL is merely 
the insertion of the LDH1 5’UTR, a deletion that caused the loss of its regulatory activity 
would result in a fluorescent profile more akin to that of CTRL. 
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Six deletion constructs were created from the parental PT5L1 (Figure 3.3A).  These 
were named according to which LDH1-derived residues were deleted with nucleotide +1 
being the transcriptional start site of LDH1 as predicted by the T. gondii genomics database 
(http://toxoDB.org version 6.0).  Deletion of nucleotides 2-24 maintained a moderate 
bradyzoite-specific decrease in GFP fluorescence of 21% ± 10% (P = 0.999; Figure 3.3B).  
In contrast, deletion of nucleotides 26-65 and 47-65 disrupted TR, as seen by their relative 
GFP fluorescent profile resembling that of CTRL.  Elimination of residues 66-105 also 
moderately alleviated TR (20% ± 10%, P = 0.999; Figure 3.3B).  Taken together, this 
suggests that deletion of residues 26-65 cause a loss of TR, with nucleotides 47-65 
constituting a possible minimal cis-acting element.  Notably, the abrogation of regions 
flanking this element (i.e.  Δ2-24 and Δ66-105) appeared to reduce its efficacy in conferring 
post-transcriptional regulation.  Upon elimination of nucleotides 86-105, bradyzoites 
expressed GFP at approximately 43% ± 6 % (P = 0.999) the amount observed in tachyzoites 
(Figure 3.3B).  This is similar to the level seen in the parental PT5L1, strongly suggesting 
that these residues do not contribute to any post-transcriptional regulatory effect in the 
LDH1 5’UTR.  In contrast, a 5’UTR lacking residues 106-132 displayed a loss of 
translational repression, suggesting the presence of a second cis-acting element within the 
LDH1 5’UTR.  The terminal nucleotides (133-151) of the LDH1 5’UTR were not analysed 
through deletion so as not to alter the nucleotide context surrounding the Kozak sequence 
because this may have impacted translation in an unpredictable manner.  Importantly, when 
relative GFP transcript amounts were evaluated for each of the above mentioned deletion 
constructs, no significant change in mRNA abundance was seen between tachyzoites and 
bradyzoites (P ≥ 0.01; Figure 3.3C).  
124 
 
 
Figure 3.3 Deletion analysis of the LDH1 5’UTR reveals a minimal and essential cis-
acting element. 
(A) Graphical representation of deletions along the LDH1 5’UTR of PT5L1.  TUB8 and 
GFP sequences are in purple and green, respectively, while LDH1 sequences are orange.  
(B) Relative GFP fluorescence (RFU) of reporter 5’UTR deletion constructs under 
tachyzoite and bradyzoite conditions.  Bars show normalized average readings ± standard 
error (N ≥ 300) obtained from at least three clones per construct.  (C) Relative 
quantification of mRNA expression of GFP in tachyzoites and bradyzoites of selected 
clones.  Expression levels were obtained via the Δ(ΔCt) method and normalized against 
the internal control, GAPDH.  Values were obtained from at least three independent 
experiments.  Bars reflect normalized mean ± standard deviation. Dark bars, tachyzoites; 
light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 0.001. 
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To validate these elements as self-contained bona fide cis-acting elements that are 
capable of conferring TR, we constructed plasmids that retained these elements in the 
CTRL background and named the transgenic parasites lines PT5L1:K106–151 and 
PT5L1:K45–85 (Table 3.1, Figure 3.4A).  In both of these constructs we also included 
nucleotides 133-151 so as not to interfere with the nucleotide context surrounding the 
Kozak sequence as outlined above.  In the latter construct, although the minimal cis-acting 
element was outlined by 47-65 through deletional analysis, we opted to use residues 45-85 
because the K45–85 region of the LDH1 5’UTR was predicted to have a modest amount of 
secondary structure (discussed further below; Figures 3.4A and 3.5A).  The transformed 
parasites were then analysed for relative GFP expression in bradyzoites.  The putative 
element contained within nucleotides 106-151 did not cause bradyzoite-specific 
downregulation of GFP expression (Figure 3.4B), thus indicating that this region alone is 
not sufficient to confer TR.  This may have been because the element was not in the proper 
context, could not adopt the proper conformation, or it may need to work cooperatively 
with other regions of the LDH1 5’UTR in order to function.  Since this element was not 
self-sufficient it was not further investigated.  As previously mentioned, the terminal 
nucleotides of the LDH1 5’UTR (from 133-151) were not screened by deletional analysis 
in the above PT5L1 model (Figure 3.3A).  However, by including these nucleotides with 
the putative 106-132 element, we inferred that this region likely does not contribute 
regulatory effects.  When assessed for GFP expression, PT5L1:K45–85 displayed a 41% ± 
6% (P = 0.999) bradyzoite-specific reduction in fluorescence which was similar to that seen 
in the parental PT5L1 (Figures 3.2B and 3.4B) while no significant change in GFP mRNA 
was seen (P ≥ 0.01; Figure 3.4C).  Taken together, this strongly suggested that these 
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residues, termed the K45–85 element, constitute a self-contained cis-acting element 
capable of causing TR in the CTRL background. 
To verify the ability of the K45–85 element to induce sustained TR in exogenous 
transcripts, another constitutively expressed gene, GRA1, was introduced into the upstream 
flanking region.  The GRA1 gene is highly expressed in both tachyzoites and bradyzoites 
and a previous report has shown that this region is sufficient to constitutively express a 
protein at high abundance in T. gondii (Messina et al., 1995).  A pair of constructs were 
created replacing TUB8 sequences by the promoter and 5’UTR from GRA1 and named 
PGRA:CTRL and PGRA:K45–85 (Table 3.1).  A decrease of 29% ± 6% (P = 0.999) in 
bradyzoite fluorescence was seen by PGRA:K45–85 while no significant difference was 
seen in PGRA:CTRL (P ≥ 0.01; Figure 3.4D).  Also, GFP mRNA levels remained 
statistically unchanged between tachyzoites and bradyzoites (Figure 3.4E).  These findings 
confirm that the K45–85 element is a functional TR-inducing cis-acting element.  
Furthermore, inclusion of this element overrides the constitutive expression seen when 
either the TUB8 or GRA1 upstream flanking regions alone are present, suggesting that the 
strong sustained TR seen is signaled through the K45–85 element. 
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Figure 3.4 Nucleotides 45-85 can induce TR in an exogenous system. 
(A) LDH1 5’UTR sequence.  Sequences kept for PT5L1:K106–151 are underlined, while 
sequences included in PT5L1:K45–85 are capitalized.  (B), (D) Relative GFP 
fluorescence (RFU) of selected LDH1 5’UTR elements under tachyzoite and bradyzoite 
conditions.  All bars show normalized average readings ± standard error (N ≥ 300) 
obtained from at least three clones per construct.  (C), (E) Relative quantification of 
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones.  Expression 
levels were obtained via the Δ(ΔCt) method and normalized against the internal control, 
GAPDH.  Values were obtained from at least three independent experiments.  Bars reflect 
normalized mean ± standard deviation. Dark bars, tachyzoites; light bars, bradyzoites; 
asterisk, bradyzoite-specific decrease where P ≤ 0.001. 
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3.3.4 Mutational analysis of K45–85 element reveals a small regulatory RNA hairpin 
Since the K45–85 element is a strong regulatory element, we hypothesized it would 
be highly conserved in Toxoplasma.  In order to probe the transcriptome for similarly 
regulated transcripts, we generated a MEME motif (Bailey et al., 2009) using the LDH1 
5’UTR variants selected so as to account for conservation of loss of TR activity (Figure 
3.3B).  This motif was then used for a MAST search (Bailey et al., 2009) against the 
annotated non-redundant UTRs of the Toxoplasma type II transcriptome as generated by 
toxodb.org using EST-based evidence.  This method identified 12 genes (excluding LDH1) 
with unacceptably high expected values (data not shown).  It was therefore concluded that 
this cis-acting element was either not detectable in the transcriptome without further 
refinement for other TR genes or it is unlikely to be conserved at the sequence level. 
It had been noted during the analysis of the LDH1 5’UTR that deletions targeting 
areas immediately flanking the minimal cis-acting element located between nucleotides 47-
65 caused a moderate loss of TR (Figure 3.3B).  Importantly, since RNA folding is in part 
a thermodynamic process (Zuker, 2003), alterations in the sequence composition at one 
location can cause changes in structure that influence the folding of adjacent regions.  It 
was therefore hypothesized that observations showing that deletion of sequences located 
immediately upstream or downstream of the minimal cis-acting element caused a moderate 
impairment of TR may have indicated that its activity relied on the adoption of a particular 
structural conformation (Figure 3.3B).  We therefore examined whether the K45–85 
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element owed its strong TR-inducing activity to the formation of a specific regulatory 
secondary structure. 
The secondary structures that mRNAs can adopt are varied and have been implicated 
in a variety of regulatory functions.  The formation of strong structures to the order of –50 
kcal∙mol-1 in the 5’UTR can inhibit scanning of the 40S ribosomal subunit (Kozak, 1991) 
which could explain the ability of the K45–85 element to confer sustained TR in the tested 
fusion 5’UTRs.  To see if such a mechanism could be responsible, the potential for the 
LDH1 5’UTR (151 nucleotides + 44 nucleotides of coding sequence downstream) to form 
inhibitory structures was assessed using the RNA secondary structure prediction software 
Mfold (Zuker, 2003).  We selected the predicted structure with the lowest free energy as it 
should represent the most stable structure (Figure 3.5A).  While the level of secondary 
structure obtained appeared to be insufficient to inhibit ribosomal scanning, the presence 
of two RNA hairpins was found in the location corresponding to the K45–85 element 
(Figure 3.4A).  Notably these two hairpins, termed Hp1 and Hp2 respectively, are 
maintained when analysing the K45–85 element in the context of PT5L1:K45–85 (Figure 
3.5B).  Interestingly, it has previously been established that RNA hairpins can serve various 
regulatory functions (Svoboda and Di Cara, 2006).  We therefore examined whether the 
formation of these hairpins was important for mRNA regulation and further tested the 
ability of these predicted structural elements to regulate GFP expression in bradyzoites. 
To assess the effects of Hp1 formation on TR, destabilizing mutations within the 
PT5L1:K45–85 construct were designed to disrupt base pairing between the stems of Hp1 
(see Materials and Methods for details).  Parasites containing this construct were termed 
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Hp1D (Figure 3.5C).  Corresponding rescue mutations were designed to restore base 
pairing of the stems and this construct was termed Hp1R (Figure 3.5C).  In selecting 
mutations, care was used to maintain a predicted C:A base pair between residues 55 and 66 
(see arrowhead, Figure 3.5A,B) and to ensure the formation of a hairpin with a similar 
calculated free energy, and therefore similar stability, as the parental PT5L1:K45–85.  
Disruption of Hp1 caused a loss of TR while the restorative mutations (Hp1R) partially 
rescued TR as evidenced by a bradyzoite-specific decrease of 25% ± 7% in GFP 
fluorescence (P = 0.999; Figure 3.5D).  Furthermore, no significant changes were observed 
in GFP transcript levels (P ≥ 0.01; Figure 3.5E).  Taken together, these data suggest that a 
hairpin involving the base pairing of nucleotides 53-57 with 64-68 is crucial for regulation.  
Previous reports have suggested that non Watson-Crick base pairing may serve an essential 
role for the recognition of certain RNA hairpins (Hermann and Westhof, 1999), raising the 
possibility that the predicted C:A pair may serve as a defining feature of this regulatory 
element.  To test this possibility, the Hp1R-UA construct was made in which the pair in 
question was mutated to form a standard Watson-Crick U:A base pair (Figure 3.5C).  
Interestingly, the mutation caused a complete loss of bradyzoite-specific GFP regulation 
and led to a profile akin to that seen in the original CTRL construct with an increase of 17% 
± 8% (P = 0.999; Figures 3.2B and 3.5D) while mRNA abundance was maintained at 
similar levels in tachyzoites and bradyzoites (P ≥ 0.01; Figure 3.5E). 
The potential involvement of Hp2 was also investigated.  Parasites with disruptive 
and restorative mutations targeted against Hp2, termed Hp2D and Hp2R respectively, were 
generated as described above (Figure 3.5C).  Both types of mutations designed against Hp2 
resulted in similar bradyzoite-specific decreases in GFP expression (26% ± 5% and 24% ± 
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5% respectively, P = 0.999; Figure 3.5D) while no change in mRNA abundance was seen 
(Figure 3.5E), suggesting that mutations to the distal part of the K45–85 element cause only 
a partial loss of TR.  Since no difference was observed between Hp2D and Hp2R, it seems 
likely that only the formation of Hp1 is necessary for inducing TR.  
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Figure 3.5 Mutational analysis of K45–85 element reveals essential structural 
component. 
(A) Secondary structure of LDH1 5’UTR was predicted using the MFOLD webserver 
(Zuker, 2003).  Forty-four nucleotides of the plasmid-derived sequence downstream of 
the LDH1 5’UTR were included in the predicted fold.  (B) Predicted secondary structure 
of K45–85 element in PT5L1:K45–85.  Two predicted hairpin structures are noted (Hp1 
and Hp2).  (C) Multiple sequence alignment of PT5L1:K45–85 and mutated constructs. 
The shaded area represents the K45–85 element.  Sequences predicted to base pair in 
Hp1 and Hp2 are underlined and mutated residues are capitalized.  (D) Relative GFP 
fluorescence (RFU) of hairpin disrupting and restorative constructs under tachyzoite and 
bradyzoite conditions.  All bars show normalized average readings ± standard error (N ≥ 
300) obtained from at least three clones per construct.  (E) Relative quantification of 
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones.  Expression 
levels were obtained via the Δ(ΔCt) method and normalized against the internal control, 
GAPDH.  Values were obtained from at least three independent experiments. Bars reflect 
normalized mean ± standard deviation.  Dark bars, tachyzoites; light bars, bradyzoites; 
asterisk, bradyzoite-specific decrease where P ≤ 0.001. 
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 Discussion 
3.4.1 Structural requirements of Hp1 suggest a recognition site for a trans-acting factor 
that is capable of targeting the LDH1 transcript for sustained TR 
The predicted secondary structure of the LDH1 5’UTR and mutational analysis of 
Hp1 suggested that an essential regulatory RNA hairpin is formed from position 53-68.  
Furthermore, base pairing between residues 53-57 with 64-68 as well as a non-canonical 
C:A pairing between residues 55 and 66 appear essential to its activity (Figure 3.5).  
Previous studies have shown that non-canonical base pairing between residues within the 
stem of RNA hairpins may serve as important recognition points for ribonucleoprotein 
assembly (Hermann and Westhof, 1999).  As RNA hairpins have been known to serve as 
potential nucleation sites for the assembly of regulatory ribonucleoproteins (Svoboda and 
Di Cara, 2006), it is possible that Hp1 serves this function in LDH1 to allow the binding of 
an unidentified TR-promoting trans-acting factor.  Upon the binding of such a factor, the 
transcript could be removed from the active translational pool.  This is a common theme 
often repeated in the literature.  For example, in mammals the post-transcriptional 
regulation of ferritin and other genes involved in iron metabolism relies on a 5’UTR-located 
conserved RNA hairpin termed the iron response element.  In periods of iron depletion, the 
iron response element is bound by the iron response protein, causing its withdrawal from 
the translational pool (Muckenthaler et al., 1998). 
The proposed unknown trans-acting factor involved in LDH1 TR could act similarly 
where it may either be responsible for, or contribute to, the recruitment of other factors 
necessary for protecting the transcript from degradation during the bradyzoite stage where 
it could be stored until translational reactivation in tachyzoites.  Such transcript 
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maintenance could be mediated through its recruitment to areas of cytoplasmic storage 
known as stress granules (SGs).  In other organisms, SGs are well characterized 
cytoplasmic bodies that form under the same stressful conditions that cause eIF2 
phosphorylation (Yamasaki and Anderson, 2008). They selectively store transcripts 
throughout stress and it has been suggested that this serves to withdraw them from the 
limited functional translational machinery, thereby giving preference to the translation of 
stress-response transcripts (Yamasaki and Anderson, 2008; Kedersha and Anderson, 2002).  
Furthermore, these structures have been implicated in the maintenance of important 
mRNAs during stressful conditions and allow for their eventual translational reactivation 
upon relief of stress (Hooper and Hilliker, 2013).  Interestingly, a previous report has shown 
that mRNA-containing granules with the properties of SGs appear in Toxoplasma under 
stressful conditions (Lirussi and Matrajt, 2011), suggesting a possible link between global 
TR and the maintenance of specific transcripts throughout stressful conditions.  It is 
possible to speculate that LDH1, as transcript that undergoes sustained TR in bradyzoites, 
could be one transcript that is selectively recruited to SGs under stress. 
The binding of specific mRNAs by RNA binding proteins that are necessary for 
maintaining them throughout sustained TR is a recurrent theme.  For example, under 
stressful conditions that cause the inactivation of mTOR in mammals, 5’ terminal 
oligopyrimidine tract-containing mRNAs are bound by the translational repressors TIA1 
and TIAR.  These transcripts are withdrawn from active translation and stored in SGs 
(Damgaard and Lykke-Anderson, 2011).  In Plasmodium the RNA binding proteins DOZI 
and PUF2 have been shown to selectively bind transcripts through a sequence-based cis-
acting element and are essential for their maintenance throughout sustained TR (Mair et 
135 
 
al., 2006; Miao et al., 2013; Braks et al., 2008).  Notably, the Toxoplasma genome is 
predicted to contain homologues to these and other regulatory RNA binding proteins.  In 
Toxoplasma, ALBA1 and ALBA2 proteins are capable of binding mRNAs as well as 
translation regulatory machinery and they localize to SGs under stressful conditions (Gissot 
et al., 2013). 
More recently, Liu and colleagues identified a Toxoplasma homologue of the 
translational repressor PUF1 that is upregulated and localized to cytoplasmic granules in 
bradyzoites (Liu et al., 2014).  PUF1 binds transcripts through the Puf-binding element, a 
UUGUN3AU consensus sequence, which is strikingly similar to the sequence starting 
within the terminal loop of Hp1 composed of UUGUN3A where the A is predicted to form 
a non-canonical pair necessary for its TR-inducing activity (Figure 5).  It is therefore very 
tempting to speculate on the involvement of PUF1 in the regulation of LDH1 translation in 
bradyzoites.  Identification of trans-acting factors involved in the sustained TR of LDH1 
may yield insight into how other similarly regulated transcripts are maintained in 
Toxoplasma bradyzoites. 
A large scale conservation of the K45–85 element amongst the Toxoplasma 
transcriptome was not found.  This is likely because its activity relies on the adoption of 
certain conformational characteristics and not on a strict sequence-based conservation.  
Recently Joyce and colleagues have published microarray data listing genes that undergo 
TR upon induction of the unfolded protein response (Joyce et al., 2013).  Unfortunately, it 
appears they were unable to identify unifying cis-acting elements present within genes 
targeted for sustained TR.  This may illustrate either the need for a comparative RNA 
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structure approach or a large variety in potential TR-inducing cis-acting elements.  
Intriguingly, a survey of the literature studying post-transcriptional gene regulation in 
Toxoplasma points to a rich abundance of cis-acting elements in its transcriptome.  For 
example, a report on the apicoplast-targeted translational elongation factor G has suggested 
that its 3’UTR contributes to promoting its translation, suggesting the presence of an 
undefined cis-acting element within (Payne et al., 2011).  Also the translation of ALBA2 
requires a putative element located in its 3’UTR (Gissot et al., 2013). Limited reports, 
coupled with the discovery of miRNA and its differential regulation in Toxoplasma (Braun 
et al., 2010), strongly suggest that transcript-specific post-transcriptional gene regulation 
is important for modulating gene expression through the use of cis-acting elements.  This 
may be reflective of the need for multiple transcript-specific regulatory mechanisms to 
adequately control gene expression in Toxoplasma. 
3.4.2 Sustained TR of LDH1 suggests that its regulation is important for bradyzoite and 
tachyzoite interconversion 
Carbohydrate metabolism in bradyzoites is radically different than in tachyzoites.  
Bradyzoites lack the ability to complete the tricarboxylic acid cycle and their 
mitochondrion is non-functional (Denton et al., 1996; Toursel et al., 2000) suggesting that 
they operate under functionally anaerobic conditions.  Since bradyzoites are unable to 
complete cellular respiration, glycolysis is used as a major source of energy (Denton et al., 
1996).  In the final step of glycolysis under anaerobic conditions, lactate dehydrogenase 
catalyses the conversion of pyruvate to lactate and regenerates NAD+ from NADH.  In 
bradyzoites, this reaction is catalysed by LDH2 which is transcriptionally upregulated to 
perform this task (Behnke et al., 2008; Yang and Parmley, 1997). The production of lactate 
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is much more active in bradyzoites than in tachyzoites, suggesting that a higher throughput 
of this process is necessary for the parasite to meet its energy requirements (Denton et al., 
1996).  LDH2 functions efficiently in the presence of the large amounts of pyruvate 
assumed to be generated in bradyzoites (Dando et al., 2001).  This characteristic is thought 
to be essential for the regeneration of NAD+ and the continual drive of glycolysis 
throughout anaerobic conditions.  In contrast, the function of LDH1 is inhibited by large 
doses of pyruvate, suggesting that it is not adapted to the bradyzoite environment (Dando 
et al., 2001).  Furthermore, two reports have shown that alterations in the expression 
profiles and levels of the LDH isoforms can influence the parasite’s ability to differentiate, 
suggesting that precise regulation of LDH isoforms must be tightly controlled (Al-Anouti 
et al., 2009; Liwak and Ananvoranich, 2009). 
In tachyzoites LDH2 is transcriptionally silenced while LDH1 protein expression is 
made possible.  Perhaps surprisingly, although the tricarboxylic acid cycle is functional, it 
has been shown that the conversion of pyruvate to lactate still occurs at substantial levels 
in tachyzoites (Denton et al., 1996).  As much as 20% of the glucose taken in by tachyzoites 
may be converted to lactate (Denton et al., 1996), highlighting the need for a functional 
LDH isoform in this stage.  As such a large contributor of energy to the parasite, it could 
be hypothesized that production of functional LDH1 protein may be an early development 
in the transition of bradyzoite to tachyzoite.  Upon the relief of stress, the LDH1 transcript 
would be released from sustained TR and made translationally competent, allowing for 
Toxoplasma to rapidly respond by compensating for the loss of LDH2 through immediate 
production of LDH1.  Such a mechanism would be faster and more energetically favourable 
than newly transcribing the LDH1 gene upon conversion to tachyzoites. 
138 
 
 Conclusion 
In this study, we identified a small structural cis-acting element that resides within 
the LDH1 5’UTR.  To our knowledge, this is the first report offering the experimental 
characterization of a specific cis-acting element that contributes to post-transcriptional gene 
regulation in Toxoplasma.  We show that this element selectively targets the LDH1 
transcript for sustained TR and can confer stage-specific expression to an otherwise 
constitutively expressed gene in a heterologous context.  This activity requires the adoption 
of an RNA hairpin structure which may be indicative of an RNA protein binding site.  The 
selectivity conferred by the K45–85 element strongly suggests that the LDH1 transcript 
which is destined for sustained TR is recognized by as of yet unidentified trans-acting 
factor(s) in Toxoplasma bradyzoites.  We further propose that upon identification by said 
factors, the transcript is withdrawn from the pool of actively translated mRNAs and sent 
for maintenance and storage.  Upon the relief of stress, it would be translationally 
reactivated in order to aid in the reconversion into tachyzoites.  By studying similarly 
regulated transcripts, it may be able to illuminate pathways, metabolic or otherwise, that 
need to be rapidly reactivated upon the relief of stress for the reconversion to tachyzoites.  
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CHAPTER IV – The use of RNA aptamer technologies for the affinity purification of 
LDH1-interacting partners and examination of short- and long-term features of stress-
induced translational repression in Toxoplasma gondii 
 Introduction 
The world’s most successful parasite, the obligate intracellular pathogen Toxoplasma 
gondii, infects warm-blooded animals the world over, including up to an estimated one 
third of the human population (Turner et al., 2013; Montoya and Liesenfeld, 2004).  Key 
to its survival and widespread distribution is its ability to react to the many hostile 
environments it encounters throughout its sexual and asexual lifecycles (Skariah et al., 
2010).  After completing its sexual reproduction in the intestine of the feline, it must survive 
in the outdoor environment for months or years until being ingested by a warm-blooded 
host (Dubey, 1998; Torrey and Yolken, 2013).  Once ingested, it must survive the harsh 
extracellular environment it encounters after destroying a previously infected host cell until 
it colonizes another (Konrad et al., 2011; Black and Boothroyd, 2000).  Once infection is 
established in an intermediate host, it must survive the anti-microbial effects of interferon 
γ produced by the innate immune system (Suzuki et al., 1988; Schroder et al., 2004).  This 
is accomplished by converting from the rapidly growing and destructive tachyzoite stage 
to the non-replicating and immunologically protected bradyzoite stage which is responsible 
for maintaining chronic infection for the life of the host (Skariah et al., 2010). 
Similar to other eukaryotes, when subjected to stressful stimuli, Toxoplasma initiates 
a robust general translational repression mediated through the phosphorylation of the alpha 
subunit of eukaryotic initiation factor 2 (eIF2α; Sullivan et al., 2004).  Phosphorylation of 
the Ser71 regulatory residue causes eIF2 to have an increased affinity for its nucleotide 
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exchange factor, decreasing its turnover rate and inhibiting cap-dependent translation 
(Sullivan et al., 2004; Sonenberg and Hinnebusch, 2009).  eIF2α phosphorylation is 
performed by one of four T. gondii eIF2α kinases (TgIF2K)s, each of which are activated 
by different signals (Narasimhan et al., 2008).  TgI2K-A is activated in response to the 
accumulation of misfolded proteins in its endoplasmic reticulum, TgIF2K-B is induced by 
oxidative stress and other cytoplasmic stresses, while TgIF2K-C and TgIF2-D both react 
to amino acid starvation, with the former selectively acting within the intracellular 
environment and the later exclusively mediating the response when the parasite finds itself 
in the extracellular milieu (Narasimhan et al., 2008; Konrad et al., 2013a; Konrad et al., 
2011; Joyce et al., 2010). 
Prolonged eIF2α phosphorylation causes the conversion of tachyzoites into 
bradyzoites and the translational control demonstrated under stressful conditions has been 
suggested to be a key part of the conversion mechanism (Konrad et al., 2013b; Joyce et al., 
2013).  While under eIF2α phosphorylation, a subset of transcripts that encode stress-
responsive proteins are preferentially translated while the majority dissociate from 
polysomes (Joyce et al., 2013).  Of this latter group, most appear to be degraded through 
standard mRNA turnover (Joyce et al., 2013).   However, a subset of translationally 
quiescent transcripts is maintained throughout the prolonged TR response (Yang and 
Parmley, 1997; Dendouga et al., 2002; Cleary et al., 2005).  This suggests a mechanism 
exists by which they are distinguished from those transcripts subject to degradation and 
would rely on the use of recognizable cis-acting elements. 
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Previously we have proposed that non-translated transcripts that are maintained 
throughout the bradyzoite stage are likely recruited to stress granules (SG)s, sites of mRNA 
storage that are formed in response to stressful environments (Holmes et al., 2014; 
Anderson and Kedersha, 2008).  In well studied eukaryotic organisms, SGs have been 
found to be formed upon eIF2α phosphorylation and consist of translationally quiescent 
mRNAs, machinery involved in cap-dependent translational initiation, and RNA-binding 
proteins that bind specific cis-acting elements (Anderson and Kedersha, 2008).  
Importantly, SGs have recently been shown to form in both extracellular tachyzoites and 
intracellular bradyzoites in Toxoplasma, demonstrating that this stress-response pathway is 
conserved in ancient eukaryotes (Lirrusi and Matrajt, 2011; Cherry and Ananvoranich, 
2014; Cherry and Ananvoranich, unpublished results). 
In our previous work, we used the lactate dehydrogenase 1 (LDH1) transcript as a 
study model to determine how specific transcripts are selected to be maintained through 
what we termed long-term sustained translational repression.  It was determined that LDH1 
harbours a cis-acting element, termed the K45–85 element, in its 5’UTR that is responsible 
for inhibiting its translation in bradyzoites while allowing the mRNA to be maintained at 
similar steady state levels to what is seen in tachyzoites (Holmes et al., 2014).  The K45–
85 element necessitates the formation of a small 16 nucleotide RNA hairpin that is 
characterized by a central non-canonical C:A base pair.  It is well documented that internal 
non-canonical base pairings and RNA hairpin loops can be important recognizable features 
that mediate the binding of RNA-binding proteins (Hermann and Westhof, 1999; Leontis 
and Westhof, 2003).  It was therefore hypothesized that upon eIF2α phosphorylation, the 
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LDH1 transcript is recruited to SGs through the actions of an unidentified trans-acting 
factor (Holmes et al., 2014). 
RNA aptamers are small, self-folding RNA segments that specifically bind a 
molecule of interest (Mayer, 2009).  They have been discovered in naturally-occurring 
biological systems or engineered from randomized RNA libraries through successive 
rounds of selective amplification of ligand-binding RNAs (Mayer, 2009).  RNA aptamers 
combined with affinity purification procedures are exceptionally suited to offer an unbiased 
approach towards identifying the protein complement that binds a known transcript 
(Srisawat and Engelke, 2001; Slobodin and Gerst, 2010).  Since LDH1 has been 
demonstrated to be an ideal model of sustained translational repression in bradyzoites 
(Holmes et al., 2014), in this study the feasibility of using RNA aptamer technologies in 
combination with the LDH1 system were examined.  Furthermore, to better understand how 
T. gondii manages stress, the LDH1 system was used to better examine the features of 
stress-induced translational control. 
 Materials and methods 
4.2.1 Plasmid construction 
All polymerase chain reactions (PCR)s performed to generate plasmids were 
conducted according to the manufacturer’s instructions (Phusion High Fidelity, Thermo 
Scientific, Ontario, Canada).  The template and primer pairings for each construct are listed 
in Appendix B. 
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4.2.1.1 Aptamer constructs 
All aptamer-containing constructs generated in this study were based off of the green 
fluorescent protein (GFP) reporter system flanked upstream by LDH1-related and / or 
tubulin-related sequences and downstream by either LDH1 or SAG1 sequences (Holmes et 
al., 2014).  The 44 nucleotide minimal S1 aptamer, which selectively binds streptavidin 
(Srisawat and Engelke, 2001), was inserted along with an EcoRV endonuclease restriction 
site directly downstream of the GFP stop codon by a PCR approach using back to back 
primers.  After PCR, the products were phosphorylated with T4 polynucleotide kinase 
according to the manufacturer’s instructions (Promega, Ontario, Canada) and ligated with 
T4 DNA ligase for 1 h at 37°C (BioBasic, Ontario, Canada).  After bacterial transformation, 
clones were screened for the incorporation of the EcoRV restriction site.  This generated 
plasmids p53L1-S1 and pT3L1-S1 from p53L1 and pT3L1, which both contain the S1 
aptamer and differ from each other only by their use of LDH1 or TUB8 upstream fragments, 
respectively (Table 4.1). 
Plasmid p53L1-S1 was used to create pT5L1-S1 and pCTRL-S1.  To do so, parental 
plasmids pT5L1 and pCTRL as well as p53L1-S1 were digested with NsiI and PacI and 
gel purified (Hettmann et al., 2000; Holmes et al., 2014).  The GFP-S1 fragment generated 
from p53L1-S1 was ligated into the opened and GFP deficient pT5L1 and pCTRL vectors 
to generate pT5L1-S1 and pCTRL-S1 respectively.  These later plasmids are both driven 
by a modified tubulin promoter with transcription initiating at the TUB8 5’UTR and also 
have SAG1 3’UTRs, similar to the previously established system (Table 4.1; Hettmann et 
al., 2000; Holmes et al., 2014).  However, in this study plasmids pT5L1-S1 and pCTRL-
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S1 were not used for parasite expression and instead used for further cloning or for the 
generation of in vitro synthesized RNA (Appendix B). 
Plasmids containing the 68 nucleotide Hepatitis delta virus (HDV) ribozyme were 
generated in a similar back-to-back strategy as described above in a two-step process. The 
HDV ribozyme, which is capable of self-cleaving directly 5’ of itself (Mercure et al., 1998), 
was inserted directly downstream of the S1 aptamer using oligonucleotides that each 
incorporated a partial modified HDV genomic strand ribozyme (Been, 2006).  This version 
of the HDV ribozyme contains an altered P1 stem and a shortened P4 stem, two changes 
which have been shown to have negligible impact on its function (Mercure et al., 1998; 
Ananvoranich et al., 1999).  Once ligated, the oligonucleotides generated a SphI restriction 
digest site for screening purposes and, used in conjunction with pT5L1-S1 or pCTRL-S1 
in a PCR reaction yielded pT5L1-S1-HDVΔG58 and pCTRL-S1-HDVΔG58, respectively 
(Table 4.1).  These plasmids encode a catalytically inactive form of the HDV ribozyme 
(Been and Perrotta, 1995).  In the second step, these plasmids were used as templates to 
create pT5L1-S1-HDV and pCTRL-S1-HDV, which each lack a PacI site for screening 
and encode a catalytically active ribozyme (Table 4.1). 
Plasmids were also designed for use with a different aptamer system derived from 
the MS2 bacteriophage (Slobodin and Gerst, 2010).  The MS2 aptamer, consisting of two 
19 nucleotide RNA hairpins separated by a small spacer, selectively binds the MS2 phage 
coat protein (CP), which in turn can be used for affinity purification (Said et al., 2009; 
Slobodin and Gerst, 2010).  Using a similar back-to-back methodology as described above, 
one copy of a MS2 hairpin was incorporated into each oligonucleotide so that they 
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generated plasmids encoding two copies of the MS2 hairpin separated by an XbaI 
restriction site directly downstream of the GFP stop codon.  These plasmids were named 
pT5L1-MS2 and pCTRL-MS2 (Table 4.1). 
4.2.1.2 Dual luciferase constructs 
Plasmids incorporating the firefly (FF) or Renilla (RN) luciferase coding sequences 
were adopted to the previously established LDH1 GFP reporter system (Holmes et al., 
2014).  The FF luciferase fragment was obtained by gel purification after digesting plasmid 
p3011FF with NsiI and PstI.  Vectors pT5L1 and pCTRL were digested with NsiI and PstI 
in order to remove the GFP coding sequence, dephosphorylated with calf intestinal 
phosphatase according to the manufacturer’s instructions to prevent self-ligation 
(Promega), and gel purified.  The appropriate fragments were then ligated and, after 
transformation, screened for insertion in the correct orientation with EcoRI and PstI.  This 
generated plasmids pT5FF and pT0FF (Table 4.1).  
To serve as an internal control for dual luciferase expression assays, a RN-containing 
plasmid was generated and termed pT0RN (Table 4.1).  Briefly, the RN coding sequence 
was PCR-amplified from pTubRn (Crater et al., 2012), digested with PstI and ligated 
within an NsiI / PstI digested and dephosphorylated open pT0FF vector following a similar 
procedure as previously mentioned.  
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Table 4.1 Names and characteristics of plasmids used in study. 
 
 
4.2.1.3 Bacterial expression vector 
For use in subsequent affinity purification, a plasmid was generated so as to 
bacterially express a fusion protein consisting of an N-terminal CP, a central GFP, and a 
C-terminal streptavidin-binding peptide (SBP).  The sequence corresponding to CP-GFP-
SBP fusion protein was PCR-amplified from a plasmid provided by Dr. Jeffrey Gerst 
(Weizmann Institute of Science, Israel).  The PCR fragment was digested with BspHI and 
XhoI and gel purified.  A pET28b vector was digested with NcoI and XhoI, gel purified and 
the ligated with the CP-GFP-SBP fragment.  The resulting plasmid, pET_CP-GFP-SBP, 
was subsequently used to bacterially express C-terminally histidine tagged CP-GFP-SBP. 
Plasmid name Promoter 5'UTR 
Coding 
sequence Aptamer 3'UTR Screening site 
p53L1-S1 LDH1 LDH1 GFP S1 LDH1 EcoRV 
pT3L1-S1 TUB8 TUB8 GFP S1 LDH1 EcoRI/EcoRV 
pT5L1-S1 TUB8 TUB8-LDH1 GFP S1 SAG1 EcoRI/EcoRV 
pCTRL-S1 TUB8 TUB8 GFP S1 SAG1 EcoRI/EcoRV 
pT5L1-S1-
HDVΔG58 TUB8 TUB8-LDH1 GFP S1-HDVΔG58 SAG1 SphI 
pCTRL-S1-
HDVΔG58 TUB8 TUB8 GFP S1-HDVΔG58 SAG1 EcoRI/EcoRV 
pT5L1-S1-HDV TUB8 TUB8-LDH1 GFP S1-HDV SAG1 ΔPacI 
pCTRL-S1-
HDV TUB8 TUB8 GFP S1-HDV SAG1 ΔPacI 
pT5L1-MS2 TUB8 TUB8-LDH1 GFP 2x MS2 loop SAG1 XbaI 
pCTRL-MS2 TUB8 TUB8 GFP 2x MS2 loop SAG1 XbaI 
pT5FF TUB8 TUB8-LDH1 FF N/A SAG1  
pT0FF TUB8 TUB8 FF N/A SAG1  
pT0RN TUB8 TUB8 RN N/A SAG1   
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4.2.2 Tissue culture and parasite transformation 
Routine culture of human foreskin fibroblasts (ATCC: SCRC-1041) was conducted 
using DMEM medium (Invitrogen) supplemented with 10% cosmic calf serum (Hyclone, 
USA) and 0.5x antibiotic-antimycotic (Invitrogen).  Upon reaching confluency at 37°C in 
a 5% CO2 atmosphere, fibroblasts were infected with the Toxoplasma gondii PLKΔHX 
strain which lacks functional HXGPRT activity (NIH AIDS program, Division of AIDS, 
NIAID, cat#2860; Roos et al., 1994; Pfefferkorn and Borotz, 1994).  Tachyzoites were 
grown in MEM medium (Invitrogen) supplemented with 1% dialysed fetal bovine serum 
(Hyclone) and 0.5x antibiotic-antimycotic at 37°C in 5% CO2.  Bradyzoites were grown 
for 3 days at 37°C in atmospheric CO2 in RPMI medium (Invitrogen) buffered with 50 mM 
HEPES at pH 8.2 and supplemented with 5% dialyzed fetal bovine serum and 0.5x 
antibiotic-antimycotic.  Bradyzoite media was changed daily in order to maintain the 
elevated pH. 
Stable transgenic lines were generated by an established electroporation protocol 
using 20 μg of purified plasmid (Roos et al., 1994).  One day after electroporation, the 
media was exchanged to include 20 µg/ml mycophenolic acid and 50 µg/ml xanthine for 
selection of the HXGPRT cassette included in the plasmid.  Clonal isolates were obtained 
by serially diluting transformed parasites into 96-well plates. 
Dual luciferase assays requiring the transient expression of FF and RN luciferases in 
tachyzoites and bradyzoites were performed using 5 μg of FF plasmid (either pT5FF or 
pT0FF) and 5 μg of pT0RN.  Four hours after electroporation, the media was changed to 
fresh tachyzoite or bradyzoite media and the parasites were grown for 24 h or 3 days, 
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respectively.  A similar strategy was used to examine extracellular parasites expressing FF 
and RN luciferases.  Three million freshly lysed tachyzoites were collected and 
electroporated with FF plasmid (either pT5FF or pT0FF) and pT0RN each at 1 μg plasmid 
/ 106 parasites.  After four hours, the media was exchanged and the parasites were allowed 
to grow for 24 hours before collection. 
4.2.3 Fluorescent microscopy and relative GFP quantification 
Stable transgenic P53L1-S1 or PT3L1-S1 (Table 1) parasites were grown for 24 h 
under tachyzoite conditions and for 5 days under bradyzoite conditions on confluent 
coverslips.  Following fixation in 3% paraformaldehyde, the coverslips were stained in 10 
μM Hoechst, rinsed in PBS, and mounted onto slides.  Relative GFP quantification was 
performed as previously described using the Northern Eclipse software (Image Scanning 
Technology, Ontario, Canada) on a Leica DMIRB inverted microscope (Holmes et al., 
2014).  Briefly, at least 100 vacuoles per life stage per clonal line (total N ≥ 300) were 
analysed by densitometry.  Relative bradyzoite fluorescence was expressed as a function 
of tachyzoite values, which were normalized to 100%.  To assess the statistical significance 
of any bradyzoite-specific decrease in GFP expression, a one-tailed z test assuming unequal 
variances was performed using the Data Analysis pack available within Microsoft Excel 
2007. 
4.2.4 Generation of in vitro transcribed RNA fragments 
DNA fragments incorporating the T7 RNA polymerase promoter were generated by 
PCR using plasmid templates (see Appendix B for appropriate template and 
oligonucleotide combinations).  Reactions were performed according to the manufacturer’s 
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instructions (OneTaq; NEB).  PCR fragments were cleaned by phenol:chloroform 
extraction, ethanol precipitated, and resuspended in DEPC-treated water prior to use for in 
vitro transcription. 
RNA fragments were generated in a standard T7 RNA polymerase reaction mixture 
consisting of 50 mM Tris pH8.0, 10 mM MgCl2, 2 mM spermidine, 25 mM NaCl, 2.5 mM 
rNTPs, 1 mM DTT, 1 U of pyrophosphatase and 20 U of RNase inhibitor (Thermo 
Scientific).  Reactions were incubated at 37°C for 3 h after which point 1 U of DNase I 
(Promega) was added.  The reaction mixture was incubated another 30 minutes to degrade 
the DNA template.  Synthesized RNA was cleaned by phenol:chloroform extraction, 
ethanol precipitated, resuspended in DEPC-treated water and quantified on a NanoDrop 
spectrophotometer (Thermo Scientific). 
4.2.5 Northern Blot 
A DIG-labeled probe corresponding to a 273 bp region of the GFP coding sequence 
was generated by PCR using a plasmid template.  The reaction was performed according 
to the manufacturer’s instructions (OneTaq; NEB) with the exception that the reaction 
mixture contained 100 μM dA/G/CTP, 67 μM dTTP, and 33 μM DIG-11-dUTP (Roche; 
Eisel et al., 2008).  The reaction was run in conjunction with non-labeled dNTP mix and 
ran on an acrylamide gel to ensure a gel shift due to labeled nucleotide incorporation.  The 
probe was phenol:chloroform extracted, ethanol precipitated, and resuspended in DEPC-
treated water prior to use. 
The northern blot protocol was adopted from the DIG Application Manual for Filter 
Hybridization from Roche (Eisel et al., 2008).  One microgram of in vitro synthesized RNA 
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was run on a 1.5% formaldehyde-agarose gel and transferred overnight to a nylon 
membrane.  After crosslinking, the blot was pre-warmed at 50°C in 5 ml of hybridization 
buffer (Roche) and hybridized overnight at 50 °C with 2 μl of snap-cooled DIG-labeled 
probe.  The blot was then washed twice in 2X SSC/0.1% SDS (1X SSC: 150 mM NaCl, 15 
mM sodium citrate) for 5 minutes at room temperature and twice in 0.1X SSC/0.1%SDS 
for 15 minutes at 65°C.  Blocking, incubation with α-DIG-alkaline phosphatase (1:10 000), 
and exposure were performed according to manufacturer’s instructions (Roche). 
4.2.6 S1 aptamer affinity purification 
RNA segments containing the S1 aptamer were isolated using a protocol adapted 
from Srisawat and Engelke (2001).  Fifty micrograms of S1-containing in vitro synthesized 
RNA were briefly heated to 75°C and snap-cooled on ice before addition to 25 μl of 
streptavidin-agarose beads (Thermo Scientific) in the presence of 200 μl of binding buffer 
(50 mM HEPES pH 7.4, 10 mM MgCl2, 100 mM NaCl, 1 mM DTT, 0.1% Triton X-100, 
10% glycerol, 20 mM vanadyl ribonucleoside complexes; modified from Srisawat and 
Engelke, 2001).  The RNA was and allowed to incubate while rotating for 1 h at 4°C.  The 
agarose resin was pelleted at 1000 rpm for 2 minutes at 4°C on a tabletop centrifuge and 
washed in 200 μl binding buffer for 5 minutes a total of ten times.  The beads were eluted 
in binding buffer supplemented with 5 mM D-biotin (BioBasic) while rotating at 4°C for 
30 minutes.  The supernatants from each sample were ethanol precipitated in the presence 
of 5 μg of linear polyacrylamide carrier and resuspended in DEPC-treated water.  Samples 
were then reverse transcribed using a GFP-specific primer according to the manufacturer’s 
instructions (M-MLV; BioBasic) with the exception of supplementing the reaction mixture 
with dNTPs to final concentration of 2 mM.  The cDNA was PCR-amplified to generate a 
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324 bp product corresponding to a segment of the GFP coding sequence.  See Appendix B 
for relevant oligonucleotides. 
4.2.7 Affinity purification of bacterially expressed CP-GFP-SBP 
The pET_CP-GFP-SBP vector was transformed into BL21 competent cells and 
grown overnight in a 2 ml starter culture.  A one litre culture was grown to 0.5 OD600 and 
induced with 0.2 mM IPTG at room temperature overnight.  The bacteria was isolated by 
centrifugation and the pellet lysed by sonication in denaturing lysis buffer (50 mM Tris pH 
8.0, 300 mM NaCl, 0.1% Triton X-100, 20 mM imidazole, 8 M urea) because it had been 
determined by SDS-PAGE that CP-GFP-SBP was restricted to inclusion bodies.  The 
supernatant was transferred to a Ni-NTA column previously equilibrated in five volumes 
of denaturing lysis buffer.  Following two washes with denaturing lysis buffer, the CP-
GFP-SBP protein was allowed to refold on the column using four washes with non-
denaturing wash buffer (same recipe omitting urea).  CP-GFP-SBP was then eluted in non-
denaturing wash buffer supplemented with 250 mM imidazole and analysed by SDS-PAGE 
for purity. 
4.2.8 Affinity purification of MS2 aptamer from tachyzoite lysates 
This procedure was performed with the intention of selectively purifying a transcript 
containing the LDH1 5’UTR and the MS2 aptamer from tachyzoite lysate using purified, 
bacterially expressed CP-GFP-SBP.  Generally, the methodology described below was 
adapted from Slobodin and Gerst (2010; 2011) who optimized a system for the recovery of 
MS2 aptamer-containing transcripts from mammalian lysate using an inducibly expressed 
CP-GFP-SBP.  One important modification from the aforementioned method is the use of 
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a smaller MS2 aptamer, containing two MS2 loop repeats (Said et al., 2009) instead of 
twenty four (Slobodin and Gerst, 2010).  Furthermore, buffer compositions were altered 
from Slobodin and Gerst (2010) to milder, less stringent buffers to promote MS2 aptamer 
binding to recombinantly expressed CP after formaldehyde crosslinking and cell lysis (Said 
et al., 2009; Corcoran et al., 2012). 
4.2.8.1 Preparation of tachyzoite lysates 
Extracellular PT5L1-MS2 tachyzoites were collected from seven 10 cm culture 
dishes and pelleted at 2500 rpm for 10 minutes at 4°C.  After being washed one time in 
PBS, the cell pellet, consisting of approximately 108 parasites, was resuspended in isotonic 
crosslinking buffer (20 mM HEPES-KOH pH 7.4, 150 mM KCl, 1.5 mM MgCl2, 1 mM 
DTT, 0.1% formaldehyde) and incubated on ice for 10 minutes to crosslink mRNA-protein 
complexes.  Crosslinking was stopped through the addition of glycine to a final 
concentration of 250 mM and incubation on ice for 10 minutes.  The cells were then pelleted 
at 6000 rpm for 5 minutes at 4°C on a tabletop centrifuge.  After rinsing in isotonic wash 
buffer (IWB; isotonic lysis buffer without formaldehyde) the cell pellet was resuspended 
in 500 μl hypotonic lysis buffer (20 mM HEPES-KOH pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 
1 mM DTT, 0.1% Triton X-100, 20 U/mL RNase inhibitor, 1 μl/ml Pefabloc protease 
inhibitor) and lysed through multiple freeze-thaw cycles followed by three short bursts of 
sonication on ice.  The supernatant was collected and protein concentration was determined 
using the RC-DC protein quantification kit (Bio-Rad).  Egg white avidin (BioBasic) was 
added at 5 μg/mg of lysate and the sample was incubated at 4°C while rotating for 1 h to 
block endogenous biotinylated proteins. 
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4.2.8.2 Preparation of CP-GFP-SBP-bound streptavidin-agarose beads 
All steps were performed at 4°C and all wash and incubation steps were performed 
while rotating.  Fifty microliters of streptavidin-agarose resin was equilibrated in 500 μl of 
IWB and pelleted at 1000 rpm for 2 minutes on a tabletop centrifuge.  The beads were then 
concurrently bound by 5 μg CP-GFP-SBP and blocked for 90 minutes in isotonic blocking 
buffer (IWB supplemented with 2% BSA, 100 μg/ml yeast tRNA, 20 U/ml RNase 
inhibitor).  To remove excess CP-GFP-SBP and blocking components, the resin was 
washed with five 5 minute washes in 500 μl IWB. 
4.2.8.3 Affinity purification and western blot analysis 
Five milligrams of prepared lysate was incubated with prepared agarose beads in 
IWB overnight while rotating at 4°C.  The beads were then subjected to five or six 5 minute 
washes in 1 ml of IWB.  The resin was eluted in 80 μl isotonic elution buffer (IWB 
supplemented with 6 mM D-biotin (BioBasic) for 30 minutes while rotating at 4°C.  The 
formaldehyde crosslinking was then reversed by addition of an equal amount of 2X 
crosslink reversal buffer (100 mM Tris pH 7.0, 10 mM EDTA, 20 mM DTT, 2% SDS) and 
heated at 65°C for 1 h.  Twenty microlitres of the sample was then run on a 10% SDS-
PAGE acrylamide gel which was then processed by silver staining or western blot.  Silver 
staining was performed using an established procedure (Shevchenko et al., 1996).  After 
transferring to a nitrocellulose membrane and blocking in 5% milk, the blot was probed 
with α-GFP (1:2500; Rockland) or α-human PABPC3 (1:1000; Applied Biological 
Materials).  The blot was then incubated in horseradish peroxidase-conjugated α-goat (1:10 
000) or α-rabbit (1:20 000) secondary antibodies as appropriate and chemiluminescent 
signals were visualized on an Alpha-Imager system. 
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4.2.9 Poly(A) tail length analysis 
The length of the poly(A) tail of selected transcripts was estimated through a two-
step RT-PCR approach (Murray and Schoenberg, 2008).  Total RNA was isolated from 
intracellular tachyzoites or bradyzoites using guanidinium isothiocyanate reagent 
according to the manufacturer’s instructions (BioBasic), resuspended in DEPC-treated 
water and 20 mM vanadyl ribonucleoside complexes, and treated with 1 U DNase for 30 
minutes at 37°C.  A reverse transcriptase reaction was performed as previously described 
(Holmes et al., 2014) using an oligonucleotide designed to bind the poly(A) tail with high 
enough annealing temperature to function in subsequent PCR analysis (Murray and 
Schoenberg, 2008; Appendix B).  PCR was performed using a standard reaction mixture 
except only a gene-specific forward primer was added at 0.2 μM.  The sequence of the 
LDH1 and GRA1 forward primers were designed to anneal 124 nucleotides upstream of the 
poly(A) tail as determined by other studies (Appendix B; Yang and Parmley, 1997; 
Cesbron-Delauw et al., 1989).  The PCR reactions were run on a 10% non-denaturing 
acrylamide gel at 200V for 1 h and stained with ethidium bromide prior to visualization 
using the Alpha-Imager system. 
4.2.10 Dual luciferase assay 
4.2.10.1 Stage differentiation trials 
After the appropriate growth period, tachyzoite- and bradyzoite-infected fibroblast 
monoloayers plates were rinsed briefly with PBS.  The monolayers were then scraped and 
lysed in 200 μl passive lysis buffer (Promega).  After a 15 minute incubation at room 
temperature, the lysate was centrifuged for 1 minute at 12 000 rpm on a tabletop centrifuge 
and the supernatant was transferred to a new tube.  To obtain FF luciferase readings, 20 μl 
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of lysate was added to 100 μl FF luciferase buffer (20 mM Tricine, 10 mM MgSO4, 5 mM 
DTT, 250 μM Coenzyme A, 250 μM ATP, 200 μM D-luciferin) as previously described 
(Crater et al., 2012).  RN readings were obtained as previously described (Crater et al., 
2012) using 20 μl of lysate and 100 μl RN luciferase buffer (100 mM K2HPO4/KH2PO4 pH 
7.4, 500 mM NaCl, 1 mM EDTA, 0.02% BSA, 10 μM coelentrazine; Liu et al., 1997).  All 
readings were performed with a 5 second integration time on a 20/20n luminometer (Turner 
BioSystems).  FF readings were normalized against the RN signal and bradyzoite relative 
fluorescent units (RFU)s were expressed as a function of tachyzoite RFUs.  A one-tailed 
Student t test assuming unequal variances was performed using the Data Analysis pack 
available through Microsoft Excel 2007. 
4.2.10.2 Extracellular dual luciferase assay 
 After growing for 24 h under optimal tachyzoite conditions, infected monolayers 
were scraped and the parasites were released from the lifted host cells by passing them 
twice through a 26 gauge needle.  After centrifugation, the parasites were resuspended in 
high potassium buffer (25 mM HEPES-KOH pH 7.4, 142 mM KCl, 5 mM NaCl, 5 mM 
MgCl2, 2 mM EGTA, 1 mg/ml BSA), which has been shown to cause stress granule 
formation in extracellular parasites (Lirussi and Matrajt, 2011).  The parasites were then 
separated into six equal aliquots and assayed over a time course of three hours for their FF 
and RN luciferase activities as previously described (Crater et al., 2012) with the exception 
that BSA was omitted from the RN luciferase detection buffer. 
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 Results and discussion 
4.3.1 Adaptation of the S1 aptamer system for affinity purification 
The LDH1 5’UTR has previously been shown to be responsible for conferring 
sustained translational repression to multiple transcripts when placed in a heterologous 
context (Holmes et al., 2014).  Since this activity depended on the presence of small 
structural element, it was hypothesized that an interaction was occurring between this cis-
acting element and an unidentified trans-acting factor (Holmes et al., 2014).  Previous 
reports have suggested four general strategies for the identification of RNA-protein 
interactions.  In the first method, an RNA-binding protein (RBP) likely to be involved in 
the interaction is immunoprecipitated and the association of the RNA in question is 
validated through detection techniques such as RT-PCR (Niranjanakumari et al., 2002).  
While this method has the advantage of retrieving in vivo RBP-RNA interactions, it 
assumes that the RBP is known and only requires validation as an interacting partner, which 
is not the case for the LDH1 5’UTR.  A second, more RNA-centric method relies on using 
a biotinylated version of the cis-acting element as a bait to selectively purify any trans-
acting factors from cell lysate (Rouault et al., 1989).  While this method has the advantage 
of using a specific sequence to capture RBPs, it can be prone to non-specific binding from 
biotinylated moieties or other RBPs and relies on a non-specific elution (Rouault et al., 
1989; Slobodin and Gerst, 2011).  Furthermore, this method presents a major technical 
challenge in the particular case of Toxoplasma since it is co-cultured with human fibroblasts 
and the potential of contaminating human protein in parasite lysates could obscure a 
genuine Toxoplasma RBP-RNA interaction.  Because of this consideration, an option that 
preserves mRNP composition prior to cell lysis was required.  This could be achieved by a 
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third option which uses a tagged oligonucleotide to capture the transcript in question 
through base pairing interactions (Baltz et al., 2012).  While decent specificity can be 
achieved with this method, the complementary binding of target and bait would not occur 
if the selected region were obscured by RBPs or if it were already involved in double 
stranded interactions.  The final option considered for retrieval of the LDH1-interacting 
trans-acting factor was an affinity purification that relied on the use of an RNA aptamer 
(Srisawat and Engelke, 2001; Slobodin and Gerst, 2010).  The procedure requires the 
aptamer to be encoded within the transcript which could then be used to for retrieval of the 
transcript and its protein complement through the aptamer’s affinity for an anchored bait 
molecule.  This system can achieve high target specificity similar to antibody-antigen 
interactions and also is amenable to competitive elution of target molecules which 
facilitates downstream analysis (Srisawat and Engelke, 2001, Slobodin and Gerst 2010; 
Slobodin and Gerst, 2011). 
Because of these benefits, the S1 aptamer system was selected.  This 44 nucleotide 
aptamer, which has been shown to selectively bind streptavidin with a dissociation constant 
of 7.0 x 10-8 M (Srisawat and Engelke, 2001), was engineered into a previously established 
reporter system directly after the GFP stop codon (Holmes et al., 2014; Figure 4.1A).  To 
ensure that the inclusion of the aptamer did not affect stage specific translational repression, 
tachyzoites and bradyzoites expressing GFP reporters flanked upstream by either the LDH1 
5’UTR or the non-regulated TUB8 5’UTRs were examined for their relative fluorescence 
(Figure 4.1B).  While the GFP reporter flanked upstream by LDH1 displayed a 51% ± 6% 
(P = 0.999, P53L1-S1) bradyzoite-specific decrease in GFP fluorescence, PT3L1-S1 
remained unregulated in the bradyzoite stage (Figure 4.1B).  This is consistent with 
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previously reported results (Holmes et al., 2014) and indicates that the insertion of 
sequences directly downstream of the GFP stop codon do not alter the ability of the LDH1 
5’UTR to confer sustained translational repression to transcripts in bradyzoites. 
To assess whether the S1 aptamer could be used for affinity purification, an in vitro 
synthesized RNA fragment consisting of the LDH1 5’UTR, the GFP coding sequence, the 
S1 aptamer and the SAG1 3’UTR (5L1-GFP-5L1-3SAG1; Figure 4.1C upper panel) was 
made and incubated with streptavidin coated beads.  After washes, the beads were 
competitively eluted using biotin, which binds streptavidin with a dissociation constant of 
10-14 M and can completely dissociate the aptamer from the beads (Srisawat and Engelke, 
2001).  An RT-PCR was performed on the eluted fractions and the RNA fragment was not 
retrieved (Figure 4.1D, upper panel).  Since large amounts of the RNA transcript were 
added to the initial binding step, the failure to retrieve it upon elution suggested that the S1 
aptamer could not bind the streptavidin beads. 
The S1 aptamer was engineered using an in vitro selection process and notably, it is 
one member of a family that was generated to selectively bind streptavidin (Srisawat and 
Engelke, 2001).  While this aptamer family shared some sequence similarity, all members 
produced an identical secondary structure (Srisawat and Engelke, 2001; Figure 4.1A).  
Furthermore, the authors suggested that the S1 aptamer must adapt the conserved secondary 
structure for it to maintain its activity.  It was therefore hypothesized that the S1 aptamer 
was unable to adopt the proper conformation in the context that it was used here.  Using 
the MFOLD algorithm (Zuker, 2003), it was found the sequence of the S1 aptamer is 
predicted to extensively interact with the SAG1 3’UTR (Figure 4.1C, upper panel).  To 
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assess if this predicted base pairing interaction was responsible for precluding the proper 
S1 conformation, an RNA fragment was generated as before while lacking the SAG1 
3’UTR (Figure 4.1C, lower panel).  This transcript, which expresses the S1 aptamer on its 
3’ terminus, was predicted to allow the aptamer to fold upon itself (Figure 4.1C, lower 
panel) and was successfully bound and eluted from the streptavidin beads (Figure 4.1D, 
lower panel).  This result underscores the reliance of the S1 aptamer on achieving a proper 
conformation for its functionality (Srisawat and Engelke, 2001).  
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Figure 4.1 The S1 aptamer does not affect regulation but must fold upon itself to bind 
streptavidin beads. 
(A) Graphical representation of S1-containing GFP reporter plasmids.  The S1 aptamer 
(Srisawat and Engelke, 2001) is placed directly after the GFP stop codon.  Orange 
segments are derived from LDH1, green from GFP, purple represents non-regulated 
sequences.  (B) Relative GFP fluorescence (RFU) of transformed parasites under 
tachyzoite and bradyzoite conditions.  Bars show normalized average readings ± standard 
error (N ≥ 300) obtained from at least three independent clones per construct.  Dark bars, 
tachyzoites; light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 
0.001.  (C) Predicted secondary structures of the S1 aptamer when placed in the context 
of the in vitro synthesized transcripts depicted in the inset.  (D) RT-PCR of affinity 
purification samples.  The washes were grouped in sets of two.  L, ladder; FT, flow 
through; E1/E2 elutions; RT +/-, cDNA or NoRT control respectively. 
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Since the S1 aptamer appeared functional when placed in a 3’ terminal position, a 
transcript was engineered to express the HDV ribozyme directly downstream of the S1 
aptamer (Figure 4.2A).  Ribozymes are RNAs that possess enzymatic activity and this class 
self-cleaving viral ribozymes have been extensively used to produce transcripts with 
defined 3’ termination sites when appended directly downstream of the desired cleavage 
site (Figure 4.2A; Chowrira et al., 1994; Schürer et al., 2002).  The HDV ribozyme, which 
is derived from the hepatitis delta virus genome, forms a conserved pseudoknot structure 
and causes the cleavage of transcripts directly at its 5’ terminus with minimal upstream 
sequence requirements (Figure 4.2B; Been, 2006; Chowrira et al., 1994).  In contrast to 
other ribozymes that generate precise 3’ termini, the HDV ribozyme has a relatively low 
requirement for its Mg2+ cofactor (1 mM), suggesting that it is ideally suited for use in 
biological systems, where the estimated amount of free Mg2+ in the cell is similar to that 
needed for optimal HDV ribozyme activity (Chowrira et al., 1994).  Importantly, the HDV 
ribozyme has been shown to be tolerant of certain sequence mutations as long as secondary 
structure is maintained.  For example, nucleotide changes within the P1 stem cause little 
effect on cleavage efficiency as long as compensatory mutations are present to preserve 
Watson-Crick base paring (Been et al., 1992; Ananvoranich et al., 1998).  Likewise, 
decreasing the P4 stem from the long wild-type sequence to a shortened stem with a 
terminal ultra-stable UUCG tetraloop shows little change in HDV cleavage activity (Figure 
4.2B; Been et al., 1992; Mercure et al., 1998).  The HDV ribozyme variant used in this 
study contains mutations in the P1 stem that maintain Watson-Crick base pairing and has 
shortened P4 stem with a UUCG tetraloop, which has been indicated to cause increased 
stability to the ribozyme (Mercure et al., 1998). 
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In order to assess if inclusion of the HDV ribozyme was able to produce 3’ terminal 
S1 aptamers in a transcript, an in vitro transcription reaction was performed to produce the 
full length 1426 nucleotide transcript which is composed of the LDH1 5’UTR, GFP coding 
sequence, S1 aptamer, HDV ribozyme and SAG1 3’UTR (Figure 4.2A).  This full length 
transcript was anticipated to be processed by the HDV ribozyme in the presence of MgCl2 
to a 1027 nucleotide shortened version that included the LDH1 5’UTR, the GFP coding 
sequence and a terminal S1 aptamer (Figure 4.2A).  For size comparison, these transcripts 
were produced along with a catalytically inactive version of the HDV ribozyme and the full 
length transcript without the S1 or HDV ribozyme sequences, consisting of 1296 
nucleotides.  The inactive ribozyme has a deletion of 1 nucleotide, G58, which removes a 
purine-purine pairing that has been shown to be essential for catalytic activity (Figure 4.2B; 
Been and Perrotta, 1995).  A northern blot of the aforementioned transcripts was performed 
to assess HDV processing (Figure 4.2C).  Large trails were detected under each of the 
samples, likely due to non-specific degradation products or through the accumulation of 
products arising from premature transcriptional termination of the T7 RNA polymerase.  
While a clearer image could have been obtained had the uppermost bands of each sample 
been gel extracted and resuspended in a MgCl2-containing buffer to induce HDV ribozyme 
cleavage prior to running the blot, it clearly shows no specific accumulation of cleavage 
product in the presence of HDV ribozyme (Figure 4.2C, lane 3).  This indicated that the 
HDV ribozyme was unable to produce a transcript with a 3’ terminal S1 aptamer in this 
context. 
Similar to the S1 aptamer, the HDV ribozyme requires the formation of a specific 
secondary structure to achieve a functional state.  Although these considerations were 
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noted, it is likely that the HDV ribozyme was unable to fold properly into its complex 
pseudoknot structure.  It had been hypothesized that the modified P4 hairpin, containing 
the ultra-stable UUCG tetraloop, would help to drive the proper folding of the ribozyme 
since this has been reported to confer additional stability to the HDV ribozyme (Been et 
al., 1992; Mercure et al., 1998).  Contrarily, previous reports have shown that sequences 
downstream of the HDV ribozyme can have great positive or negative effect on its 
functionality likely through promoting its correct folding or by creating unwanted base 
pairing with the ribozyme (Chowrira et al., 1994).  Since the use of the S1 aptamer and S1-
HDV ribozyme methodologies both fell victim to the similar drawback of RNA misfolding, 
it was abandoned in favour of a strategy that was less reliant on the adoption of complex 
RNA structures.  
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Figure 4.2 The HDV ribozyme does not produce S1 terminal transcripts. 
(A) Graphical representation of S1-HDV in vitro synthesized transcript and cleavage 
product.  (B) Diagramme of properly folded HDV ribozyme used in this study.  The 
stems of the pseudoknot and nucleotide G58 are annotated.  (C) Northern blot of in vitro 
synthesized transcripts.  Lane numbering corresponds to the samples indicated under the 
blot. 
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4.3.2 Adaptation of the MS2 aptamer system for affinity purification 
The MS2 loop aptamer consists of a small 19 nucleotide RNA hairpin that 
specifically binds that MS2 bacteriophage coat protein (CP) with dissociation constant of 
3 x 10-9 M (Said et al., 2009; Slobodin and Gerst, 2010).  This interaction has been utilized 
for the development of affinity purification methodologies where a CP fusion protein binds 
a transcript encoding the MS2 loop aptamer and is then selectively withdrawn from protein 
lysate.  For example, Slobodin and Gerst (2010) developed a CP fused to GFP and a 
streptavidin-binding peptide (SBP; Figure 4.3A).  This CP-GFP-SBP was expressed and 
shown to co-localize with MS2 loop-containing transcripts in vivo, showing that the GFP 
moiety could be used for live cell imaging (Slobodin and Gerst, 2010).  Furthermore the 
SBP portion was compatible with streptavidin-agarose resin and permitted a clean, 
competitive elution in the presence of biotin (Slobodin and Gerst, 2010).  However, because 
the CP has a propensity to oligomerize in vivo, the authors suggested that it be should only 
be expressed while using an inducible system to prevent non-specific binding (Slobodin 
and Gerst, 2010).  This system was adapted for use in Toxoplasma and the LDH1-GFP 
reporter system.  However, because of the propensity for CP to oligomerize and because 
the MS2 aptamer was incorporated into a GFP cassette (Figure 4.3A), which would make 
live-cell transcript visualization impractical, it was decided to bacterially express the CP-
GFP-SBP capturing molecule. 
After incorporation into the pET vector system, a C-terminally histidine tagged CP-
GFP-SBP was expressed in a bacterial system.  As is common for GFP-containing proteins 
expressed in E. coli (Peternel et al., 2008), the recombinant protein partitioned to the 
insoluble fraction and was therefore solubilized in an 8 M urea buffer and allowed to refold 
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on the column.  This procedure isolated the CP-GFP-SBP protein at high purity as assessed 
by SDS-PAGE analysis (Figure 4.3B, lane P).  While the choice to bacterially express the 
CP-GFP-SBP had advantages over allowing it to be produced in vivo, it also raised several 
important technical issues.  For example, while the cellular expression of CP-GFP-SBP has 
the advantage of being able to preserve the MS2-CP interaction along with the mRNP 
composition through formaldehyde crosslinking (Slobodin and Gerst, 2010; Slobodin and 
Gerst, 2011), using a bacterially expressed CP-GFP-SBP instead requires the interaction to 
occur post-fixation.  Therefore, modifications were made to the recovery procedure that 
take this into consideration.  For example, gentler lysis, binding, and wash buffers were 
modeled after those that were used for MS2 aptamer affinity purification using a bacterially 
expressed CP (Said et al., 2009; Corcoran et al., 2012). 
After crosslinking in formaldehyde, approximately 108 extracellular tachyzoites 
expressing the MS2-tagged GFP transcript were lysed in a gentle hypotonic lysis buffer, 
yielding a total of 5 mg total protein.  Notably, this amount of total protein has been 
recommended as the minimum amount to use for this procedure as using input amounts 
significantly lower than this may not yield sufficient protein for downstream western blot 
analysis (Slobodin and Gerst, 2011).  After blocking endogenous biotin moieties with 
avidin, the protein lysate was applied to a streptavidin-agarose resin that was pre-bound 
with CP-GFP-SBP.  The resin was washed five or six times and eluted with biotin.  When 
the samples from the affinity purification procedure were run on an SDS-PAGE gel, a 
single 48 kDa protein, likely corresponding to the CP-GFP-SBP targeting molecule, was 
observed in the eluate (Figure 4.3B).  A silver staining procedure had been performed with 
the hopes that other protein bands would be seen and could be identified using a mass 
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spectrometry approach (Figure 4.3B).  However, since only the CP-GFP-SBP band was 
observed, it was thought that perhaps any other isolated proteins were under the detection 
limit for silver staining.  After repeating the affinity purification procedure either in the 
presence of absence of CP-GFP-SBP, a western blot was performed (Figure 4.3C).  Probing 
with α-GFP revealed a 26 kDa band corresponding to the free GFP produced by the MS2-
tagged transcript in the parasite lysate as well as a 48 kDa band in the eluted fraction 
corresponding to the CP-GFP-SBP fusion (Figure 4.3C).  This indicates that successful 
binding and elution of the CP-GFP-SBP targeting molecule to the streptavidin-agarose 
resin was achieved through its SBP moiety.  In order to assess if the MS2-transcript was 
able to be purified using this methodology, the western was probed for PABP with the 
thought that since it is a ubiquitous RBP, it should be retrieved upon successful affinity 
purification of any MS2-tagged transcript.  Multiple Toxoplasma-reactive bands were seen 
in the parasite lysate when the blot was probed with α-human PABPC3 (Figure 4.3D).  
However, no PABPC3-reactive protein was observed in the eluted sample, consistent with 
the possibility that the CP-GFP-SBP targeting molecule was unable to capture the MS2-
containing transcript (Figure 4.3D).  In addition, after reversing the formaldehyde 
crosslinking from the same eluted sample, RT-PCR analysis was performed, however no 
products corresponding to the GFP amplicon were seen (data not shown).  Although care 
was made to minimize the risk, technical issues such as post-lysis RNA degradation cannot 
be completely discounted.  However, it is likely that the MS2-CP interaction did not occur.  
173 
 
 
Figure 4.3 CP-GFP-SBP binds streptavidin but not the MS2 aptamer. 
(A) Cartoon representation of the materials used.  Bacterially expressed CP-GFP-SBP 
fusion protein (green) should bind streptavidin-agarose resin (white) and the MS2 
aptamer (pink).  The MS2 aptamer is encoded directly after GFP in a reporter construct.  
(B) Silver stained SDS-PAGE of affinity purification trial using PT5L1-MS2 parasites.  
Lanes: P, purified CP-GFP-SBP; L, protein ladder; FT, diluted flow through sample, W1-
6, washes, E, biotin elution.  (C)  Western blot of affinity purification trial done in parallel 
with and without the CP-GFP-SBP targeting molecule.  The blot was probed for GFP.  
Dark arrowhead outlines the 26 kDa GFP from the parasite lysate while the white arrow 
indicates the 48 kDa CP-GFP-SBP fusion.  Lanes: as in (B); w/o, without CP-GFP-SBP; 
w/, with CP-GFP-SBP.  (D) Western blot from (C) probed with anti-human PABPC3.  
Lanes are indicated as before; OE, over-exposed elution. 
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Two important issues could have disfavoured the binding of the MS2 loop aptamer 
by the CP.  First, since the bacterially expressed CP-GFP-SBP was insoluble, it was 
solubilized and denatured through the use of 8 M urea.  While the protein was subsequently 
allowed to refold, it is very possible that the CP was unable to adopt its proper 
conformation.  This issue likely could have been avoided had the central GFP portion been 
removed from the CP-GFP-SBP fusion since GFP is known to aggregate into insoluble 
bacterial inclusion bodies (Peternel et al., 2008).  Alternatively, a mutant CP that is 
defective in oligomerization exists (Said et al., 2009) and could have been used for 
expression of the fusion within Toxoplasma, with the hope that the MS2-CP interaction 
would have occurred under more natural conditions in the cell. 
The second major issue that could have prevented MS2 binding echoes the problems 
encountered with the S1 aptamer approach, namely that the MS2 aptamer may not have 
folded into the necessary conformation to permit CP binding.  The MS2 aptamer is a small, 
19 nucleotide RNA hairpin that has a weak predicted free energy (ΔG = -6.80 kcal/mol; 
Said et al., 2009; Zuker, 2003).  This indicates that its stability is relatively low and 
therefore an individual hairpin is prone to be influenced surrounding upstream and flanking 
sequences.  To combat this issue, multiple units of the MS2 aptamer are typically expressed 
in tandem.  For example, like this study, Said et al. (2009) expressed two MS2 hairpins in 
tandem while twenty four were used by Slobodin and Gerst (2010).  By using such a large 
copy number of the MS2 hairpin (Slobodin and Gerst, 2010), it is likely that at least some 
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of the MS2 units could be shielded from the non-specific base pairing that would disrupt 
their activity. 
In contrast, this study consistently used a minimalist approach when inserting 
sequences within the GFP reporter system with the goal of minimizing potential unintended 
consequences caused by the introduction of large sequence insertions.  For example, instead 
of using the full length 84 nucleotide S1 aptamer (Srisawat and Engelke, 2001), the minimal 
sequence was used.  Similarly, instead of opting to use a large copy number of MS2 
hairpins, only two were used.  While these minimal elements have been described as 
successful in purification procedures (Srisawat and Engelke, 2001; Said et al., 2009), they 
were not here.  The primary difference between this study and others using minimal 
aptamer motifs is that in those cases the aptamers were rationally placed while accounting 
for the secondary structure of its surroundings.  For example, in a proof of concept 
experiment using the S1 aptamer for the purification of RNaseP components, the S1 
aptamer was placed at the end of a previously established stem loop (Srisawat and Engelke, 
2001).  This positioning likely encouraged the aptamer to form a self-folding domain since 
both upstream and downstream flanking sequences formed a stable, well defined RNA stem 
(Srisawat and Engelke, 2001). 
In the future, such a strategy could be used for inserting an aptamer within the GFP 
reporter system and would likely yield more positive results.  This could be accomplished 
in a number of ways.  First, an aptamer could be inserted within a naturally occurring or an 
engineered stable hairpin, mimicking its previous use in RNase P (Srisawat and Engelke, 
2001).  Alternatively, multiple tandem copies of an aptamer could be used (Slobodin and 
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Gerst, 2010).  However, to improve the folding efficiency of individual aptamers, these 
could be placed between two engineered long and stable RNA hairpins.  Conceptually, 
these external hairpins would self-anneal and promote the internal sequences to act as a 
self-folding RNA domain.   
4.3.3 The LDH1 poly(A) tail is not shortened during sustained translational repression 
Controlling the length of a transcript’s poly(A) tail is a common mechanism for 
modulating its translational competency (Godwin et al., 2013).  The poly(A) tail serves as 
a substrate for poly(A) binding protein (PABP) which in turn interacts with eIF4G, causing 
an increase in translation and circularization of the transcript in what has been termed the 
closed loop model of translation (Sonenberg and Hinnebusch, 2009).  In contrast, a 
common theme amongst translationally repressed transcripts is their deadenylation which 
can either lead to their degradation or, if the poly(A) tail is kept very short, their sustained 
translational repression (Godwin et al., 2013).  Since this mechanism is widely conserved 
and the LDH1 transcript is maintained in a translationally quiescent state in bradyzoites 
(Yang and Parmley, 1997; Holmes et al., 2014), changes in the polyadenylation state of the 
LDH1 transcript were examined in order to gain an insight into its stage-specific regulation. 
An RT-PCR approach was undertaken to estimate the poly(A) tail length of LDH1 
and, for comparative purposes, the constitutively expressed GRA1 transcript in intracellular 
tachyzoites and bradyzoites (Figure 4.4A; Murray and Schoenberg, 2008; Cesbron-Delauw 
et al., 1989).  In this procedure, a modified oligo-dT primer is used as a substrate in a 
reverse transcriptase reaction for the synthesis of cDNA from polyadenylated mRNA 
(Figure 4.4A; Murray and Schoenberg, 2008).  Next, a transcript-specific forward primer 
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is added and a conventional PCR is performed.  The sizes of the resulting products represent 
a range spanning the length of the poly(A) tail (Murray and Schoenberg, 2008).  Following 
this procedure, it was apparent that tachyzoites and bradyzoites produce an LDH1 transcript 
with similar poly(A) tail lengths (Figure 4.4B).  After subtracting the 124 nucleotides 
resulting from the sequence upstream of the polyadenylation start site, the LDH1 poly(A) 
tail is estimated to vary between 25 and 200 nucleotides in both life stages.  While it may 
seem as though a smaller poly(A) tail is favoured in both tachyzoites and bradyzoites due 
to its intensity on the gel (Figure 4.4B), it is important to note that PCR has a propensity 
for favouring the production of small amplicons over larger ones.  Similar results were 
obtained for the non-regulated GRA1 in tachyzoites and bradyzoites (Figure 4.4B).  
However, the primary product appears significantly smaller than the predicted 124 bp 
minimal product based on the previous reporting of the polyadenylation site (Cesbron-
Delauw et al., 1989), suggesting that the GRA1 3’UTR contains multiple polyadenylation 
sites.  
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Figure 4.4 The LDH1 poly(A) is not shortened in bradyzoites. 
(A) Cartoon representation showing the methodology of the poly(A) tail length 
estimation assay.  Primer PAT-Rv binds within the poly(A) tail through an oligo-dT 
region and is used to synthesize cDNA.  A PCR is then performed upon the addition of 
a gene-specific primer.  (B) Acrylamide gel showing the poly(A) tail lengths of LDH1 
and GRA1 transcripts in tachyzoites and bradyzoites.  The sizes of the ladder bands are 
indicated in bp on the side on the gel.  Note: for size estimation, 124 bp corresponding 
to sequences upstream of the polyadenylation site must be subtracted. 
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While the finding that the LDH1 poly(A) tail is unregulated during sustained 
translational repression runs contrary to most other investigated systems, a similar result 
has been found in the apicomplexan parasite Plasmodium (Braks et al., 2008).  Similar to 
LDH1, the transcripts of P25 and P28 are maintained in a translationally quiescent state in 
female gametocytes.  Upon fertilization, these transcripts are released and translated.  
Interestingly, northern blot analysis of these transcripts revealed that their poly(A) is 
maintained in an elongated state while repressed (Braks et al., 2008).  Together, these 
results suggest that, contrary to well-studied metazoans whose transcripts undergo 
deadenylation while silenced and awaiting developmental progression, apicomplexans are 
not regulated in this manner.  Importantly, a BLAST search against the Toxoplasma 
genome using the Xenopus cytoplasmic polyadenylation binding element protein, which is 
commonly involved in poly(A) tail shortening (Godwin et al., 2013), revealed no hits 
suggesting that this common regulatory mechanism may be absent.  Furthermore, the long 
poly(A) observed in repressed transcripts in apicomplexan parasites raises interesting 
questions regarding the involvement of PABP. 
One of the most well studied proteins involved in stage-dependent translational 
repression in Plasmodium is the DEAD-box helicase DOZI, which is a homolog of yeast 
DHH1.  DOZI is required for sustained translational repression of P25 and P28 in female 
gametocytes (Mair et al., 2006).  A study examining DOZI-associated factors involved in 
translational repression identified a variety classic proteins involved in translational 
repression, including the Plasmodium homolog of BRUNO and a number of ALBA 
proteins as well as PABP, which was the protein identified with the highest abundance 
(Mair et al., 2010).  While it could easily be expected that this association with 
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translationally repressed transcripts has little biological significance aside from the obvious 
poly(A) binding activity, the apicomplexan PABP has several features that could merit 
investigation. 
When encountered with conditions of cellular stress, a generalized translational 
repression is induced while a small subset of transcripts, corresponding primarily to stress-
responsive gene products, are preferentially translated (Joyce et al., 2013).  Intriguingly, 
PABP is preferentially translated under these conditions along with bradyzoite-specific 
transcription factors and translational repressors such as the Toxoplasma homolog of PUF1 
(Joyce et al., 2013).  This is a particularly interesting finding considering that translation is 
stunted and most transcripts are thought to be rapidly degraded under these conditions 
(Joyce et al., 2013).  One might instead expect that the large scale transcript degradation 
hypothesized to occur upon stressful insult would yield an abundant source of available 
PABP to serve any immediate needs under stress. 
Also, PABP has been shown to interact with the Toxoplasma ABLA proteins, which 
form mRNA granules under stress and are involved in translational control (Gissot et al., 
2013).  Furthermore, polyadenylated mRNA has been found to aggregate into stress 
granules upon stressful insult (Lirussi and Matrajt, 2011).  Presumably, PABP would be 
similarly located.  Intriguingly, a chance BLAST search of Toxoplasma using the stress 
granule marker TIA1 protein as a query revealed PABP as the top hit with an expected 
value of 2e-25.  In metazoans, TIA1 is regarded as an important protein involved in the 
aggregation of stress granules through its C-terminal prion-like domain (Anderson and 
Kedersha, 2008).  Interestingly, unlike the metazoan PABPs, Toxoplasma PABP is 
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predicted to contain a nearly 200 amino acid prion-like domain near its C-terminus 
(Lancaster et al., 2014).  These PABP features along with the observation that repressed 
transcripts display long poly(A) tails may suggest that it acts as a stress granule aggregator 
under stressful conditions. 
4.3.4 Transcript-specific translational repression is not an immediate event 
The transition of tachyzoites to bradyzoites is known to occur in response to cellular 
stresses that cause the phosphorylation of eIF2α (Narasimhan et al., 2008).  This causes a 
generalized translational repression which is maintained throughout the bradyzoite life 
stage (Narasimhan et al., 2008).  Recently it has been shown using a GFP reporter system 
that the LDH1 5’UTR is responsible for conferring a sustained translational repression to 
its transcript through a cis-acting element and that if this element was missing or mutated, 
repression was relieved in bradyzoites (Holmes et al., 2014).  This indicates that in addition 
to the generalized translational repression mediated through eIF2α phosphorylation, 
transcript-specific mechanisms are also important for mediating long term translational 
control.  While not mutually exclusive with the generalized model of translational 
repression, this raises the question as to whether the transcript-specific regulation of LDH1 
is an early event, occurring rapidly after stressful insult or a gradual long-term process.  If 
it were to occur rapidly, it would be expected that LDH1 would be repressed upon stressful 
insult relative to a transcript that remains unregulated in bradyzoites.  In contrast, if 
transcript-specific repression were a gradual process, LDH1 would show similar expression 
relative to a control transcript that remains constitutively expressed in bradyzoites.  
Determining the relative speed at which LDH1 is repressed would allow for insight into 
transcript-specific translational repression in Toxoplasma. 
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In order to answer this question, the previously described GFP reporter system was 
converted to a dual luciferase system.  Notably, GFP is a very stable protein with an 
estimated half-life of 26 h (Kitsera et al., 2007), making it unsuitable for studying rapid 
changes in post-transcriptional gene regulation.  In contrast, firefly (FF) and Renilla (RN) 
luciferases have half-lives of approximately 3 hours making them more ideal for the study 
of rapid changes in gene expression (Leclerc et al., 2000).  Therefore, the GFP coding 
sequence was exchanged for the corresponding FF and RN sequences in order to create 
plasmids that would express FF in a regulated (PT5FF) and unregulated manner (PT0FF) 
while RN would be under the control of unregulated upstream and downstream sequences 
(PT0RN) according to previously established conventions (Figure 4.5A; Holmes et al., 
2014).  Importantly, when assessed for their relative expression in tachyzoites and 
bradyzoites, repression was restricted to PT5FF in bradyzoites, indicating that the exchange 
of GFP for FF does not affect regulation (Figure 4.5B). 
In order to assess the rapidity with which LDH1 encounters transcript-specific 
repression, extracellular parasites were subjected to a high potassium buffer and their 
relative FF expression was assessed over a time course assay (Figure 4.5C).  This buffer 
mimics the host’s cytoplasmic ionic composition and would typically be seen as the parasite 
leaves its parasitophorus vacuole upon egress (Lirrusi and Matrajt, 2011).  Also, this buffer 
has previously been reported to cause a robust stress in the parasite, inducing eIF2α 
phosphorylation and the aggregation of mRNAs into stress granules (Lirussi and Matrajt, 
2011; Gissot et al., 2013).  Interestingly, both PT5FF and PT0FF showed a similar decay 
over a three hour time period (Figure 4.5C).  When normalized against the PT0RN internal 
control, it becomes apparent that PT5FF and PT0FF are expressed at similar relative levels 
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relative to one another throughout the selected time points (Figure 4.5D).  This indicates 
that transcripts containing the LDH1 5’UTR are not preferentially repressed after initial 
stressful insult and in contrast suggests that a period of generalized translational repression 
is induced upon stressful insult.  These observations are consistent with the model 
postulated by Joyce and colleagues whereby a stressful insult causes rapid eIF2α 
phosphorylation and a generalized translational repression that affects the wide majority of 
transcripts independently of repressive cis-acting elements like that seen in LDH1 (Joyce 
et al., 2013; Holmes et al., 2014).  Furthermore, these results clearly indicate that the 
translational control observed in extracellular tachyzoites is different than that seen in fully 
developed bradyzoites since PT0FF and PCTRL are regulated differently in the two 
stressful situations despite both being characterized as sustaining eIF2α phosphorylation 
(Figure 4.5B, Holmes et al., 2014; Narasimhan et al., 2008; Joyce et al., 2010).  
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Figure 4.5 The LDH1 5’UTR does not confer immediate translational repression in 
extracellular parasites. 
(A) Cartoon representation of plasmids used for the dual luciferase assay.  Purple 
segments represent TUB8 or SAG1 sequences; orange, the LDH1 5’UTR; yellow and 
blue FF and RN coding sequences, respectively.  (B) Relative expression of FF luciferase 
normalized against RN levels in tachyzoites and bradyzoites.  Bars represent mean ± 
standard deviation.  Yellow bars, unregulated PT0FF; orange, PT5FF; dark bars, 
tachyzoites; light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 
0.001.  (C) FF luciferase shows a time-dependent decay.  Data points ± standard 
deviation (N = 3) expressed as a function of the initial timepoint.  These data points are 
not normalized against RN luciferase.  Orange, PT5FF; yellow, PT0FF.  (D) Dual 
luciferase assay with data from (C) normalized against internal PT0RN control.  Bars 
indicated mean ± standard deviation (N = 3). 
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Interestingly, although all stressful stimuli tested to date seem to result in the same 
central response of eIF2α phosphorylation and translational repression, the biological 
outcomes to the parasite can be quite different depending on the circumstances.  For 
example, exposure to the extracellular environment activates the GCN2-like TgIF2K-D 
kinase, causing eIF2α phosphorylation and a generalized translational repression at the step 
of translational initiation which in turn induces the aggregation of transcripts into stress 
granules (Konrad et al., 2011; Lirussi and Matrajt, 2011).  Furthermore, both eIF2α 
phosphorylation and formation of stress granules are essential for sustained viability of 
extracellular parasites indicating that this can act as a coordinated survival mechanism 
(Konrad et al., 2011; Lirussi and Matrajt, 2011).  In contrast, intracellular tachyzoites 
undergoing amino acid starvation see eIF2α phosphorylation mediated through TgIF2K-C 
(Konrad et al., 2013a).  However this stimulus leads to the autophagic loss of the parasite’s 
unique mitochondrion and inevitable cell death (Ghosh et al., 2011).  Finally, a collection 
of other stimuli that induce cytoplasmic or endoplasmic reticulum stress activate TgIF2K-
B and -A respectively and cause the conversion to bradyzoites, which are marked by 
mitochondrial dysfunction and the production of stress-responsive transcripts (Narasimhan 
et al., 2008; Toursel et al., 2000; Behnke et al., 2008). 
 Conclusion 
It is therefore apparent that while many different stressful stimuli can initiate 
translational repression, care should be taken when substituting one study model for 
another.  This has a direct consequence on the question of whether or not to revisit an 
aptamer-based affinity purification approach for the identification of the putative trans-
acting factor involved in the sustained translational repression of LDH1.  While important 
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lessons have been learned regarding aptamer selection and potential placement within a 
transcript, the current technological limitations require a recommended minimum of 5 mg 
total protein lysate from which to begin such an experiment with any hopes of achieving 
an identification by western blot (Slobodin and Gerst, 2011).  In this study, attaining that 
amount of protein required seven 10 cm culture plates yielding 108 extracellular 
tachyzoites.  Bradyzoites grow at several orders of magnitude less than tachyzoites and the 
purification procedures currently available are far less efficient for the former than the 
latter.  It would therefore make it highly impractical and would be ill advised to follow a 
similar attempt in the future. 
In contrast, the study of the fate of the LDH1 transcript in bradyzoites and 
extracellular tachyzoites has the potential to yield great insight into post-transcriptional 
gene regulation in Toxoplasma.  Results shown here demonstrate that LDH1, and likely 
other transcripts, are not regulated in their poly(A) tail length while translationally 
repressed.  Also, sustained translational repression of LDH1 is not an immediate event and 
likely occurs in bradyzoites specifically.  This could be achieved if a translational repressor 
were to be produced or activated specifically in bradyzoites.  Conceptually, this trans-
acting factor would be responsible for binding and inducing, either directly or indirectly, 
the sustained translational quiescence of LDH1 and other transcripts.  
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CHAPTER V – General discussion 
 The emerging role of securinine as an inducer of differentiation 
As an important component of traditional Chinese medicines, securinine has long to 
know to possess biological activities and one of the most characterized is its action as an 
antagonist of the GABA receptor (Raj and Luczkiewicz, 2008).  Because it is capable of 
acting on the central nervous system of the host, displays anti-cancer activity, and causes 
the conversion of tachyzoites into bradyzoites, it has been proposed that securinine shows 
potential as an anti-toxoplasmosis in cancer patients (Raj and Luczkiewicz, 2008; Rana et 
al., 2010; Holmes et al., 2011).  However the mechanism of action remains undescribed in 
Toxoplasma.  Since the publication of our results, research into the anti-cancer effects of 
securinine has continued and yielded some very interesting results regarding its activities 
and potential mechanism(s) of action. 
It has been revealed that securinine causes the cell cycle arrest of leukemia, colon, 
and breast cancer cells in the G1 phase, reducing their growth and proliferation (Gupta et 
al., 2011; Xia et al., 2011; Li et al., 2014).  Furthermore, securinine has been shown to be 
a potent inducer of monocytic differentiation in leukemia cells and this activity is 
independent of its GABA antagonistic activities but involves DNA damage (Gupta et al., 
2011).  Interestingly, bradyzoites are characterized by a cell cycle arrest in the G1 phase 
and the induction of differentiation (Radke et al., 2003).  Furthermore, these activities occur 
in the same range (IC50 = 10 μM) that securinine has been shown to inhibit Toxoplasma 
growth and induce differentiation to bradyzoites (Gupta et al., 2011; Holmes et al., 2011). 
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Investigations into the molecular targets of securinine have discovered a few novel 
possibilities for its mechanism of action.  In Plasmodium, securinine has been found to bind 
and allosterically increase the activity of the essential enzyme dUTPase and decrease 
parasite replication (Vu et al., 2013).  dUTPase catalyses the conversion of dUTP to dUMP, 
an essential step in the production of dTTP and has been described as a potential drug target 
for apicomplexan parasites (Quesada-Soriano et al., 2010).  However, it is important to 
note that a decrease, not an increase, of dUTPase activity has been linked to inhibition of 
parasite growth (Quesada-Soriano et al., 2010).  Although securinine has been shown to 
activate Plasmodium dUTPase and cause inhibition of parasite growth, no mechanistic 
relationship between the two activities has been suggested or investigated (Vu et al., 2013).  
In contrast, one of the biological targets of securinine in mammalian cells may have 
interesting applications for future investigations into Toxoplasma differentiation. 
Securinine has been shown to bind and inhibit protein disulfide isomerase (PDI) in 
mammalian cells (Hoffstrom et al., 2010).  PDI is an important chaperone protein involved 
in mediating the correct folding of proteins in the endoplasmic reticulum by ensuring the 
correct formation of disulfide bridges (Obukuro et al., 2013).  Its inhibition either through 
nitrosylation or by securinine has been shown to cause an accumulation of unfolded 
proteins in the ER lumen (Obukuro et al., 2013).  Notably, this accumulation is known to 
activate the PERK-like eIF2α kinase TgIF2K-A, causing a generalized translational 
repression and bradyzoite differentiation in Toxoplasma (Narasimhan et al., 2008).  
Furthermore, production of nitric oxide (NO), which nitrosylates and inactivates PDI, is 
known to be upregulated by macrophages during infection and be necessary for bradyzoite 
differentiation in vivo, suggesting that an unexplored link between PDI and differentiation 
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may exist (Obukuro et al., 2013; Bohne et al., 1994).  It is therefore tempting to speculate 
that inactivation of PDI by securinine is conserved in Toxoplasma.  While NO has been 
thought to cause bradyzoite differentiation through inhibition of mitochondrial enzymes 
(Bohne et al., 1994; Tomavo and Boothroyd, 1995), it may also have an unexplored role in 
PDI inactivation and ER stress induction in bradyzoites.  If future investigations were to 
find securinine binds and inhibits Toxoplasma PDI, which maintains 55% sequence 
similarity with its human counterpart, it could be used to specifically probe the involvement 
of PDI in mediating bradyzoite differentiation. 
 A unifying model of transcript-specific translational repression and bradyzoite 
development 
There is overwhelming evidence that sustained cellular stress causes the 
differentiation of tachyzoites to bradyzoites.  Furthermore, a generalized translational 
repression plays a vital role in this process.  Taken together, recent results in stress-induced 
translational repression combined with insights into transcript-specific translational 
repression can be combined into a cohesive model.  This model integrates translational 
repression and bradyzoite differentiation with mRNP granule accumulation and selective 
transcript storage and maintenance within the context of developmental progression in 
Toxoplasma. 
Upon stressful insult, such as oxidative stress, the accumulation of nitrogen reactive 
species or unfolded proteins in the lumen of the endoplasmic reticulum, one of the four 
encoded eIF2α kinases is activated in Toxoplasma (Narasimhan et al., 2008).  eIF2α is 
phosphorylated, reducing the turnover of eIF2-GFP and availability of charged ternary 
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complex inhibiting translational initiation (Sullivan et al., 2004; Sonenberg and 
Hinnebusch, 2009).  Translating ribosomes complete elongation but after termination, are 
not able to re-initiate due to the lack of available charged ternary complex (Anderson and 
Kedersha, 2008).  Transcripts stalled in the translational initiation stage accumulate in the 
cytoplasm (Anderson and Kedersha, 2008).  As in metazoans, these stalled transcripts 
would accumulate into cytoplasmic granules known as stress granules (Anderson and 
Kedersha, 2008).  This has been observed in extracellular parasites but has only been 
indirectly observed in intracellular parasites using RNA-binding proteins (RBP)s as 
markers of aggregation (Lirussi and Matrajt, 2011; Gissot et al., 2013; Cherry and 
Ananvoranich, 2014).  Since stressful insult causes the immediate translational repression 
of transcripts that would remain unregulated in bradyzoites (Figure 4.5C,D) it could be 
hypothesized that most transcripts are recruited to stress granules without regard for their 
selection, at least in the short term.  This could be mediated through a ubiquitous RBP with 
aggregation-like properties.  While in metazoans this function is performed by the prion-
like TIA1 (Anderson and Kedersha, 2008), in Toxoplasma it may be mediated by PABP 
which is predicted to have a prion-like domain, is a classical marker of stress granules, and 
has been shown to be involved in translational repression complexes in Plasmodium 
(Section 4.3.3; Anderson and Kedersha, 2008; Mair et al., 2010; Gissot et al., 2013). 
Stress granules, which have been described as loosely aggregated complexes that 
remain in equilibrium with the translational machinery, help to withdraw the stalled 
transcripts from the limited translational pool (Stoecklin and Kedersha, 2013; Yamasaki 
and Kedersha, 2008).  This withdrawal is thought to allow the translational machinery to 
favour stress-responsive transcripts for translation (Yamasaki and Kedersha, 2008).  At 
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least some of these transcripts contain specific cis-acting elements that aid them to be 
preferentially translated under stress (Joyce et al., 2013).  These transcripts include PABP, 
the translational repressor PUF1, and a variety of bradyzoite-specific AP2 transcription 
factors (Joyce et al., 2013).  It therefore follows that their production is important for the 
conversion of tachyzoites into bradyzoites. 
Notably, tachyzoite to bradyzoite conversion is a lengthy process, dependent on cell 
cycle progression, and it is common to see parasites expressing both tachyzoite and 
bradyzoite-specific markers as their cell division slows (Radke et al., 2003).  This indicates 
that the parasite goes through a transitional period, where a balance exists between 
“tachyzoite” and “bradyzoite” protein synthesis.  This balance is likely shifted towards 
“bradyzoite” production through two complementary mechanisms.  First, the stress-
induced expression of PABP and PUF1 (Joyce et al., 2013), and perhaps other transcript-
specific translational repressor proteins, would increase the stability of mRNP aggregation 
through their ability to bind cis-acting elements in specifically repressed transcripts, such 
as that of LDH1.  This would decrease the amount of competition that these “tachyzoite” 
transcripts would be able to provide against stress-responsive “bradyzoite” transcripts.  
Transcript-specific translational repressors are known to be important for the long-term 
aggregation and translational inactivation of stage-specific transcripts and the inclusion of 
transcript-specific translational repressors in granules has been characterized as a late stage 
of mRNP aggregation, signaling a maturation of the stress granules (Anderson and 
Kedersha, 2008).  This has been observed in apicomplexan parasites.  For example in 
Plasmodium, PUF2 is essential for the long-term storage of transcripts that are 
transcriptionally silent in sporozoites and female gametocytes and has granular distribution 
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(Gomes-Santos et al., 2011; Miao et al., 2013).  Furthermore, PUF1 and the translational 
regulator ALBA proteins show granular distribution in bradyzoites (Liu et al., 2014; Gissot 
et al., 2013).   
In the second complementary mechanism, the production of stress-induced AP2 
transcription factors initiates a cascade of downstream bradyzoite-specific transcription 
(Behnke et al., 2010; Behnke et al., 2008).  This would increase the relative proportion of 
“bradyzoite” transcripts that could compete for the translational machinery against the 
disadvantaged “tachyzoite” transcripts that are assembled in weakly associated stress 
granules.  Taken together these two mechanisms would form a positive feedback loop 
where the increase in “bradyzoite” transcripts leads to more “bradyzoite” proteins, 
presumably including more transcript-specific translational repressors.  In turn, this 
increases the specificity and stability of mRNP aggregates, causing their maturation from 
loosely assembled stress granules into more stable germ-like granules, decreasing their 
ability to compete for translational machinery and causing more efficient bradyzoite protein 
production.  Coupled with the inevitable degradation and removal of “tachyzoite” 
transcripts whose genomic loci are no longer transcribed, this mechanism would be 
consistent with a model of progressive bradyzoite differentiation.  Interestingly, it has been 
shown that the expression of bradyzoite-induced transcripts shifts gradually over the period 
of days until reaching maturation, consistent with this hypothesis (Cleary et al., 2002). 
Upon reaching a certain state bradyzoite maturation, the pressure on the translational 
machinery may decrease.  Although eIF2α phosphorylation is maintained throughout the 
bradyzoite stage (Narasimhan et al., 2008; Konrad et al., 2013), transcripts that are 
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translationally quiescent during the initial stages of a stressful insult become translationally 
permissive in bradyzoites (Section 4.3.4).  This suggests that as mRNP storage granules 
stabilize and the transcription of tachyzoite genes ceases, the subset of transcripts that are 
able to translated under the conditions of generalized translational repression expands 
somewhat.  Again this is supported by the observation that the transcription of bradyzoite 
genes occurs gradually as the parasite matures (Cleary et al., 2002). 
Finally, the process of bradyzoite to tachyzoite transition likely works in a manner 
similar to the above hypothesized mechanism of bradyzoite conversion.  Similar to 
bradyzoite differentiation, the reactivation of bradyzoites to tachyzoites has been shown to 
be a gradual process, with the first signs of tachyzoite antigens being produced in 
approximately 18 hours after reactivation is induced (Radke et al., 2003).  This would be 
consistent with a model whereby upon the relief of stress, eIF2α phosphorylation decreases, 
likely causing an uptick in translation (Konrad et al., 2013).  Essential tachyzoite transcripts 
that were tightly stored in germ-like storage granules would gradually emerge from 
repression and enter the translational pool.  The products of these stored transcripts would 
then drive metabolic and transcriptional changes, causing a cascade that amplifies the 
conversion from bradyzoite to tachyzoite.  This hypothesis is consistent with previous 
research performed in Plasmodium where the premature release of transcripts from storage 
granules in salivary gland sporozoites, some of which are transcription factors, causes the 
premature progression into liver stage parasites (Gomes-Santos et al., 2011). 
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 Potential components and characteristics of sustained translational repression 
The above stated hypothesis supposes heavily on the existence of mRNA-containing 
germ-like granules in Toxoplasma bradyzoites.  While these have not been directly 
observed to date, they are likely to exist since proteins involved in translational repression 
have displayed granular localization in bradyzoites (Liu et al., 2014; Gissot et al., 2013; 
Cherry and Ananvoranich, unpublished results).  Furthermore these observations echo the 
composition of mRNA-containing germ-like granules found in the salivary gland 
sporozoite and female gametocyte stages of Plasmodium development (Gomes-Santos et 
al., 2011; Mair et al., 2010).  It therefore follows that the components of germ-like granules 
in bradyzoites would be similar to what is found in their Plasmodium cousins. 
Transcripts that undergo sustained translational repression are likely sequestered in 
germ-like granules.  This would most assuredly include LDH1, and likely other transcripts 
that have been suggested to be post-transcriptionally silenced in bradyzoites such as the 
RNA-binding TgDRE and the canonical tachyzoite marker SAG1 (Yang and Parmley, 
1997; Dendouga et al., 2002; Cleary et al., 2005).  Undoubtedly, other transcripts would 
be sequestered to these granules and would likely have the general function of being 
important for early tachyzoite survival; prime candidates would be tachyzoite-specific 
transcription factors, similar to what has been described in Plasmodium (Gomes-Santos et 
al., 2011).  Verification of transcripts recruited into germ-like granules could be 
accomplished by a fluorescent in situ hybridization approach. 
Since transcripts require specific cis-acting elements for sustained translational 
repression in bradyzoites, translational repressor proteins that bind specific sequences are 
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also likely to be included in germ-like granules.  Examples in Toxoplasma likely include 
PUF1 and ALBA proteins, all of which show granular distribution in bradyzoites (Liu et 
al., 2014, Gissot et al., 2013).  Again this echoes findings in Plasmodium and metazoans 
(Mair et al., 2010; Voronina et al., 2007).  These proteins would be responsible for the 
sustained translational repression of specific transcripts through the use of cis-acting 
elements.  For example, in vitro assays show that Toxoplasma PUF1 binds the consensus 
PUF binding element from repressed Plasmodium transcripts (Liu et al., 2014).  This 
consensus bears a striking resemblance to the unpaired nucleotides within the small 
regulatory hairpin in the LDH1 5’UTR (Holmes et al., 2014) and the verification of this 
interaction through in vitro binding assays and in vivo functional assays is an obvious 
progression of this work. 
The final component of germ-like granules in bradyzoites would be proteins involved 
in the storage and maintenance of transcripts.  Potential examples include the DEAD-box 
helicase homolog of Plasmodium DOZI and PABP.  In Toxoplasma, this helicase displays 
granular distribution in bradyzoites and is capable of rescuing a temperature sensitive yeast 
DHH1 mutant indicating that it likely fulfills the same function in stress response (Cherry 
and Ananvoranich, unpublished results; Cherry and Ananvoranich, 2014).  Furthermore, 
DOZI has been shown to be essential to the maintenance of germ-like granules in 
Plasmodium (Mair et al., 2006).  In contrast to metazoans, translationally repressed 
transcripts in Toxoplasma and Plasmodium maintain long poly(A) tails (Godwin et al., 
2013; Figure 4.4; Braks et al., 2008), indicating that PABP is likely a major component of 
mature germ-like granules.  PABP has indeed been found as a major component of DOZI-
associated granules in Plasmodium and other potential protein candidates contained within 
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bradyzoite germ-like granules likely mirror those found within similar granules in 
Plasmodium (Mair et al., 2010).  Future studies, which could be facilitated with the novel 
application of CRISPR/Cas9 technology to Toxoplasma (Shen et al., 2014; Sidik et al., 
2014), could be directed towards their localization and stress-related functions. 
 Conclusions and Significance 
This work has focused on two areas, the first of which is the discovery of anti-
Toxoplasma compounds.  The serendipitous finding that securinine is an inducer of 
bradyzoite conversion may signal that it has applications in future studies regarding stress-
response and differentiation.  Furthermore, since it is a biologically active molecule that 
has been successfully used in animals and humans, it may be possible to use securinine, or 
a derivative thereof as a medicinal tool for treating or preventing recurrent toxoplasmosis.  
Notably, this work the first and only to show that securinine can induce cellular 
differentiation outside of metazoans. 
The second area of research focuses on outlining the features of transcript-specific 
translational repression in bradyzoites.  These studies show that transcripts are selected for 
long-term sustained translational repression through the use of cis-acting elements.  This 
suggests the involvement of a yet to be identified trans-acting factor that specifically 
recognizes the transcript.  This work is the first to functionally characterize a cis-acting 
element involved in post-transcriptional regulation in Toxoplasma. 
This work also shows that differences exist between metazoan and apicomplexan 
sustained translational repression, namely through maintenance of the poly(A) tail.  Finally, 
the observation that transcripts undergo a tight translational repression after initial stressful 
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insult that is later not as strict in mature bradyzoites suggests that the mechanisms 
regulating translational control change throughout bradyzoite development.  
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APPENDICES 
Appendix A. List of oligonucleotides used in Chapter 3 
Primer combinations used to create each construct are listed.  Inserted restriction sites 
are underlined.  Red nucleotides represent mutated or inserted nucleotides. 
Template 
name Product NAME SEQUENCE 
Full length flank 
gDNA p5L1, p53L1 KpnI_ups-600LDH1 
cccggtaCCTGCTGTGCGAATG
TGTC 
  HindIII_dws-600LDH1 
aagcTTGCTGACTAAAAATGA
GC 
gDNA p3L1, p53L1 PACI_3UTRups780LDH1 
cccttaattaaGCGTTGGCAAAAC
AGG 
  BamHI_3UTPdws780LDH1 
aaaggatCCTCTATGTATCATGG
GCC 
 Deletions   
pT5L1 pT5L1Δ2-24 ss_del25_06_5UTRL1 
GCTTCGATTTCCAAACGCGA
TTTATTC 
  as_del25_06_5UTRL1 
GCTGGGAACGCGAATTCAA
GAAAAAATG 
pT5L1 pT5L1Δ26-65 ss_del20_04_5UTRL1 
GCTAGACTAACCGGTGCACT
TTTGCAC 
  as_del20_05_5UTRL1 
GCTAAATCAAAAAAATCTG
GTCGAGTGTG 
pT5L1 pT5L1Δ47-65 ss_del20_04_5UTRL1 
GCTAGACTAACCGGTGCACT
TTTGCAC 
  
as_del40_C_5UTRL1=as_del2
0_04_5UTRL1 
GCTAAATCGCGTTTGGAAAT
CGAAAATC 
pT5L1 pT5L1Δ66-105 
ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1 
GCTTTCGCAGACAACATCTG
GCAGCCTcc 
  as_del40_B_5UTRL1 
GCTACAAGGCGGATTGGAA
TAAATCG 
pT5L1 pT5L1Δ86-105 
ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1 
GCTTTCGCAGACAACATCTG
GCAGCCTcc 
  as_del20_02_5UTRL1 
GCTAAAAGTGCACCGGTTA
GTCTGCTA 
pT5L1 pT5L1Δ106-132 ss_del27-5URL1 
GCT CAT TTT TAG TCA GCA 
AGC TTA ATT C 
    as_del27_5UTRL1 
GCTGTCTTGCGTACACGTGC
AAAAGTGC 
Keep Series 
pT5L1 pT5L1:K106-151 
ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1 
GCTTTCGCAGACAACATCTG
GCAGCCTcc 
  as_del25_06_5UTRL1 
GCTGGGAACGCGAATTCAA
GAAAAAATG 
step1: 
pT5L1 pT5L1:K45-85 ss_del27-5URL1 gctcatttttagtcagcaagcttaattc 
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  as_del20_02_5UTRL1 
GCTAAAAGTGCACCGGTTA
GTCTGCTA 
step2: 
pT5L1Δ8
6-132  
ss_del40_C_5UTRL1=ss_del2
0_05_5UTRL1 
GCTATTCCAATCCGCCTTGT
AGCAGACTA 
    as_del25_06_5UTRL1 
GCTGGGAACGCGAATTCAA
GAAAAAATG 
GRA plasmids 
PLKΔHX 
pGRA:CTRL,pG
RA:K45-85 gra1_upstrm_fw 
aaaGGTACCaaaacctcgaggctgctag
t 
    gra1_upstrm_rv aaaGAATTCcttgcttgatttcttcaaag 
K45-85 mutations 
pT5L1 pT5L1:Hp1D MH_Fw_KB_P2dis 
CGAGCTCTAACCGGTGCACT
TTTAGC 
  MH_Rv_KB_P2same 
ATCAAGGCGGATTGGAATA
G 
pT5L1 pT5L1:Hp1R MH_Fw_KB_P2dis 
CGAGCTCTAACCGGTGCACT
TTTAGC 
  MH_Rv_KB_P2res 
TACAAGCGGGCATGCAATA
GCGCT 
pT5L1 pT5L1:Hp1R-UA MH_Fw_KB_P2dis 
CGAGCTCTAACCGGTGCACT
TTTAGC 
  Rb_KB_P2res_Uabp 
TACAAGCGAGCATGCAATA
GCGCTGGGAA 
pT5L1 pT5L1:Hp2D MH_Fw_KB_P3same 
ACTTTTAGCGCTCATTTTTA
G 
  MH_Rv_KB_P3dis 
CCAGCTGTTAGTCTGCTACA
AGGC 
pT5L1 pT5L1:Hp2R MH_Fw_KB_P3res 
ACTTTTACCGGTACCTTTTT
AG 
    MH_Rv_KB_P3dis 
CCAGCTGTTAGTCTGCTACA
AGGC 
qRT-PCR  
RNA (RT 
reaction) cDNA 25T_oligo 
TTTTTTTTTTTTTTTTTTTTTT
TTT 
cDNA ldh1 LDH1_sense ATGGCACCCGCACTTGT 
  LDH1_RTPCR_RV2 
AGGTCACATGGCTCAGGTCA
A 
cDNA gfp qPCR_GFP_FW CAAGACCCGCCACAACATC 
  qPCR_GFP_RV 
CTCTTTTCGTTGGGATCTTTC
G 
cDNA bag1 qPCR_BAG_FW 
AGGCTGAGTCACGACAAAA
ATG 
  qPCR_BAG_RV 
GCCGTCTCGAACAACATATC
G 
cDNA gapdh qPCR_GAPDH_Fw GGTGTTCCGTGCTGCGAT 
   qPCR_GAPDH_Rv GCCTTTCCGCCGACAAT 
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Appendix B. List of oligonucletodies used in Chapter 4 
Primer combinations used to create each construct are listed.  Inserted restriction sites 
are underlined.  Red nucleotides represent aptamer / ribozyme sequences. 
Template name Product NAME SEQUENCE 
Aptamer constructs 
p53L1 p53L1-S1 
PacI_3UTRups
780LDH1 cccttaattaaGCGTTGGCAAAACAGG 
  
S1_stop_GFP_
MH 
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat 
pT3L1 pT3L1-S1 
PacI_3UTRups
780LDH1 cccttaattaaGCGTTGGCAAAACAGG 
  
S1_stop_GFP_
MH 
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat 
pT5L1-S1 
pT5L1-S1-
HDVΔG58 
3enddRz3SAG
_Sense 
catgcttcggcatgcgaatgggac tta att aat cac cgt 
tgt gc 
  
5enddRz-
S1aptAntisense 
TTGCCCACTAGCCGCCAGCGAGGAG
GCTGGGACCATGGCTAGC gat atc ccg 
gcc cgc gac ta 
pT5L1-S1 
pCTRL-S1-
HDVΔG58 
3enddRz3SAG
_Sense 
catgcttcggcatgcgaatgggac tta att aat cac cgt 
tgt gc 
  
5enddRz-
S1aptAntisense 
TTGCCCACTAGCCGCCAGCGAGGAG
GCTGGGACCATGGCTAGC gat atc ccg 
gcc cgc gac ta 
pT5L1-S1-
HDVΔG58 pT5L1-S1-HDV 
Fw_delPacI-
3SAG TTAAgTAATCACCGTTGTGC 
  HDV rv repair gtcccattcgCcatgccgaag 
pT5L1-S1-
HDVΔG58 
pCTRL-S1-
HDV 
Fw_delPacI-
3SAG TTAAgTAATCACCGTTGTGC 
  HDV rv repair gtcccattcgCcatgccgaag 
pT5L1 pT5L1-MS2 
MS2-SAG1 
3’UTR sense 
AGA CAGACACCATCAGGGTCTG 
TTA ATT AAT CAC CGT TGT GC 
  
MS2-GFP 
antisense 
AGA CGTACCCTGATGGTGTACG TTA 
AGC ACC ATC TGC AGC TT  
pCTRL pCTRL-MS2 
MS2-SAG1 
3’UTR sense 
AGA CAGACACCATCAGGGTCTG 
TTA ATT AAT CAC CGT TGT GC 
    
MS2-GFP 
antisense 
AGA CGTACCCTGATGGTGTACG TTA 
AGC ACC ATC TGC AGC TT  
CP-GFP-SBP bacterial expression construct 
pUG-MS2CP-
GFP-SBP 
CP-GFP-SBP 
fragment BspHI_CP_Fw ccc tca tga atg ctt cta act tta ctc agt 
    XhoI_SBP_Rv ggg ctc gag tgg ttc tct ctg tcc ttg ag 
Dual luciferase assay construct 
pTubRN_NoB RN fragment 
PstI_Rncds_F
w 
AAA CTG CAG ATG GCT TCC AAG 
GTG TAC GA 
    
PStI_Rncds_R
v 
AAA CTG CAG TTA CTG CTC GTT 
CTT CAG CA 
In vitro transcription fragments 
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pT5L1-S1 
T7-5L1-GFP-
S1-3SAG1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
  3UTRSAG1 
GGATCCCCCTCGGGGGGGCAAGAAT
TG 
pT5L1-S1 T7-5L1-GFP-S1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
  
S1_stop_GFP_
MH 
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat 
pT5L1-S1-
HDVΔG58 
T7-5L1-GFP-
S1-HDVΔG58-
3SAG1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
  3UTRSAG1 
GGATCCCCCTCGGGGGGGCAAGAAT
TG 
pT5L1-S1-HDV 
T7-5L1-GFP-
S1-HDV-
3SAG1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
  3UTRSAG1 
GGATCCCCCTCGGGGGGGCAAGAAT
TG 
pT5L1 
T7-5L1-GFP-
3SAG1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
  3UTRSAG1 
GGATCCCCCTCGGGGGGGCAAGAAT
TG 
pT5L1-MS2 
T7-5L1-GFP-
MS2-SAG1 
MH_T7LDH1
5UTR 
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT 
    3UTRSAG1 
GGATCCCCCTCGGGGGGGCAAGAAT
TG 
RT-PCR 
T7-5L1-GFP-S1 / 
T7-5L1-GFP-S1-
3SAG1 GFP cDNA 3GFP1940 GCCATGTGTAATCCCAGC 
GFP cDNA GFP fragment 5GFPMYC ATGCAGGAGCAGAAGCTC 
    3GFP1491 GTCGTGCCGCTTCATATG 
Northern probe 
pT5L1 DIG-GFP probe 5GFP1667 GAATACAACTACAACTCC 
    3GFP1940 GCCATGTGTAATCCCAGC 
PAT assay 
RNA cDNA PAT_Rv 
GTG TGT GTG TGT GTC TCT TTT TTT 
TTT T 
cDNA 
LDH1-
poly(A)_tail 
LDH1_PAT_F
w TTG TCC ACT GTC ATG TCG AAA AC 
  PAT_Rv 
GTG TGT GTG TGT GTC TCT TTT TTT 
TTT T 
cDNA 
GRA1-
poly(A)_tail 
GRA1_PAT_F
w GGT GGT TGT TGC TCA GTT CAA TT 
    PAT_Rv 
GTG TGT GTG TGT GTC TCT TTT TTT 
TTT T 
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